Gene	Gene synonym	Ensembl	Gene description	Uniprot	Chromosome	Position	Protein class	Biological process	Molecular function	Disease involvement	Evidence	HPA evidence	UniProt evidence	NeXtProt evidence	RNA tissue specificity	RNA tissue distribution	RNA tissue specificity score	RNA tissue specific nTPM	RNA single cell type specificity	RNA single cell type distribution	RNA single cell type specificity score	RNA single cell type specific nTPM	RNA cancer specificity	RNA cancer distribution	RNA cancer specificity score	RNA cancer specific FPKM	RNA brain regional specificity	RNA brain regional distribution	RNA brain regional specificity score	RNA brain regional specific nTPM	RNA blood cell specificity	RNA blood cell distribution	RNA blood cell specificity score	RNA blood cell specific nTPM	RNA blood lineage specificity	RNA blood lineage distribution	RNA blood lineage specificity score	RNA blood lineage specific nTPM	RNA cell line specificity	RNA cell line distribution	RNA cell line specificity score	RNA cell line specific nTPM	RNA tissue cell type enrichment	RNA mouse brain regional specificity	RNA mouse brain regional distribution	RNA mouse brain regional specificity score	RNA mouse brain regional specific nTPM	RNA pig brain regional specificity	RNA pig brain regional distribution	RNA pig brain regional specificity score	RNA pig brain regional specific nTPM	Antibody	Reliability (IH)	Reliability (Mouse Brain)	Reliability (IF)	Subcellular location	Secretome location	CCD Protein	CCD Transcript	Blood concentration - Conc. blood IM [pg/L]	Blood concentration - Conc. blood MS [pg/L]	Blood expression cluster	Tissue expression cluster	Cell line expression cluster	Single cell expression cluster	Subcellular main location	Subcellular additional location	Antibody RRID	Pathology prognostics - Breast cancer	Pathology prognostics - Cervical cancer	Pathology prognostics - Colorectal cancer	Pathology prognostics - Endometrial cancer	Pathology prognostics - Glioma	Pathology prognostics - Head and neck cancer	Pathology prognostics - Liver cancer	Pathology prognostics - Lung cancer	Pathology prognostics - Melanoma	Pathology prognostics - Ovarian cancer	Pathology prognostics - Pancreatic cancer	Pathology prognostics - Prostate cancer	Pathology prognostics - Renal cancer	Pathology prognostics - Stomach cancer	Pathology prognostics - Testis cancer	Pathology prognostics - Thyroid cancer	Pathology prognostics - Urothelial cancer	RNAsingleCellTypeSpecific
PON1	ESA, PON	ENSG00000005421	Paraoxonase 1	P27169	7	95297676-95324532	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters		Hydrolase	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	103	liver: 531.8	Cell type enriched	Detected in some	10	Hepatocytes: 433.7	Cancer enriched	Detected in some	78	liver cancer: 97.8	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in some		liver cancer: 1.0;prostate cancer: 2.7	Liver - Hepatocytes	Not detected	Not detected			Low region specificity	Detected in all			HPA001610	Approved				Secreted to blood			96000000000	17000000000		Cluster 62: Liver - Hemostasis	Cluster 41: Non-specific - Cilium assembly	Cluster 13: Hepatocytes - Oxidoreductase activity			HPA001610: AB_1079656	unprognostic (2.02e-2)	unprognostic (2.41e-2)	unprognostic (3.04e-1)	unprognostic (3.54e-2)	unprognostic (2.70e-1)		prognostic favorable (7.24e-7)	unprognostic (2.24e-1)	unprognostic (1.95e-1)	unprognostic (9.02e-3)	unprognostic (1.76e-3)	unprognostic (3.97e-2)	unprognostic (6.74e-9)	unprognostic (1.09e-3)	unprognostic (2.29e-2)	unprognostic (2.07e-1)	unprognostic (5.54e-3)	Hepatocytes
ABCB4	GBD1, MDR2, MDR3, PFIC-3, PGY3	ENSG00000005471	ATP binding cassette subfamily B member 4	P21439	7	87401696-87480435	Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters	Lipid transport, Transport	Translocase	Disease variant, Intrahepatic cholestasis	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	16	liver: 123.2	Cell type enriched	Detected in some	10	Hepatocytes: 204.6	Cancer enriched	Detected in some	11	liver cancer: 16.3	Low region specificity	Detected in single			Group enriched	Detected in some	5	memory B-cell: 4.4;naive B-cell: 8.1	Lineage enriched	Detected in many	7	B-cells: 8.1	Cancer enhanced	Detected in some		skin cancer: 9.2	Colon - Enteric glia cells, Heart muscle - Cardiomyocytes, Skeletal muscle - Skeletal myocytes, Skin - Fibroblast_1	Low region specificity	Detected in many							HPA049395, HPA053288	Enhanced		Approved	Nucleoplasm,Plasma membrane,Focal adhesion sites,Cytosol						Cluster 21: B-cells - Adaptive immune response	Cluster 62: Liver - Hemostasis	Cluster 33: Skin cancer - Membrane components	Cluster 13: Hepatocytes - Oxidoreductase activity	Nucleoplasm, Plasma membrane	Focal adhesion sites, Cytosol	HPA049395: AB_2680745, HPA053288: AB_2682102	unprognostic (7.92e-2)	unprognostic (8.87e-2)	unprognostic (1.97e-1)	unprognostic (1.90e-1)	unprognostic (8.95e-2)	unprognostic (1.06e-2)	unprognostic (2.35e-3)	unprognostic (9.91e-2)	unprognostic (3.53e-1)	unprognostic (1.19e-1)	unprognostic (2.44e-3)	unprognostic (8.43e-2)	unprognostic (2.83e-2)	unprognostic (8.01e-3)	unprognostic (7.12e-2)	unprognostic (2.11e-2)	unprognostic (2.47e-1)	Hepatocytes
FMO3	FMOII	ENSG00000007933	Flavin containing dimethylaniline monoxygenase 3	P31513	1	171090901-171117819	Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins		Monooxygenase, Oxidoreductase	Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	41	liver: 1123.3	Cell type enriched	Detected in some	31	Hepatocytes: 411.6	Cancer enriched	Detected in many	13	liver cancer: 94.9	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in some		liver cancer: 3.5	Colon - Endothelial cells, Liver - Hepatocytes, Lung - Fibroblast_1	Not detected	Not detected			Not detected	Not detected			HPA013750	Enhanced										Cluster 62: Liver - Hemostasis	Cluster 59: Fibroblasts - Metabolism	Cluster 13: Hepatocytes - Oxidoreductase activity			HPA013750: AB_1848968	unprognostic (1.87e-2)	unprognostic (6.30e-2)	unprognostic (1.00e-1)	unprognostic (6.81e-3)	unprognostic (2.64e-1)	unprognostic (1.31e-3)	prognostic favorable (3.46e-4)	prognostic favorable (5.60e-5)	unprognostic (2.95e-1)	unprognostic (9.34e-2)	unprognostic (3.02e-1)	unprognostic (7.21e-2)	prognostic unfavorable (1.13e-4)	unprognostic (1.84e-1)	unprognostic (2.59e-1)	unprognostic (3.45e-1)	unprognostic (7.27e-2)	Hepatocytes
MASP2	MASP1P1	ENSG00000009724	Mannan binding lectin serine peptidase 2	O00187	1	11026523-11047239	Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins	Complement pathway, Immunity, Innate immunity	Hydrolase, Protease, Serine protease	Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	64	liver: 476.5	Cell type enriched	Detected in some	40	Hepatocytes: 641.9	Cancer enriched	Detected in some	71	liver cancer: 41.9	Region enriched	Detected in single	9	cerebellum: 6.4	Not detected in immune cells	Not detected			Not detected	Not detected			Low cancer specificity	Detected in many			Liver - Hepatocytes	Not detected	Not detected			Low region specificity	Detected in all			HPA029313, HPA029314	Uncertain		Supported	Golgi apparatus	Secreted to blood			340000000	820000000		Cluster 62: Liver - Hemostasis	Cluster 35: Liver cancer - Metabolism	Cluster 13: Hepatocytes - Oxidoreductase activity	Golgi apparatus		HPA029313: AB_10669654, HPA029314: AB_10670029	unprognostic (7.00e-2)	unprognostic (8.37e-2)	unprognostic (2.75e-2)	unprognostic (2.89e-1)	unprognostic (1.86e-1)	unprognostic (3.26e-3)	prognostic favorable (1.60e-4)	unprognostic (2.92e-3)	unprognostic (3.13e-2)	unprognostic (4.04e-2)	unprognostic (6.90e-3)	unprognostic (8.30e-4)	unprognostic (7.14e-2)	unprognostic (3.91e-1)	unprognostic (2.62e-2)	unprognostic (1.05e-1)	unprognostic (1.09e-4)	Hepatocytes
NPC1L1	SLC65A2	ENSG00000015520	NPC1 like intracellular cholesterol transporter 1	Q9UHC9	7	44512535-44541330	FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters	Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transport		FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	9	intestine: 54.2;liver: 48.1	Cell type enriched	Detected in some	4	Hepatocytes: 33.9	Group enriched	Detected in many	5	liver cancer: 8.5;pancreatic cancer: 7.8;stomach cancer: 4.8	Low region specificity	Detected in single			Not detected in immune cells	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	Gastric cancer: 9.0;liver cancer: 7.8	Kidney - Proximal tubular cells, Testis - Late spermatids	Not detected	Not detected			Low region specificity	Detected in many			CAB070127, CAB070128	Enhanced										Cluster 41: Intestine & Liver - Lipid metabolism	Cluster 19: Stomach & Colon cancer - Absorption	Cluster 29: Hepatocytes - Metabolism			CAB070127: AB_10002744, CAB070128: AB_10000815	unprognostic (2.96e-2)	unprognostic (2.23e-1)	unprognostic (7.57e-3)	unprognostic (8.43e-2)	unprognostic (1.62e-1)	unprognostic (2.07e-1)	unprognostic (9.40e-2)	unprognostic (6.75e-2)	unprognostic (1.44e-1)	unprognostic (1.96e-2)	unprognostic (4.51e-2)	unprognostic (7.59e-2)	unprognostic (8.08e-10)	unprognostic (1.64e-2)	unprognostic (2.83e-1)	unprognostic (3.62e-2)	unprognostic (5.83e-2)	Hepatocytes
CPS1		ENSG00000021826	Carbamoyl-phosphate synthase 1	P31327	2	210477682-210679107	Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins	Urea cycle	Allosteric enzyme, Ligase	Disease variant, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	5	liver: 1063.2	Cell type enriched	Detected in many	16	Hepatocytes: 1781.9	Cancer enriched	Detected in many	8	liver cancer: 136.1	Low region specificity	Detected in many			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in many		cervical cancer: 126.2	Testis - Early spermatids, Testis - Late spermatids	Not detected	Not detected			Not detected	Not detected			CAB003781, HPA021400	Enhanced		Supported	Nucleoli,Nucleoli rim					8300000		Cluster 85: Liver - Metabolism	Cluster 40: Non-specific - Enzymes	Cluster 13: Hepatocytes - Oxidoreductase activity	Nucleoli, Nucleoli rim		CAB003781: , HPA021400: AB_1847197	unprognostic (1.67e-2)	unprognostic (3.72e-2)	unprognostic (4.02e-2)	unprognostic (7.21e-7)	unprognostic (3.81e-2)	unprognostic (2.52e-1)	prognostic favorable (6.93e-5)	unprognostic (1.23e-2)	unprognostic (2.65e-1)	unprognostic (1.35e-2)	unprognostic (5.38e-2)	unprognostic (1.94e-3)	unprognostic (2.38e-4)	unprognostic (5.90e-2)	unprognostic (1.13e-1)	unprognostic (3.14e-2)	unprognostic (3.74e-2)	Hepatocytes
C8B		ENSG00000021852	Complement C8 beta chain	P07358	1	56929207-56966140	Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	156	liver: 840.0	Cell type enriched	Detected in some	8	Hepatocytes: 250.0	Cancer enriched	Detected in some	181	liver cancer: 107.0	Not detected	Not detected			Immune cell enriched	Detected in single	22	basophil: 2.1	Lineage enriched	Detected in single	22	granulocytes: 2.1	Cancer enriched	Detected in single	14	liver cancer: 1.3	Liver - Hepatocytes, Testis - Late spermatids	Not detected	Not detected			Low region specificity	Detected in many			HPA023694	Supported				Secreted to blood				6700000000	Cluster 41: Basophils - Cellular respiration	Cluster 60: Liver - Hemostasis & Lipid metabolism	Cluster 35: Liver cancer - Metabolism	Cluster 29: Hepatocytes - Metabolism			HPA023694: AB_1847128				unprognostic (6.65e-2)			prognostic favorable (9.31e-5)	unprognostic (2.37e-1)			unprognostic (2.37e-1)			unprognostic (1.29e-2)	unprognostic (6.57e-2)	unprognostic (5.12e-3)		Hepatocytes
ABCC2	CMOAT, cMRP, DJS, MRP2	ENSG00000023839	ATP binding cassette subfamily C member 2	Q92887	10	99782640-99852594	Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters	Lipid transport, Transport	Translocase	Cancer-related genes, Disease variant, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		intestine: 40.2;liver: 121.7	Cell type enriched	Detected in many	6	Hepatocytes: 215.9	Cancer enriched	Detected in many	5	liver cancer: 24.0	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in many		liver cancer: 68.9;Rhabdoid: 77.1	Kidney - Proximal tubular cells, Testis - Early spermatids	Not detected	Not detected			Low region specificity	Detected in many			HPA071145	Enhanced										Cluster 41: Intestine & Liver - Lipid metabolism	Cluster 61: Liver - Metabolism	Cluster 13: Hepatocytes - Oxidoreductase activity			HPA071145: 	unprognostic (1.49e-3)	unprognostic (5.92e-2)	unprognostic (1.59e-1)	unprognostic (3.67e-1)	unprognostic (1.93e-2)	unprognostic (2.33e-1)	unprognostic (2.51e-1)	unprognostic (7.15e-3)	unprognostic (5.68e-2)	unprognostic (2.01e-1)	unprognostic (4.30e-1)	unprognostic (1.40e-3)	prognostic unfavorable (1.93e-5)	unprognostic (1.31e-1)	unprognostic (3.22e-2)	unprognostic (2.95e-1)	unprognostic (1.26e-2)	Hepatocytes
HSD17B6	HSE, RODH, SDR9C6	ENSG00000025423	Hydroxysteroid 17-beta dehydrogenase 6	O14756	12	56752161-56787790	Enzymes, Metabolic proteins, Predicted intracellular proteins	Lipid metabolism, Steroid metabolism	Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	26	liver: 1804.3	Cell type enriched	Detected in many	7	Hepatocytes: 1769.5	Cancer enriched	Detected in many	5	liver cancer: 170.3	Low region specificity	Detected in all			Low immune cell specificity	Detected in some			Low lineage specificity	Detected in single			Low cancer specificity	Detected in many			Adipose subcutaneous - Smooth muscle cells, Adipose visceral - Mesothelial cells, Kidney - Fibroblasts, Liver - Hepatocytes, Liver - Hepatocytes, Skin - Smooth muscle cells	Not detected	Not detected			Low region specificity	Detected in all			HPA059141	Enhanced		Approved	Nucleoplasm,Vesicles						Cluster 32: T-cells - Unknown function	Cluster 62: Liver - Hemostasis	Cluster 41: Non-specific - Cilium assembly	Cluster 13: Hepatocytes - Oxidoreductase activity	Nucleoplasm, Vesicles		HPA059141: AB_2683922	unprognostic (7.70e-2)	unprognostic (8.76e-2)	unprognostic (5.08e-2)	unprognostic (1.92e-2)	unprognostic (2.01e-1)	unprognostic (3.79e-2)	prognostic favorable (6.32e-4)	unprognostic (1.06e-2)	unprognostic (3.21e-1)	unprognostic (1.44e-1)	unprognostic (1.35e-1)	unprognostic (6.74e-2)	unprognostic (2.50e-10)	unprognostic (1.26e-1)	unprognostic (1.79e-1)	unprognostic (1.08e-1)	unprognostic (1.05e-1)	Hepatocytes
ITIH1	H1P, IATIH, ITIH	ENSG00000055957	Inter-alpha-trypsin inhibitor heavy chain 1	P19827	3	52777595-52792068	Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins		Protease inhibitor, Serine protease inhibitor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	782	liver: 1504.9	Cell type enriched	Detected in some	18	Hepatocytes: 803.2	Cancer enriched	Detected in some	598	liver cancer: 329.1	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Adipose subcutaneous - Smooth muscle cells, Adipose visceral - Smooth muscle cells, Liver - Hepatocytes	Not detected	Not detected			Not detected	Not detected			HPA041639, HPA042049	Approved		Approved	Vesicles	Secreted to blood			4490000	59000000000	Cluster 25: Monocytes - Inflammatory response	Cluster 62: Liver - Hemostasis	Cluster 35: Liver cancer - Metabolism	Cluster 29: Hepatocytes - Metabolism	Vesicles		HPA041639: AB_10796349, HPA042049: AB_10797379	unprognostic (1.87e-4)	unprognostic (1.31e-3)	unprognostic (2.38e-1)	unprognostic (8.55e-2)	unprognostic (1.03e-1)	unprognostic (2.64e-3)	prognostic favorable (1.89e-5)	unprognostic (2.27e-2)	unprognostic (1.70e-1)	unprognostic (1.30e-1)	unprognostic (2.91e-2)	unprognostic (8.45e-2)	unprognostic (4.53e-4)	unprognostic (4.02e-3)	unprognostic (5.70e-3)	unprognostic (2.08e-1)	unprognostic (2.24e-2)	Hepatocytes
F7		ENSG00000057593	Coagulation factor VII	P08709	13	113105788-113120685	Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins	Blood coagulation, Hemostasis	Hydrolase, Protease, Serine protease	Disease variant, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	102	liver: 160.2	Cell type enriched	Detected in some	5	Hepatocytes: 120.7	Cancer enriched	Detected in some	17	liver cancer: 41.4	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	breast cancer: 4.0;liver cancer: 8.8	Liver - Hepatocytes	Not detected	Not detected			Not detected	Not detected			HPA004826			Approved	Mitochondria	Secreted to blood			351000000	1300000000		Cluster 62: Liver - Hemostasis	Cluster 35: Liver cancer - Metabolism	Cluster 29: Hepatocytes - Metabolism	Mitochondria		HPA004826: AB_10602805	unprognostic (2.06e-1)	unprognostic (2.55e-1)	unprognostic (1.03e-1)	unprognostic (1.34e-1)	unprognostic (3.27e-1)	unprognostic (1.91e-1)	unprognostic (1.50e-3)	unprognostic (3.81e-1)	unprognostic (4.36e-3)	unprognostic (1.16e-1)	unprognostic (4.19e-3)	unprognostic (1.15e-1)	unprognostic (1.35e-3)	unprognostic (3.36e-3)	unprognostic (1.09e-1)	unprognostic (2.86e-1)	unprognostic (1.47e-1)	Hepatocytes
NTHL1	NTH1, OCTS3	ENSG00000065057	Nth like DNA glycosylase 1	P78549	16	2039815-2047866	Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins	DNA damage, DNA repair	Glycosidase, Hydrolase, Lyase	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in all	13	Hepatocytes: 911.2	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low immune cell specificity	Detected in many			Low lineage specificity	Detected in all			Low cancer specificity	Detected in all			Liver - Hepatocytes, Thyroid - Fibroblasts	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB025152	Supported									Cluster 12: Non-specific - Basic cellular processes	Cluster 35: Non-specific - Unknown function	Cluster 17: RS4;11 - Unknown function	Cluster 13: Hepatocytes - Oxidoreductase activity			CAB025152: 	unprognostic (1.06e-1)	unprognostic (9.71e-2)	unprognostic (1.23e-1)	unprognostic (2.54e-1)	unprognostic (7.89e-2)	unprognostic (1.77e-1)	unprognostic (2.86e-1)	unprognostic (2.46e-2)	unprognostic (4.98e-2)	unprognostic (1.11e-1)	unprognostic (2.77e-2)	unprognostic (6.78e-2)	unprognostic (6.53e-2)	unprognostic (2.27e-1)	unprognostic (1.34e-1)	unprognostic (5.08e-2)	unprognostic (1.62e-2)	Hepatocytes
SPP2	SPP24	ENSG00000072080	Secreted phosphoprotein 2	Q13103	2	234050679-234077134	Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	4373	liver: 519.1	Cell type enriched	Detected in some	24	Hepatocytes: 249.6	Cancer enriched	Detected in some	112	liver cancer: 65.3	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Liver - Hepatocytes	Low region specificity	Detected in some			Low region specificity	Detected in all								Secreted to blood				480000000		Cluster 60: Liver - Hemostasis & Lipid metabolism	Cluster 22: Rhabdoid cancers - Neuronal signaling	Cluster 13: Hepatocytes - Oxidoreductase activity										prognostic favorable (2.33e-6)	unprognostic (7.02e-3)		unprognostic (9.62e-3)								Hepatocytes
AFM	ALB2, ALBA	ENSG00000079557	Afamin	P43652	4	73481745-73504001	Plasma proteins, Predicted secreted proteins	Protein transport, Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	12	liver: 961.6	Cell type enriched	Detected in some	8	Hepatocytes: 297.6	Cancer enriched	Detected in single	167	liver cancer: 62.0	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Kidney - Proximal tubular cells, Liver - Hepatocytes	Not detected	Not detected			Not detected	Not detected			HPA017006, HPA052437	Enhanced		Uncertain	Plasma membrane	Secreted to blood			54900000000	8700000000		Cluster 85: Liver - Metabolism	Cluster 41: Non-specific - Cilium assembly	Cluster 13: Hepatocytes - Oxidoreductase activity	Plasma membrane		HPA017006: AB_1844635, HPA052437: AB_2732575							prognostic favorable (1.80e-4)				unprognostic (5.73e-2)		unprognostic (4.24e-2)					Hepatocytes
CPB2	CPU, PCPB, TAFI	ENSG00000080618	Carboxypeptidase B2	Q96IY4	13	46053186-46105033	Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins	Blood coagulation, Fibrinolysis, Hemostasis	Carboxypeptidase, Hydrolase, Metalloprotease, Protease	FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	84	liver: 1484.1	Cell type enriched	Detected in some	5	Hepatocytes: 1241.5	Cancer enriched	Detected in some	112	liver cancer: 268.4	Low region specificity	Detected in many			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in some	6	liver cancer: 12.3	Liver - Hepatocytes, Lung - Alveolar cells type 2	Not detected	Not detected			Not detected	Not detected			HPA004146	Approved				Secreted to blood				8500000000		Cluster 60: Liver - Hemostasis & Lipid metabolism	Cluster 35: Liver cancer - Metabolism	Cluster 13: Hepatocytes - Oxidoreductase activity			HPA004146: AB_1078397	unprognostic (3.44e-2)	unprognostic (1.25e-1)	unprognostic (2.94e-2)	unprognostic (1.89e-2)	unprognostic (7.69e-2)	unprognostic (1.17e-2)	prognostic favorable (2.06e-4)	unprognostic (1.89e-1)	unprognostic (2.74e-1)	unprognostic (2.48e-1)	unprognostic (3.17e-2)	unprognostic (4.83e-2)	unprognostic (3.20e-3)	unprognostic (1.34e-1)	unprognostic (7.10e-2)	unprognostic (3.34e-2)	unprognostic (9.61e-2)	Hepatocytes
CFHR2	CFHL2, FHR2, HFL3	ENSG00000080910	Complement factor H related 2	P36980	1	196943738-196959622	Plasma proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	2752	liver: 1311.8	Cell type enriched	Detected in some	19	Hepatocytes: 1242.3	Cancer enriched	Detected in single	175	liver cancer: 8.7	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Liver - Hepatocytes									HPA038915, HPA040726, HPA049813	Supported				Secreted to blood				4800000000	Cluster 6: Non-specific - Transcription	Cluster 60: Liver - Hemostasis & Lipid metabolism	Cluster 61: Liver - Metabolism	Cluster 13: Hepatocytes - Oxidoreductase activity			HPA038915: AB_2676269, HPA040726: AB_2677101, HPA049813: AB_2680895							unprognostic (1.25e-2)											Hepatocytes
HAL	HIS	ENSG00000084110	Histidine ammonia-lyase	P42357	12	95972662-95996365	Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins	Histidine metabolism	Lyase	Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	11	liver: 198.2;skin 1: 61.1	Cell type enriched	Detected in some	5	Hepatocytes: 98.9	Cancer enriched	Detected in some	11	liver cancer: 23.7	Not detected	Not detected			Group enriched	Detected in many	4	basophil: 56.9;neutrophil: 73.3	Lineage enriched	Detected in many	5	granulocytes: 73.3	Cancer enhanced	Detected in some		Leukemia: 6.4;liver cancer: 3.5	Adipose visceral - Neutrophils, Heart muscle - Neutrophils, Lung - Neutrophil_2, Skeletal muscle - Neutrophils, Skin - Keratinocyte (granular), Stomach - Neutrophils	Not detected	Not detected			Low region specificity	Detected in many			HPA038547, HPA038548	Enhanced		Approved	Cytosol					280000	Cluster 9: Neutrophils - Innate immune response	Cluster 85: Liver - Metabolism	Cluster 66: Myeloid cells - Innate immune response	Cluster 29: Hepatocytes - Metabolism	Cytosol		HPA038547: AB_10669541, HPA038548: AB_10673175	unprognostic (3.39e-1)	unprognostic (4.46e-2)	unprognostic (1.53e-2)	unprognostic (1.46e-1)	unprognostic (2.32e-2)	unprognostic (1.20e-2)	unprognostic (5.05e-2)	unprognostic (2.80e-2)	unprognostic (1.52e-1)	unprognostic (1.33e-2)	unprognostic (9.41e-2)	unprognostic (2.45e-1)	unprognostic (1.31e-3)	unprognostic (1.89e-2)	unprognostic (3.74e-1)	unprognostic (4.03e-2)	unprognostic (2.87e-2)	Hepatocytes
GCKR		ENSG00000084734	Glucokinase regulator		2	27496839-27523684	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level			Tissue enriched	Detected in some	19	liver: 136.4	Cell type enriched	Detected in some	4	Hepatocytes: 74.4	Cancer enriched	Detected in some	8	liver cancer: 14.9	Low region specificity	Detected in many			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in some		liver cancer: 6.1	Stomach - Gastric mucous cells, Testis - Early spermatids, Testis - Late spermatids	Not detected	Not detected			Low region specificity	Detected in all			CAB034098, HPA045855, HPA052227	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol						Cluster 11: Basophils - Unknown function	Cluster 62: Liver - Hemostasis	Cluster 61: Liver - Metabolism	Cluster 13: Hepatocytes - Oxidoreductase activity	Nucleoplasm	Nucleoli, Cytosol	CAB034098: AB_2247323, HPA045855: , HPA052227: 	unprognostic (3.31e-1)	unprognostic (2.11e-3)	unprognostic (2.27e-1)	unprognostic (6.97e-2)	unprognostic (1.68e-2)	unprognostic (5.70e-2)	unprognostic (2.31e-1)	unprognostic (1.70e-1)	unprognostic (1.52e-1)	unprognostic (4.12e-1)	unprognostic (2.25e-3)	unprognostic (1.65e-1)	unprognostic (1.02e-7)	unprognostic (6.51e-2)	unprognostic (1.18e-1)	unprognostic (9.27e-3)	unprognostic (1.50e-2)	Hepatocytes
F11	FXI	ENSG00000088926	Coagulation factor XI	P03951	4	186266189-186289681	Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Blood coagulation, Hemostasis	Heparin-binding, Hydrolase, Protease, Serine protease	Disease variant, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	4	liver: 243.2	Cell type enriched	Detected in some	7	Hepatocytes: 70.0	Cancer enriched	Detected in some	13	liver cancer: 16.8	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in single		liver cancer: 2.1	Kidney - Ascending Loop of Henle cells, Liver - Hepatocytes, Lung - Alveolar cells type 2	Not detected	Not detected			Low region specificity	Detected in some			HPA039808			Approved	Vesicles	Secreted to blood				4400000000		Cluster 85: Liver - Metabolism	Cluster 35: Liver cancer - Metabolism	Cluster 29: Hepatocytes - Metabolism	Vesicles		HPA039808: AB_2676693			unprognostic (1.28e-1)		unprognostic (3.15e-1)		prognostic favorable (3.29e-5)	unprognostic (1.88e-1)			unprognostic (2.08e-1)	unprognostic (2.11e-1)	unprognostic (1.85e-3)	unprognostic (2.91e-2)	unprognostic (7.65e-2)			Hepatocytes
FETUB		ENSG00000090512	Fetuin B	Q9UGM5	3	186635969-186653141	Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Fertilization	Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	27	liver: 234.6	Cell type enriched	Detected in some	6	Hepatocytes: 46.8	Cancer enriched	Detected in some	12	liver cancer: 44.0	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Kidney - Ascending Loop of Henle cells, Liver - Hepatocytes, Testis - Early spermatids, Testis - Late spermatids	Not detected	Not detected			Not detected	Not detected			HPA035132, HPA035133	Supported		Approved	Vesicles	Secreted to blood			47500000000	3600000000		Cluster 62: Liver - Hemostasis	Cluster 60: Keratinocytes - Epithelial cell function	Cluster 13: Hepatocytes - Oxidoreductase activity	Vesicles		HPA035132: AB_10601650, HPA035133: 		unprognostic (9.01e-2)		unprognostic (1.95e-1)	unprognostic (4.62e-1)	unprognostic (8.74e-2)	unprognostic (6.28e-3)	unprognostic (1.24e-2)	unprognostic (7.55e-2)	unprognostic (9.78e-2)	unprognostic (1.73e-2)			unprognostic (9.18e-2)	unprognostic (1.79e-1)	unprognostic (8.39e-2)		Hepatocytes
APOH	B2G1, BG	ENSG00000091583	Apolipoprotein H	P02749	17	66212033-66256525	Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins		Heparin-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	563	liver: 17965.3	Cell type enriched	Detected in some	23	Hepatocytes: 7945.2	Cancer enriched	Detected in many	232	liver cancer: 2878.9	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in some	48	liver cancer: 169.7	Kidney - Proximal tubular cells, Liver - Hepatocytes, Lung - Alveolar cells type 2, Pancreas - Alpha cells	Low region specificity	Detected in many			Not detected	Not detected			HPA001654, HPA003732, CAB022214	Enhanced		Supported	Golgi apparatus	Secreted to blood			247000000000	41000000000		Cluster 62: Liver - Hemostasis	Cluster 35: Liver cancer - Metabolism	Cluster 13: Hepatocytes - Oxidoreductase activity	Golgi apparatus		CAB022214: , HPA001654: AB_1078181, HPA003732: AB_1078183			unprognostic (2.11e-2)	unprognostic (1.87e-1)	unprognostic (1.28e-1)		prognostic favorable (2.39e-7)	unprognostic (1.26e-1)		unprognostic (5.99e-2)	unprognostic (2.88e-3)		prognostic unfavorable (1.10e-6)	unprognostic (1.26e-2)	unprognostic (5.76e-2)			Hepatocytes
IGFALS	ALS	ENSG00000099769	Insulin like growth factor binding protein acid labile subunit	P35858	16	1790413-1794971	Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins	Cell adhesion		Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	11	liver: 116.7	Cell type enriched	Detected in some	6	Hepatocytes: 66.3	Cancer enhanced	Detected in many		liver cancer: 11.1	Low region specificity	Detected in some			Not detected in immune cells	Not detected			Not detected	Not detected			Low cancer specificity	Detected in some			Liver - Hepatocytes	Not detected	Not detected			Low region specificity	Detected in some			HPA040692, HPA040948	Supported				Secreted to blood			14700000000	26000000000		Cluster 62: Liver - Hemostasis	Cluster 40: Non-specific - Enzymes	Cluster 13: Hepatocytes - Oxidoreductase activity			HPA040692: AB_10794067, HPA040948: AB_10794999	unprognostic (2.74e-3)	unprognostic (1.95e-1)	unprognostic (9.13e-2)	prognostic unfavorable (6.06e-4)	unprognostic (2.54e-1)	unprognostic (1.37e-2)	prognostic favorable (5.97e-4)	unprognostic (5.54e-4)	unprognostic (3.00e-1)	unprognostic (1.17e-1)	unprognostic (9.06e-2)	unprognostic (1.05e-2)	unprognostic (1.10e-1)	unprognostic (1.49e-1)	unprognostic (1.23e-1)	unprognostic (4.39e-1)	unprognostic (5.51e-2)	Hepatocytes
SERPIND1	D22S673, HC-II, HC2, HCF2, HLS2	ENSG00000099937	Serpin family D member 1	P05546	22	20774113-20787720	Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins	Blood coagulation, Chemotaxis, Hemostasis	Heparin-binding, Protease inhibitor, Serine protease inhibitor	Disease variant, FDA approved drug targets, Thrombophilia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	14	liver: 1253.1	Cell type enriched	Detected in some	9	Hepatocytes: 240.8	Cancer enriched	Detected in many	80	liver cancer: 334.4	Low region specificity	Detected in some			Not detected in immune cells	Not detected			Not detected	Not detected			Group enriched	Detected in many	19	liver cancer: 33.1;ovarian cancer: 108.6	Liver - Hepatocytes, Thyroid - Fibroblasts	Low region specificity	Detected in all			Low region specificity	Detected in single			CAB008639, HPA055767	Supported		Approved	Vesicles	Secreted to blood				50000000000	Cluster 24: B-cells - Unknown function	Cluster 60: Liver - Hemostasis & Lipid metabolism	Cluster 39: Non-specific - Unknown function	Cluster 29: Hepatocytes - Metabolism	Vesicles		CAB008639: AB_1618010, HPA055767: AB_2682912	unprognostic (1.68e-1)	unprognostic (8.27e-2)	unprognostic (4.40e-2)	prognostic favorable (4.09e-4)	unprognostic (5.42e-2)	unprognostic (1.23e-1)	unprognostic (1.12e-3)	unprognostic (1.56e-1)	unprognostic (1.13e-1)	unprognostic (1.74e-1)	unprognostic (1.21e-2)	unprognostic (2.88e-1)	unprognostic (3.94e-9)	unprognostic (2.01e-1)	unprognostic (4.66e-2)	unprognostic (8.36e-3)	unprognostic (1.46e-1)	Hepatocytes
SLC10A1	NTCP	ENSG00000100652	Solute carrier family 10 member 1	Q14973	14	69775416-69797241	Metabolic proteins, Predicted membrane proteins, Transporters	Host-virus interaction, Ion transport, Sodium transport, Symport, Transport	Host cell receptor for virus entry, Receptor	Disease variant	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	164	liver: 426.9	Cell type enriched	Detected in some	23	Hepatocytes: 136.7	Cancer enriched	Detected in some	79	liver cancer: 65.2	Low region specificity	Detected in some			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Liver - Hepatocytes	Not detected	Not detected			Low region specificity	Detected in all			HPA042727	Approved									Cluster 45: Eosinophils - Innate immune response	Cluster 60: Liver - Hemostasis & Lipid metabolism	Cluster 6: BEWO - Unknown function	Cluster 13: Hepatocytes - Oxidoreductase activity			HPA042727: AB_10960691	unprognostic (3.42e-1)	unprognostic (9.39e-2)	unprognostic (1.51e-2)	unprognostic (2.11e-2)	unprognostic (1.93e-2)	unprognostic (6.51e-3)	prognostic favorable (9.53e-6)	unprognostic (6.07e-3)	unprognostic (8.95e-2)	unprognostic (2.17e-1)	unprognostic (5.75e-3)	unprognostic (1.22e-1)	unprognostic (1.71e-2)	unprognostic (1.05e-1)	unprognostic (3.21e-1)	unprognostic (2.45e-1)	unprognostic (5.69e-2)	Hepatocytes
HAO1	GOX, GOX1	ENSG00000101323	Hydroxyacid oxidase 1	Q9UJM8	20	7882985-7940458	Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins	Amino-acid biosynthesis	Oxidoreductase	FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	583	liver: 607.8	Cell type enriched	Detected in some	11	Hepatocytes: 308.1	Cancer enriched	Detected in some	184	liver cancer: 93.4	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in single		prostate cancer: 1.0	Kidney - Proximal tubular cells, Liver - Hepatocytes	Not detected	Not detected			Low region specificity	Detected in many			HPA049552, HPA072442	Enhanced		Supported	Vesicles					240000		Cluster 62: Liver - Hemostasis	Cluster 61: Liver - Metabolism	Cluster 13: Hepatocytes - Oxidoreductase activity	Vesicles		HPA049552: AB_2680814, HPA072442: 					unprognostic (4.88e-2)		unprognostic (2.87e-3)				unprognostic (1.08e-2)	unprognostic (1.25e-1)						Hepatocytes
DHODH		ENSG00000102967	Dihydroorotate dehydrogenase (quinone)	Q02127	16	72008588-72027664	Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins	Pyrimidine biosynthesis	Oxidoreductase	Disease variant, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in all	8	liver: 105.9	Cell type enriched	Detected in many	4	Hepatocytes: 134.0	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low immune cell specificity	Detected in all			Low lineage specificity	Detected in all			Low cancer specificity	Detected in all				Low region specificity	Detected in all			Low region specificity	Detected in all			HPA010123, HPA011942	Approved		Enhanced	Nucleoplasm,Mitochondria,Cytosol						Cluster 12: Non-specific - Basic cellular processes	Cluster 85: Liver - Metabolism	Cluster 36: Non-specific - Unknown function	Cluster 29: Hepatocytes - Metabolism	Mitochondria	Nucleoplasm, Cytosol	HPA010123: AB_1847648, HPA011942: AB_1847649	unprognostic (4.88e-2)	unprognostic (1.10e-1)	unprognostic (1.90e-1)	unprognostic (2.12e-2)	unprognostic (1.41e-3)	unprognostic (2.10e-1)	unprognostic (4.27e-2)	unprognostic (1.31e-2)	unprognostic (1.26e-1)	unprognostic (2.68e-1)	unprognostic (2.14e-1)	unprognostic (6.40e-2)	unprognostic (9.26e-3)	unprognostic (1.98e-1)	unprognostic (1.97e-1)	unprognostic (1.14e-1)	unprognostic (1.81e-1)	Hepatocytes
FGL1	HFREP-1, HPS	ENSG00000104760	Fibrinogen like 1	Q08830	8	17864380-17910365	Plasma proteins, Predicted secreted proteins	Adaptive immunity, Immunity			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	6	liver: 4163.9	Cell type enriched	Detected in many	7	Hepatocytes: 7130.1	Cancer enriched	Detected in some	40	liver cancer: 399.3	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in many	4	liver cancer: 59.7	Testis - Early spermatids, Testis - Late spermatids	Low region specificity	Detected in many			Low region specificity	Detected in many								Secreted to blood				57000000		Cluster 85: Liver - Metabolism	Cluster 35: Liver cancer - Metabolism	Cluster 29: Hepatocytes - Metabolism				unprognostic (3.62e-2)	unprognostic (1.14e-2)		unprognostic (1.75e-5)	unprognostic (3.00e-1)	unprognostic (3.54e-2)	unprognostic (7.89e-2)	unprognostic (2.15e-1)	unprognostic (2.62e-1)		unprognostic (2.71e-1)	unprognostic (1.09e-2)	unprognostic (2.86e-7)	prognostic unfavorable (5.38e-4)	unprognostic (3.62e-1)	unprognostic (2.58e-2)	unprognostic (1.35e-1)	Hepatocytes
SULT2A1	DHEA-ST, STD	ENSG00000105398	Sulfotransferase family 2A member 1	Q06520	19	47870467-47886315	Enzymes, Metabolic proteins, Predicted intracellular proteins	Bile acid catabolism, Lipid degradation, Lipid metabolism, Steroid metabolism	Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	liver: 1072.1	Cell type enriched	Detected in some	11	Hepatocytes: 1791.1	Cancer enriched	Detected in some	52	liver cancer: 244.3	Not detected	Not detected			Immune cell enhanced	Detected in single		basophil: 2.9	Lineage enriched	Detected in single	6	granulocytes: 2.9	Cancer enriched	Detected in some	8	liver cancer: 9.3		Not detected	Not detected			Low region specificity	Detected in all			CAB018755, HPA041487, HPA063633	Enhanced		Supported	Cytosol					1200000	Cluster 11: Basophils - Unknown function	Cluster 85: Liver - Metabolism	Cluster 35: Liver cancer - Metabolism	Cluster 13: Hepatocytes - Oxidoreductase activity	Cytosol		CAB018755: AB_650242, HPA041487: AB_2677507, HPA063633: AB_2685066			unprognostic (2.14e-1)				unprognostic (6.79e-3)							unprognostic (6.82e-2)	unprognostic (1.36e-1)		unprognostic (1.31e-2)	Hepatocytes
HAMP	HEPC, HFE2B, LEAP-1, LEAP1	ENSG00000105697	Hepcidin antimicrobial peptide	P81172	19	35280716-35285143	Disease related genes, Human disease related genes, Potential drug targets, Predicted secreted proteins, Transporters		Antibiotic, Antimicrobial, Fungicide, Hormone	Disease variant	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	5	liver: 2054.8	Cell type enriched	Detected in some	15	Hepatocytes: 2866.1	Group enriched	Detected in many	12	glioma: 6.5;liver cancer: 16.3	Low region specificity	Detected in all			Group enriched	Detected in some	7	myeloid DC: 1.5;plasmacytoid DC: 4.6	Lineage enriched	Detected in single	10	dendritic cells: 4.6	Cancer enriched	Detected in some	4	liver cancer: 50.2		Not detected	Not detected			Not detected	Not detected								Secreted to blood			1900000	10000000	Cluster 47: Plasmacytoid DCs - Protein folding	Cluster 85: Liver - Metabolism	Cluster 35: Liver cancer - Metabolism	Cluster 13: Hepatocytes - Oxidoreductase activity				unprognostic (5.53e-2)	unprognostic (5.02e-4)	unprognostic (2.10e-3)	unprognostic (4.69e-3)	unprognostic (5.35e-2)	unprognostic (2.24e-1)	unprognostic (3.92e-2)	unprognostic (9.36e-2)	unprognostic (2.73e-2)	unprognostic (1.06e-1)	unprognostic (4.61e-1)	unprognostic (1.86e-1)	unprognostic (3.68e-7)	unprognostic (4.11e-2)	unprognostic (3.93e-2)	unprognostic (4.08e-2)	unprognostic (7.77e-2)	Hepatocytes
PON3		ENSG00000105852	Paraoxonase 3	Q15166	7	95359872-95396375	Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins		Hydrolase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	20	liver: 616.7	Cell type enriched	Detected in many	10	Hepatocytes: 527.2	Group enriched	Detected in many	9	liver cancer: 30.8;lung cancer: 7.8	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in many		liver cancer: 15.8	Heart muscle - Fibroblasts, Liver - Hepatocytes, Lung - Alveolar cells type 2, Skin - Sebaceous gland cells, Thyroid - Thyroid glandular cells	Low region specificity	Detected in all			Not detected	Not detected			HPA014848, CAB025250	Enhanced				Secreted to blood			1760000000	380000000		Cluster 62: Liver - Hemostasis	Cluster 40: Non-specific - Enzymes	Cluster 13: Hepatocytes - Oxidoreductase activity			CAB025250: , HPA014848: AB_1855540	unprognostic (2.67e-1)	unprognostic (1.03e-1)	unprognostic (6.28e-3)	unprognostic (5.52e-3)	unprognostic (1.36e-1)	unprognostic (4.87e-1)	unprognostic (1.44e-3)	unprognostic (6.32e-2)	unprognostic (1.11e-1)	unprognostic (6.44e-3)	unprognostic (9.14e-2)	unprognostic (7.18e-3)	unprognostic (8.30e-9)	unprognostic (1.66e-1)	unprognostic (1.04e-2)	unprognostic (8.29e-2)	unprognostic (5.12e-2)	Hepatocytes
TFR2	HFE3, TFRC2	ENSG00000106327	Transferrin receptor 2	Q9UP52	7	100620416-100642779	Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters		Receptor	Disease variant, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	15	liver: 346.1	Cell type enriched	Detected in some	5	Hepatocytes: 347.4	Cancer enriched	Detected in many	70	liver cancer: 136.2	Not detected	Not detected			Group enriched	Detected in some	22	basophil: 2.5;eosinophil: 1.9	Lineage enriched	Detected in single	25	granulocytes: 2.5	Cancer enriched	Detected in some	7	Leukemia: 23.3	Liver - Hepatocytes, Stomach - Parietal cells	Low region specificity	Detected in many			Low region specificity	Detected in all			CAB016255, HPA017171, HPA073125	Enhanced		Approved	Golgi apparatus					410000	Cluster 46: Basophils - DNA binding	Cluster 60: Liver - Hemostasis & Lipid metabolism	Cluster 32: Myeloid leukemia - Oxygen transport	Cluster 29: Hepatocytes - Metabolism	Golgi apparatus		CAB016255: AB_628395, HPA017171: , HPA073125: 	unprognostic (4.18e-2)	unprognostic (1.97e-2)	unprognostic (2.74e-1)	unprognostic (1.04e-1)	unprognostic (1.26e-2)	unprognostic (4.13e-2)	prognostic favorable (2.48e-4)	unprognostic (2.29e-2)	unprognostic (4.49e-2)	unprognostic (9.26e-2)	unprognostic (1.93e-1)	unprognostic (2.90e-1)	unprognostic (1.18e-9)	unprognostic (6.51e-2)	unprognostic (1.68e-1)	unprognostic (3.28e-1)	unprognostic (8.18e-2)	Hepatocytes
C5	C5a, C5b, CPAMD4	ENSG00000106804	Complement C5	P01031	9	120952335-121050275	Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins	Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Inflammatory response, Innate immunity		FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	29	liver: 433.7	Cell type enriched	Detected in many	14	Hepatocytes: 441.1	Cancer enriched	Detected in many	17	liver cancer: 73.0	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in all		liver cancer: 19.6	Liver - Hepatocytes, Thyroid - Fibroblasts	Low region specificity	Detected in single			Not detected	Not detected			HPA029339	Supported				Secreted to blood			113000000000	39000000000	Cluster 45: Eosinophils - Innate immune response	Cluster 62: Liver - Hemostasis	Cluster 35: Liver cancer - Metabolism	Cluster 29: Hepatocytes - Metabolism			HPA029339: AB_10601125	unprognostic (2.51e-1)	unprognostic (5.88e-3)	unprognostic (2.50e-3)	unprognostic (1.57e-2)	unprognostic (5.05e-2)	unprognostic (9.52e-3)	prognostic favorable (9.43e-4)	unprognostic (1.83e-1)	unprognostic (3.19e-2)	unprognostic (1.55e-1)	unprognostic (2.35e-2)	unprognostic (4.41e-2)	unprognostic (1.46e-5)	unprognostic (5.91e-2)	unprognostic (1.20e-1)	unprognostic (3.67e-2)	unprognostic (2.75e-1)	Hepatocytes
VTN	VN	ENSG00000109072	Vitronectin	P04004	17	28367284-28373091	Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins	Cell adhesion	Heparin-binding	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	61	liver: 6039.5	Cell type enriched	Detected in many	4	Hepatocytes: 4406.1	Cancer enriched	Detected in many	85	liver cancer: 2216.6	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in many		cervical cancer: 79.3;liver cancer: 130.1	Adipose visceral - Mesothelial cells, Liver - Hepatocytes	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB016695, CAB016765, HPA060933, HPA068011	Supported		Supported	Endoplasmic reticulum,Vesicles	Secreted to blood			606000000000	33000000000		Cluster 62: Liver - Hemostasis	Cluster 35: Liver cancer - Metabolism	Cluster 29: Hepatocytes - Metabolism	Endoplasmic reticulum, Vesicles		CAB016695: AB_1624536, CAB016765: , HPA060933: AB_2684389, HPA068011: 	unprognostic (1.19e-1)	unprognostic (2.12e-1)	unprognostic (2.29e-2)	unprognostic (6.13e-2)	unprognostic (9.74e-2)	unprognostic (8.42e-2)	prognostic favorable (3.74e-4)	unprognostic (6.20e-2)	unprognostic (3.97e-1)	unprognostic (8.95e-2)	unprognostic (3.24e-3)	unprognostic (1.01e-2)	prognostic unfavorable (4.10e-11)	unprognostic (8.82e-3)	unprognostic (2.27e-1)	unprognostic (4.86e-3)	unprognostic (7.09e-2)	Hepatocytes
UGT2B10		ENSG00000109181	UDP glucuronosyltransferase family 2 member B10	P36537	4	68815994-68832023	Enzymes, Metabolic proteins, Predicted membrane proteins		Glycosyltransferase, Transferase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	149	liver: 233.7	Cell type enriched	Detected in some	10	Hepatocytes: 274.6	Cancer enriched	Detected in single	296	liver cancer: 93.8	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in single	10	liver cancer: 2.3	Kidney - Proximal tubular cells, Liver - Hepatocytes, Testis - Early spermatids, Testis - Late spermatids									HPA045108	Uncertain										Cluster 60: Liver - Hemostasis & Lipid metabolism	Cluster 35: Liver cancer - Metabolism	Cluster 13: Hepatocytes - Oxidoreductase activity			HPA045108: AB_2679218			unprognostic (3.50e-3)				unprognostic (1.92e-3)						unprognostic (4.17e-1)					Hepatocytes
HPX		ENSG00000110169	Hemopexin	P02790	11	6431049-6442617	Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins	Host-virus interaction, Transport			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	908	liver: 5440.6	Cell type enriched	Detected in some	17	Hepatocytes: 5001.6	Cancer enriched	Detected in many	79	liver cancer: 571.1	Low region specificity	Detected in some			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in some		breast cancer: 3.5;liver cancer: 8.7	Breast - Breast glandular cells, Liver - Hepatocytes	Not detected	Not detected			Low region specificity	Detected in all			CAB016725, HPA065318, HPA068847	Approved				Secreted to blood			425000000000	190000000000		Cluster 62: Liver - Hemostasis	Cluster 35: Liver cancer - Metabolism	Cluster 29: Hepatocytes - Metabolism			CAB016725: , HPA065318: , HPA068847: 	unprognostic (3.39e-2)	unprognostic (9.26e-2)	unprognostic (3.88e-1)	unprognostic (6.19e-4)	unprognostic (2.05e-2)	unprognostic (2.41e-1)	prognostic favorable (2.26e-4)	unprognostic (6.33e-2)	unprognostic (5.67e-3)	unprognostic (3.88e-1)	unprognostic (5.08e-3)	unprognostic (2.78e-2)	unprognostic (5.82e-12)	unprognostic (2.01e-1)	unprognostic (4.48e-1)	unprognostic (1.84e-2)	unprognostic (2.14e-2)	Hepatocytes
APOA5	APOA-V, RAP3	ENSG00000110243	Apolipoprotein A5	Q6Q788	11	116789367-116792420	Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins	Lipid transport, Transport		Disease variant	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	216	liver: 582.1	Cell type enriched	Detected in some	44	Hepatocytes: 1109.5	Cancer enriched	Detected in single	489	liver cancer: 112.2	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in single	23	liver cancer: 3.1	Testis - Early spermatids, Testis - Late spermatids	Not detected	Not detected												Secreted to blood			114000000	21000000		Cluster 62: Liver - Hemostasis	Cluster 35: Liver cancer - Metabolism	Cluster 13: Hepatocytes - Oxidoreductase activity				unprognostic (1.57e-4)						unprognostic (4.67e-3)	unprognostic (5.57e-2)		unprognostic (2.60e-3)		unprognostic (2.40e-1)		unprognostic (2.31e-4)				Hepatocytes
APOC3		ENSG00000110245	Apolipoprotein C3	P02656	11	116829706-116833072	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins	Lipid degradation, Lipid metabolism, Lipid transport, Transport		Cancer-related genes, Disease variant, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	25	liver: 27649.0	Cell type enriched	Detected in some	9	Hepatocytes: 88653.4	Cancer enriched	Detected in many	643	liver cancer: 4021.9	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in some	6	liver cancer: 42.7	Kidney - Proximal tubular cells, Liver - Hepatocytes	Low region specificity	Detected in some			Not detected	Not detected			HPA065365, HPA073918	Supported		Approved	Nucleoplasm,Nucleoli,Cell Junctions	Secreted to blood			106000000000	45000000000		Cluster 60: Liver - Hemostasis & Lipid metabolism	Cluster 35: Liver cancer - Metabolism	Cluster 13: Hepatocytes - Oxidoreductase activity	Nucleoplasm	Nucleoli, Cell Junctions	HPA065365: AB_2732733, HPA073918: 							prognostic favorable (3.77e-4)				unprognostic (2.33e-1)		prognostic unfavorable (6.87e-5)	unprognostic (1.60e-2)	unprognostic (5.21e-2)			Hepatocytes
SLCO1B3	OATP1B3, OATP8, SLC21A8	ENSG00000111700	Solute carrier organic anion transporter family member 1B3	Q9NPD5	12	20810702-20916911	Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters	Ion transport, Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	16	liver: 265.1	Cell type enriched	Detected in some	25	Hepatocytes: 200.7	Cancer enriched	Detected in many	4	liver cancer: 5.4	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in many		Bile duct cancer: 51.9	Liver - Hepatocytes									HPA004943, HPA050892	Enhanced		Supported	Plasma membrane							Cluster 62: Liver - Hemostasis	Cluster 19: Stomach & Colon cancer - Absorption	Cluster 13: Hepatocytes - Oxidoreductase activity	Plasma membrane		HPA004943: AB_1854758, HPA050892: AB_2681265		unprognostic (5.36e-2)	unprognostic (1.25e-1)	unprognostic (6.95e-2)		unprognostic (1.63e-2)	unprognostic (1.89e-2)	unprognostic (7.09e-2)		unprognostic (3.08e-2)	unprognostic (1.54e-2)	unprognostic (7.37e-2)		unprognostic (1.50e-1)	unprognostic (6.61e-3)		unprognostic (2.36e-3)	Hepatocytes
SLC17A2	NPT3	ENSG00000112337	Solute carrier family 17 member 2	O00624	6	25912754-25930691	Metabolic proteins, Predicted membrane proteins, Transporters	Ion transport, Sodium transport, Symport, Transport			Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Tissue enriched	Detected in single	165	liver: 79.5	Cell type enriched	Detected in some	18	Hepatocytes: 27.3	Cancer enriched	Detected in some	8	liver cancer: 14.3	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Liver - Hepatocytes	Not detected	Not detected			Not detected	Not detected			HPA038270	Uncertain										Cluster 62: Liver - Hemostasis	Cluster 35: Liver cancer - Metabolism	Cluster 13: Hepatocytes - Oxidoreductase activity			HPA038270: AB_10672511							prognostic favorable (8.54e-4)						unprognostic (1.90e-2)		unprognostic (4.14e-2)			Hepatocytes
C9		ENSG00000113600	Complement C9	P02748	5	39284140-39424868	Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins	Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity		Age-related macular degeneration, Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	288	liver: 1397.0	Cell type enriched	Detected in some	7	Hepatocytes: 1962.5	Cancer enriched	Detected in single	244	liver cancer: 90.4	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Liver - Hepatocytes	Not detected	Not detected			Low region specificity	Detected in many			CAB002151, HPA029577	Uncertain				Secreted to blood			69600000000	64000000000		Cluster 60: Liver - Hemostasis & Lipid metabolism	Cluster 12: Lymphoid cancers - Adaptive immune response	Cluster 29: Hepatocytes - Metabolism			CAB002151: AB_563670, HPA029577: AB_10603779	unprognostic (1.00e-1)	unprognostic (1.57e-1)	unprognostic (1.50e-1)		unprognostic (2.01e-1)	unprognostic (6.58e-2)	unprognostic (1.30e-1)	unprognostic (2.91e-1)	unprognostic (5.49e-3)		unprognostic (1.91e-2)	unprognostic (1.29e-2)	unprognostic (2.19e-2)	unprognostic (9.43e-5)	unprognostic (1.36e-1)	unprognostic (1.80e-1)	unprognostic (2.04e-1)	Hepatocytes
KNG1	BDK, BK, KNG	ENSG00000113889	Kininogen 1	P01042	3	186717348-186744410	Disease related genes, Plasma proteins, Predicted secreted proteins	Blood coagulation, Hemostasis, Inflammatory response	Protease inhibitor, Thiol protease inhibitor, Vasoactive, Vasodilator	Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	7	liver: 3195.2	Cell type enriched	Detected in some	6	Hepatocytes: 1674.3	Cancer enriched	Detected in some	126	liver cancer: 608.6	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Group enriched	Detected in some	17	Gastric cancer: 7.0;liver cancer: 9.1	Kidney - Ascending Loop of Henle cells, Liver - Hepatocytes, Liver - Hepatocytes	Not detected	Not detected			Not detected	Not detected			HPA001616, HPA001645, CAB009809	Enhanced				Secreted to blood			90000000000	47000000000		Cluster 85: Liver - Metabolism	Cluster 35: Liver cancer - Metabolism	Cluster 13: Hepatocytes - Oxidoreductase activity			CAB009809: AB_2134781, HPA001616: AB_1079216, HPA001645: AB_1079215	unprognostic (3.88e-1)	unprognostic (1.63e-1)	unprognostic (2.82e-1)	unprognostic (3.27e-1)	unprognostic (8.30e-3)	unprognostic (2.04e-1)	prognostic favorable (1.28e-6)	unprognostic (1.29e-2)	unprognostic (1.10e-1)	unprognostic (1.97e-2)	unprognostic (9.96e-2)	unprognostic (1.65e-1)	unprognostic (3.45e-3)	unprognostic (5.20e-2)	unprognostic (2.46e-1)	unprognostic (4.52e-2)		Hepatocytes
HRG	HPRG, HRGP	ENSG00000113905	Histidine rich glycoprotein	P04196	3	186660216-186678234	Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins	Angiogenesis, Blood coagulation, Chemotaxis, Fibrinolysis, Hemostasis	Heparin-binding	Disease variant, Thrombophilia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	173	liver: 5433.2	Cell type enriched	Detected in some	9	Hepatocytes: 401.6	Cancer enriched	Detected in some	262	liver cancer: 406.7	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Kidney - Ascending Loop of Henle cells, Liver - Hepatocytes	Not detected	Not detected			Not detected	Not detected			HPA050269, HPA054598	Supported				Secreted to blood			120000000000	28000000000		Cluster 62: Liver - Hemostasis	Cluster 35: Liver cancer - Metabolism	Cluster 29: Hepatocytes - Metabolism			HPA050269: AB_2681068, HPA054598: AB_2682539		unprognostic (2.67e-1)		unprognostic (1.74e-2)		unprognostic (7.58e-5)	prognostic favorable (9.64e-5)	unprognostic (1.44e-1)		unprognostic (2.98e-3)	unprognostic (2.22e-1)		unprognostic (1.55e-2)	unprognostic (1.14e-1)	unprognostic (5.50e-2)	unprognostic (1.05e-1)	unprognostic (1.46e-2)	Hepatocytes
PROC		ENSG00000115718	Protein C, inactivator of coagulation factors Va and VIIIa	P04070	2	127418427-127429242	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Blood coagulation, Hemostasis	Hydrolase, Protease, Serine protease	Cancer-related genes, Disease variant, FDA approved drug targets, Thrombophilia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	40	liver: 598.5	Cell type enriched	Detected in many	4	Hepatocytes: 343.5	Cancer enriched	Detected in many	22	liver cancer: 118.3	Low region specificity	Detected in many			Immune cell enriched	Detected in some	9	plasmacytoid DC: 59.7	Lineage enriched	Detected in many	9	dendritic cells: 59.7	Cancer enriched	Detected in many	5	liver cancer: 25.6	Kidney - Proximal tubular cells, Kidney - Proximal tubular cells, Liver - Hepatocytes, Skin - Outer root sheath cells					Low region specificity	Detected in all			HPA005550, CAB016721, CAB016792	Approved				Secreted to blood				5200000000	Cluster 3: Plasmacytoid DCs - Unknown function	Cluster 62: Liver - Hemostasis	Cluster 35: Liver cancer - Metabolism	Cluster 13: Hepatocytes - Oxidoreductase activity			CAB016721: , CAB016792: , HPA005550: AB_1079687	unprognostic (2.46e-2)	unprognostic (1.08e-1)	unprognostic (1.38e-1)	unprognostic (1.58e-1)	unprognostic (6.64e-2)	unprognostic (3.13e-2)	unprognostic (4.90e-3)	unprognostic (2.63e-1)	unprognostic (1.67e-1)	unprognostic (3.29e-1)	unprognostic (3.74e-3)	unprognostic (2.56e-2)	unprognostic (8.12e-3)	unprognostic (2.01e-2)	unprognostic (1.71e-1)	unprognostic (4.60e-3)	unprognostic (8.06e-2)	Hepatocytes
CFHR3	CFHL3, DOWN16, FHR-3, FHR3, HLF4	ENSG00000116785	Complement factor H related 3	Q02985	1	196774813-196795407	Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins			Hemolytic uremic syndrome	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	582	liver: 505.7	Cell type enriched	Detected in some	4	Hepatocytes: 141.1	Cancer enriched	Detected in single	80	liver cancer: 27.9	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in some		thyroid cancer: 2.9															Secreted to blood			582000000	3100000000		Cluster 60: Liver - Hemostasis & Lipid metabolism	Cluster 29: TT & NCI-H1385 - Synaptic signal transduction	Cluster 29: Hepatocytes - Metabolism				unprognostic (1.73e-1)	unprognostic (2.11e-1)	unprognostic (7.16e-2)	unprognostic (6.77e-2)	unprognostic (4.46e-1)	unprognostic (4.20e-3)	prognostic favorable (2.86e-5)	unprognostic (1.78e-1)	unprognostic (2.05e-2)	unprognostic (1.98e-1)	unprognostic (1.19e-2)	unprognostic (6.11e-3)	unprognostic (2.06e-10)	unprognostic (2.67e-4)	unprognostic (3.00e-1)	unprognostic (3.29e-2)	unprognostic (1.32e-1)	Hepatocytes
HSD11B1	HSD11, HSD11B, SDR26C1	ENSG00000117594	Hydroxysteroid 11-beta dehydrogenase 1	P28845	1	209686178-209734949	Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins	Lipid metabolism, Steroid metabolism	Oxidoreductase	Disease variant, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	13	liver: 968.3	Cell type enriched	Detected in many	12	Hepatocytes: 637.6	Cancer enriched	Detected in all	28	liver cancer: 197.4	Low region specificity	Detected in all			Immune cell enhanced	Detected in some		memory CD4 T-cell: 5.6	Lineage enriched	Detected in single	17	T-cells: 5.6	Cancer enhanced	Detected in many		Esophageal cancer: 19.5	Colon - Fibroblasts, Kidney - Fibroblasts	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA047729	Enhanced								110000	Cluster 35: T-regs - Unknown function	Cluster 60: Liver - Hemostasis & Lipid metabolism	Cluster 59: Fibroblasts - Metabolism	Cluster 13: Hepatocytes - Oxidoreductase activity			HPA047729: AB_2680135	unprognostic (1.08e-3)	unprognostic (2.13e-1)	unprognostic (2.32e-1)	unprognostic (1.40e-1)	unprognostic (1.57e-1)	unprognostic (3.68e-1)	unprognostic (2.02e-2)	unprognostic (1.12e-1)	unprognostic (1.30e-1)	unprognostic (3.63e-2)	unprognostic (8.35e-3)	unprognostic (8.69e-2)	prognostic unfavorable (1.97e-10)	unprognostic (3.41e-2)	unprognostic (3.91e-2)	unprognostic (6.45e-2)	unprognostic (1.59e-2)	Hepatocytes
SERPINC1	AT3, ATIII, MGC22579	ENSG00000117601	Serpin family C member 1	P01008	1	173903800-173917327	Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins	Blood coagulation, Hemostasis	Heparin-binding, Protease inhibitor, Serine protease inhibitor	Disease variant, FDA approved drug targets, Thrombophilia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	1341	liver: 5056.6	Cell type enriched	Detected in some	30	Hepatocytes: 2568.1	Cancer enriched	Detected in some	871	liver cancer: 1504.0	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	Gastric cancer: 2.5;liver cancer: 7.6	Kidney - Proximal tubular cells, Liver - Hepatocytes	Not detected	Not detected			Low region specificity	Detected in many			HPA001816, CAB016790, HPA024007	Supported				Secreted to blood				120000000000	Cluster 45: Eosinophils - Innate immune response	Cluster 62: Liver - Hemostasis	Cluster 35: Liver cancer - Metabolism	Cluster 13: Hepatocytes - Oxidoreductase activity			CAB016790: , HPA001816: AB_1079926, HPA024007: AB_1856732	unprognostic (1.28e-2)	unprognostic (2.22e-1)	unprognostic (3.83e-2)	unprognostic (5.98e-2)	unprognostic (6.91e-2)	unprognostic (1.93e-2)	prognostic favorable (3.40e-5)	unprognostic (1.75e-2)	unprognostic (8.67e-2)	unprognostic (3.48e-2)	unprognostic (4.74e-2)	unprognostic (1.91e-1)	unprognostic (2.36e-2)	unprognostic (5.28e-3)	unprognostic (5.80e-2)	unprognostic (6.35e-2)	unprognostic (8.21e-2)	Hepatocytes
TTR	CTS, CTS1, HsT2651, PALB	ENSG00000118271	Transthyretin	P02766	18	31557009-31598833	Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Transport	Hormone, Thyroid hormone	Amyloidosis, Cancer-related genes, Disease variant, FDA approved drug targets, Neuropathy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	7	choroid plexus: 142023.1	Cell type enriched	Detected in many	7	Hepatocytes: 26918.3	Group enriched	Detected in many	28	liver cancer: 928.2;pancreatic cancer: 666.0	Group enriched	Detected in all	7	cerebellum: 621.7;hippocampal formation: 1730.9;thalamus: 688.2	Not detected in immune cells	Not detected			Not detected	Not detected			Group enriched	Detected in many	10	Gastric cancer: 190.6;liver cancer: 219.1	Liver - Hepatocytes, Pancreas - Alpha cells, Testis - Early spermatids	Group enriched	Detected in all	5	basal ganglia: 1538.3;hippocampal formation: 4891.0;pons and medulla: 5758.5;thalamus: 3400.4	Region enhanced	Detected in all		medulla oblongata: 1381.8	CAB002517, HPA002550, CAB062567, CAB073406	Supported		Approved	Golgi apparatus	Secreted to blood			345000000000	99000000000	Cluster 1: Neutrophils - Mixed function	Cluster 88: Choroid plexus - Transmembrane transport	Cluster 35: Liver cancer - Metabolism	Cluster 13: Hepatocytes - Oxidoreductase activity	Golgi apparatus		CAB002517: AB_563965, CAB062567: AB_2665620, CAB073406: , HPA002550: AB_1080419	unprognostic (6.79e-3)		unprognostic (3.38e-2)	unprognostic (4.10e-1)	unprognostic (1.74e-1)		unprognostic (1.84e-2)	unprognostic (8.15e-2)	unprognostic (3.74e-2)		unprognostic (9.66e-3)	unprognostic (8.72e-2)	unprognostic (1.23e-2)	unprognostic (8.35e-3)	unprognostic (5.26e-1)		unprognostic (3.52e-2)	Hepatocytes
ARG1		ENSG00000118520	Arginase 1	P05089	6	131470832-131584332	Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins	Adaptive immunity, Arginine metabolism, Immunity, Innate immunity, Urea cycle	Hydrolase	Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	4	liver: 1203.5	Cell type enriched	Detected in some	18	Hepatocytes: 1111.5	Cancer enriched	Detected in some	45	liver cancer: 167.7	Low region specificity	Detected in single			Immune cell enriched	Detected in some	5	neutrophil: 44.9	Lineage enriched	Detected in many	5	granulocytes: 44.9	Group enriched	Detected in some	7	Leukemia: 1.6;liver cancer: 1.8	Adipose visceral - Neutrophils, Heart muscle - Neutrophils, Lung - Neutrophil_2, Skeletal muscle - Neutrophils, Skin - Keratinocyte (granular), Stomach - Neutrophils, Thyroid - Neutrophils	Region enhanced	Detected in single		cerebellum: 2.4	Low region specificity	Detected in all			HPA003595, CAB009434, HPA024006, CAB056159, CAB080011	Enhanced								9500000	Cluster 9: Neutrophils - Innate immune response	Cluster 60: Liver - Hemostasis & Lipid metabolism	Cluster 32: Myeloid leukemia - Oxygen transport	Cluster 13: Hepatocytes - Oxidoreductase activity			CAB009434: AB_2058955, CAB056159: AB_2665582, CAB080011: , HPA003595: AB_1078190, HPA024006: AB_1844987	unprognostic (2.00e-1)	unprognostic (2.09e-1)	unprognostic (2.49e-1)	unprognostic (1.74e-1)	unprognostic (9.95e-2)	unprognostic (7.96e-2)	unprognostic (7.73e-2)	unprognostic (1.68e-1)	unprognostic (1.22e-1)	unprognostic (1.56e-2)	unprognostic (7.55e-3)	unprognostic (8.35e-2)	unprognostic (1.25e-2)	unprognostic (2.90e-2)	unprognostic (2.75e-1)	unprognostic (1.11e-2)	unprognostic (1.79e-2)	Hepatocytes
CPN1		ENSG00000120054	Carboxypeptidase N subunit 1	P15169	10	100042193-100081869	Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins		Carboxypeptidase, Hydrolase, Metalloprotease, Protease	Disease variant	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	54	liver: 81.6	Cell type enriched	Detected in some	4	Hepatocytes: 35.8	Group enriched	Detected in some	12	liver cancer: 26.6;melanoma: 7.9	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in some	5	skin cancer: 33.8	Liver - Hepatocytes	Low region specificity	Detected in some			Not detected	Not detected								Secreted to blood				13000000000		Cluster 62: Liver - Hemostasis	Cluster 16: Skin cancer - Melanocyte processes	Cluster 29: Hepatocytes - Metabolism						unprognostic (2.97e-2)	unprognostic (2.23e-2)			unprognostic (3.93e-2)		unprognostic (1.64e-1)		unprognostic (6.75e-2)		unprognostic (2.93e-2)	unprognostic (5.26e-2)	unprognostic (2.63e-1)			Hepatocytes
PLG		ENSG00000122194	Plasminogen	P00747	6	160702238-160754097	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins	Blood coagulation, Fibrinolysis, Hemostasis, Tissue remodeling	Hydrolase, Protease, Serine protease	Cancer-related genes, Disease variant, FDA approved drug targets, Thrombophilia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	11	liver: 2666.4	Cell type enriched	Detected in some	5	Hepatocytes: 1638.0	Cancer enriched	Detected in some	84	liver cancer: 180.7	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in single	6	liver cancer: 2.2	Kidney - Proximal tubular cells, Kidney - Proximal tubular cells, Liver - Hepatocytes, Lung - Respiratory ciliated cells					Low region specificity	Detected in many			CAB000668, CAB016678, HPA021602, HPA048823, HPA053770	Supported		Approved	Vesicles	Secreted to blood			140000000000	45000000000		Cluster 85: Liver - Metabolism	Cluster 35: Liver cancer - Metabolism	Cluster 29: Hepatocytes - Metabolism	Vesicles		CAB000668: , CAB016678: AB_1621208, HPA021602: AB_1855453, HPA048823: AB_2680532, HPA053770: AB_2682256		unprognostic (1.70e-1)		unprognostic (2.16e-3)	unprognostic (2.44e-1)		unprognostic (8.54e-3)	unprognostic (1.41e-1)		unprognostic (1.76e-3)	unprognostic (6.28e-2)	unprognostic (7.25e-2)	prognostic favorable (4.22e-4)	unprognostic (3.97e-3)	unprognostic (5.21e-2)		unprognostic (2.33e-2)	Hepatocytes
SARDH	DMGDHL1, SDH	ENSG00000123453	Sarcosine dehydrogenase	Q9UL12	9	133663560-133739955	Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins		Oxidoreductase	Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	6	epididymis: 47.9;liver: 114.4;pancreas: 43.2	Cell type enriched	Detected in some	7	Hepatocytes: 109.4	Cancer enriched	Detected in many	8	liver cancer: 18.7	Low region specificity	Detected in all			Group enriched	Detected in some	5	memory CD4 T-cell: 3.3;naive CD4 T-cell: 6.7;T-reg: 8.8	Lineage enriched	Detected in single	16	T-cells: 8.8	Low cancer specificity	Detected in many			Adipose visceral - Adipose progenitor cells, Kidney - Proximal tubular cells, Liver - Hepatocytes	Low region specificity	Detected in all			Not detected	Not detected			HPA057267, HPA058086	Approved		Approved	Mitochondria					230000	Cluster 20: T-cells - T-cell receptor	Cluster 85: Liver - Metabolism	Cluster 12: Lymphoid cancers - Adaptive immune response	Cluster 13: Hepatocytes - Oxidoreductase activity	Mitochondria		HPA057267: AB_2683388, HPA058086: AB_2683601	unprognostic (3.64e-2)	unprognostic (4.87e-2)	unprognostic (2.31e-2)	unprognostic (1.38e-1)	prognostic unfavorable (4.62e-4)	unprognostic (5.83e-2)	unprognostic (1.42e-3)	unprognostic (2.21e-1)	unprognostic (1.58e-1)	unprognostic (1.43e-1)	unprognostic (2.23e-1)	unprognostic (1.74e-1)	unprognostic (7.74e-3)	unprognostic (2.78e-1)	unprognostic (3.48e-1)	unprognostic (9.73e-2)	unprognostic (1.30e-2)	Hepatocytes
SERPINA7	TBG	ENSG00000123561	Serpin family A member 7	P05543	X	106032435-106038727	Plasma proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	612	liver: 282.2	Cell type enriched	Detected in some	11	Hepatocytes: 165.2	Cancer enriched	Detected in single	203	liver cancer: 82.4	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in single	17	liver cancer: 5.2	Liver - Hepatocytes	Not detected	Not detected			Not detected	Not detected			HPA002803	Approved				Secreted to blood			39800000000	25000000000		Cluster 62: Liver - Hemostasis	Cluster 35: Liver cancer - Metabolism	Cluster 29: Hepatocytes - Metabolism			HPA002803: AB_1079915			unprognostic (6.22e-2)				unprognostic (1.63e-3)				unprognostic (3.34e-1)	unprognostic (2.62e-1)	unprognostic (2.15e-3)		unprognostic (2.95e-1)			Hepatocytes
C4BPB	C4BP	ENSG00000123843	Complement component 4 binding protein beta	P20851	1	207088860-207099993	Human disease related genes, Plasma proteins, Predicted secreted proteins	Complement pathway, Immunity, Innate immunity			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	11	liver: 471.3	Cell type enriched	Detected in many	6	Hepatocytes: 662.0	Cancer enriched	Detected in many	19	liver cancer: 83.7	Not detected	Not detected			Immune cell enhanced	Detected in single		plasmacytoid DC: 1.1	Low lineage specificity	Detected in single			Cancer enhanced	Detected in many		Bile duct cancer: 38.1	Adipose subcutaneous - Macrophages, Testis - Late spermatids					Not detected	Not detected			HPA000925, HPA051620	Approved		Uncertain	Golgi apparatus	Secreted to blood			265000000000	1100000000	Cluster 3: Plasmacytoid DCs - Unknown function	Cluster 62: Liver - Hemostasis	Cluster 46: Non-specific - Unknown function	Cluster 13: Hepatocytes - Oxidoreductase activity	Golgi apparatus		HPA000925: , HPA051620: AB_2681554	unprognostic (1.73e-1)	unprognostic (2.62e-1)	unprognostic (3.26e-1)	unprognostic (2.07e-3)	unprognostic (1.72e-1)	unprognostic (2.54e-2)	unprognostic (4.58e-3)	unprognostic (9.49e-2)	unprognostic (1.37e-1)	unprognostic (4.25e-1)	unprognostic (6.39e-2)	unprognostic (2.64e-2)	unprognostic (1.21e-2)	unprognostic (1.55e-1)	unprognostic (1.03e-1)	unprognostic (1.05e-2)	unprognostic (8.25e-2)	Hepatocytes
GNMT		ENSG00000124713	Glycine N-methyltransferase	Q14749	6	42960754-42963880	Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins		Methyltransferase, Transferase	Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	9	liver: 296.5;pancreas: 600.1	Cell type enriched	Detected in many	12	Hepatocytes: 1154.2	Group enriched	Detected in many	20	liver cancer: 69.6;prostate cancer: 49.8	Low region specificity	Detected in many			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in many		prostate cancer: 5.3	Breast - Breast glandular cells, Liver - Hepatocytes, Prostate - Prostate glandular cells	Region enriched	Detected in some	4	cerebellum: 15.7	Low region specificity	Detected in many			HPA027501	Enhanced		Supported	Cytosol					390000	Cluster 8: Neutrophils - Inflammatory response	Cluster 25: Pancreas - Digestion	Cluster 24: Prostate cancer - Lipid metabolism	Cluster 13: Hepatocytes - Oxidoreductase activity	Cytosol		HPA027501: AB_1849879	unprognostic (1.53e-2)	unprognostic (8.02e-4)	unprognostic (3.11e-2)	unprognostic (4.24e-3)	unprognostic (3.91e-2)	unprognostic (6.40e-4)	prognostic favorable (1.86e-4)	unprognostic (4.08e-6)	unprognostic (1.01e-1)	unprognostic (2.67e-2)	unprognostic (1.63e-3)	unprognostic (2.52e-1)	unprognostic (3.50e-3)	unprognostic (1.03e-1)	unprognostic (1.99e-1)	unprognostic (2.49e-2)	unprognostic (4.92e-2)	Hepatocytes
PLGLB2	PLGP1	ENSG00000125551	Plasminogen like B2	Q02325	2	87748087-87759476	Predicted secreted proteins				Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence	No human protein/transcript evidence	Tissue enriched	Detected in some	163	liver: 454.4	Cell type enriched	Detected in some	11	Hepatocytes: 67.0	Cancer enriched	Detected in single	25	liver cancer: 1.2	Low region specificity	Detected in some			Not detected in immune cells	Not detected			Not detected	Not detected			Low cancer specificity	Detected in some												HPA053770			Approved	Vesicles	Secreted to blood					Cluster 17: Basophils - Unknown function	Cluster 62: Liver - Hemostasis	Cluster 12: Lymphoid cancers - Adaptive immune response	Cluster 13: Hepatocytes - Oxidoreductase activity	Vesicles		HPA053770: AB_2682256	unprognostic (1.10e-2)	unprognostic (8.78e-2)			unprognostic (3.42e-2)	unprognostic (7.03e-4)	unprognostic (1.68e-2)	unprognostic (3.77e-1)		unprognostic (1.82e-2)	unprognostic (5.74e-2)	unprognostic (2.94e-1)	unprognostic (5.04e-4)	unprognostic (6.39e-2)	unprognostic (4.06e-2)	unprognostic (3.22e-2)	unprognostic (7.11e-2)	Hepatocytes
PROZ	PZ	ENSG00000126231	Protein Z, vitamin K dependent plasma glycoprotein	P22891	13	113158648-113172386	Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins	Blood coagulation, Hemostasis	Serine protease homolog		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	8	liver: 109.2	Cell type enriched	Detected in some	7	Hepatocytes: 64.6	Cancer enriched	Detected in single	27	liver cancer: 12.1	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Low cancer specificity	Detected in some			Kidney - Proximal tubular cells, Liver - Hepatocytes	Not detected	Not detected							HPA052006	Supported				Secreted to blood			1720000000	650000000	Cluster 12: Non-specific - Basic cellular processes	Cluster 85: Liver - Metabolism	Cluster 12: Lymphoid cancers - Adaptive immune response	Cluster 29: Hepatocytes - Metabolism			HPA052006: AB_2681691	unprognostic (5.03e-2)	unprognostic (4.05e-2)	unprognostic (1.11e-1)	unprognostic (2.36e-1)	unprognostic (6.48e-2)	unprognostic (1.39e-1)	prognostic favorable (3.46e-4)	unprognostic (4.10e-1)	unprognostic (2.21e-1)	unprognostic (2.50e-1)	unprognostic (5.20e-2)	unprognostic (2.87e-1)	unprognostic (9.83e-2)	unprognostic (5.63e-2)	unprognostic (1.41e-1)	unprognostic (9.99e-2)	unprognostic (2.51e-4)	Hepatocytes
LBP	BPIFD2	ENSG00000129988	Lipopolysaccharide binding protein	P18428	20	38346482-38377013	Plasma proteins, Predicted secreted proteins, Transporters	Immunity, Innate immunity, Lipid transport, Transport	Antibiotic, Antimicrobial		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	23	liver: 1338.5	Cell type enriched	Detected in some	9	Hepatocytes: 392.6	Cancer enriched	Detected in many	20	liver cancer: 356.7	Region enhanced	Detected in single		medulla oblongata: 1.1	Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in some		Brain cancer: 7.8;thyroid cancer: 2.8	Breast - Adipocytes (Breast), Kidney - Proximal tubular cells, Thyroid - Macrophages	Low region specificity	Detected in all			Low region specificity	Detected in many			HPA001508, CAB025905	Approved				Secreted to blood			25000000000	1300000000		Cluster 62: Liver - Hemostasis	Cluster 20: Connective tissue cells - ECM organization	Cluster 29: Hepatocytes - Metabolism			CAB025905: , HPA001508: AB_1079241	unprognostic (4.20e-2)	prognostic unfavorable (5.56e-4)	unprognostic (4.54e-2)	unprognostic (2.47e-1)	unprognostic (3.80e-2)	unprognostic (2.53e-2)	unprognostic (5.50e-2)	unprognostic (2.48e-3)	unprognostic (6.15e-2)	unprognostic (2.12e-1)	unprognostic (7.93e-2)	unprognostic (2.62e-1)	prognostic unfavorable (3.62e-12)	prognostic unfavorable (5.76e-4)	unprognostic (1.69e-1)	unprognostic (1.22e-1)	unprognostic (1.67e-1)	Hepatocytes
ANGPTL8	C19orf80, RIFL, TD26	ENSG00000130173	Angiopoietin like 8	Q6UXH0	19	11237450-11241943	Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Lipid metabolism	Hormone	Diabetes mellitus	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	11	liver: 409.8	Cell type enriched	Detected in some	7	Hepatocytes: 126.2	Cancer enriched	Detected in some	37	liver cancer: 84.6	Low region specificity	Detected in many			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in some	9	liver cancer: 9.4	Breast - Adipocytes (Breast)	Not detected	Not detected			Not detected	Not detected			HPA042131			Approved	Nucleoplasm,Golgi apparatus	Secreted to blood			836000	350000		Cluster 60: Liver - Hemostasis & Lipid metabolism	Cluster 35: Liver cancer - Metabolism	Cluster 29: Hepatocytes - Metabolism	Golgi apparatus	Nucleoplasm	HPA042131: AB_10794413	unprognostic (2.37e-2)	unprognostic (1.86e-1)	unprognostic (1.15e-1)	unprognostic (1.31e-2)	unprognostic (1.17e-1)	unprognostic (1.00e-1)	unprognostic (3.73e-1)	unprognostic (2.80e-1)	unprognostic (3.49e-1)	unprognostic (1.02e-1)	unprognostic (9.67e-2)	unprognostic (1.35e-1)	prognostic unfavorable (1.84e-6)	unprognostic (1.09e-1)	unprognostic (3.55e-1)	unprognostic (4.57e-1)	unprognostic (1.75e-2)	Hepatocytes
APOC1		ENSG00000130208	Apolipoprotein C1	P02654	19	44914247-44919349	Cancer-related genes, Candidate cardiovascular disease genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins	Lipid transport, Transport		Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in all	8	liver: 16232.1	Cell type enriched	Detected in many	8	Hepatocytes: 34731.7	Cancer enriched	Detected in all	21	liver cancer: 3253.7	Low region specificity	Detected in all			Immune cell enriched	Detected in single	9	myeloid DC: 5.6	Lineage enriched	Detected in single	12	dendritic cells: 5.6	Cancer enhanced	Detected in all		Leukemia: 229.9;liver cancer: 258.0	Liver - Hepatocytes, Lung - Macrophages, Skin - Sebaceous gland cells	Low region specificity	Detected in all							HPA051518	Supported				Secreted to blood			20300000000	15000000000	Cluster 28: Myeloid DCs - Unknown function	Cluster 62: Liver - Hemostasis	Cluster 32: Myeloid leukemia - Oxygen transport	Cluster 13: Hepatocytes - Oxidoreductase activity			HPA051518: AB_2681519	unprognostic (3.51e-2)	unprognostic (3.31e-3)	unprognostic (1.14e-1)	unprognostic (2.59e-2)	unprognostic (2.06e-1)	unprognostic (1.47e-1)	prognostic favorable (1.15e-7)	unprognostic (9.51e-3)	unprognostic (1.30e-1)	unprognostic (4.18e-2)	unprognostic (1.11e-1)	unprognostic (2.52e-1)	unprognostic (7.13e-3)	unprognostic (3.48e-3)	unprognostic (1.65e-1)	unprognostic (2.01e-3)	unprognostic (1.65e-1)	Hepatocytes
CYP2E1	CYP2E	ENSG00000130649	Cytochrome P450 family 2 subfamily E member 1	P05181	10	133520406-133561220	Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins	Fatty acid metabolism, Lipid metabolism	Monooxygenase, Oxidoreductase	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	309	liver: 10379.8	Cell type enriched	Detected in many	23	Hepatocytes: 6502.1	Cancer enriched	Detected in some	278	liver cancer: 265.3	Low region specificity	Detected in all			Immune cell enhanced	Detected in some		MAIT T-cell: 2.5;myeloid DC: 6.2	Group enriched	Detected in many	16	dendritic cells: 6.2;T-cells: 2.5	Low cancer specificity	Detected in many			Liver - Hepatocytes	Not detected	Not detected			Low region specificity	Detected in all			HPA009128, HPA029564	Enhanced		Approved	Endoplasmic reticulum,Mitochondria	Intracellular and membrane					Cluster 28: Myeloid DCs - Unknown function	Cluster 62: Liver - Hemostasis	Cluster 12: Lymphoid cancers - Adaptive immune response	Cluster 13: Hepatocytes - Oxidoreductase activity	Endoplasmic reticulum, Mitochondria		HPA009128: AB_1078613, HPA029564: AB_10602213	unprognostic (6.32e-2)	unprognostic (1.51e-2)	unprognostic (3.83e-5)	unprognostic (1.27e-1)	unprognostic (3.37e-2)	unprognostic (1.26e-1)	unprognostic (2.92e-3)	unprognostic (6.36e-3)	unprognostic (2.41e-2)	unprognostic (1.49e-1)	unprognostic (1.63e-1)	unprognostic (3.21e-2)	unprognostic (1.70e-4)	unprognostic (1.72e-1)	unprognostic (8.36e-2)	unprognostic (3.78e-1)	unprognostic (9.59e-2)	Hepatocytes
F12		ENSG00000131187	Coagulation factor XII	P00748	5	177402141-177409564	Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins	Blood coagulation, Fibrinolysis, Hemostasis	Hydrolase, Protease, Serine protease	Disease variant, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	226	liver: 604.6	Cell type enriched	Detected in many	5	Hepatocytes: 379.9	Cancer enriched	Detected in many	21	liver cancer: 171.0	Low region specificity	Detected in many			Group enriched	Detected in some	5	classical monocyte: 1.2;eosinophil: 3.6	Group enriched	Detected in many	5	granulocytes: 3.6;monocytes: 1.2	Low cancer specificity	Detected in many			Kidney - Proximal tubular cells, Liver - Hepatocytes, Stomach - Mitotic cells (Stomach)	Low region specificity	Detected in single			Low region specificity	Detected in many			HPA003825	Approved				Secreted to blood			1040000	7000000000	Cluster 52: Eosinophils - Transcription	Cluster 60: Liver - Hemostasis & Lipid metabolism	Cluster 41: Non-specific - Cilium assembly	Cluster 29: Hepatocytes - Metabolism			HPA003825: AB_1078790	unprognostic (9.75e-2)	unprognostic (1.71e-1)	unprognostic (2.93e-1)	unprognostic (4.47e-2)	unprognostic (1.01e-1)	unprognostic (2.32e-1)	prognostic favorable (4.63e-5)	unprognostic (6.97e-2)	unprognostic (1.26e-2)	unprognostic (3.96e-2)	unprognostic (4.41e-1)	unprognostic (6.54e-2)	prognostic unfavorable (7.09e-4)	unprognostic (4.11e-2)	unprognostic (3.69e-1)	unprognostic (3.40e-6)	unprognostic (6.48e-2)	Hepatocytes
APCS	MGC88159, PTX2, SAP	ENSG00000132703	Amyloid P component, serum	P02743	1	159587826-159588865	Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	76	liver: 3629.2	Cell type enriched	Detected in some	10	Hepatocytes: 4184.4	Cancer enriched	Detected in some	25	liver cancer: 826.2	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in some	8	liver cancer: 12.6	Liver - Hepatocytes	Not detected	Not detected			Low region specificity	Detected in many			CAB007817, HPA053294	Supported				Secreted to blood			27700000000	39000000000		Cluster 60: Liver - Hemostasis & Lipid metabolism	Cluster 61: Liver - Metabolism	Cluster 13: Hepatocytes - Oxidoreductase activity			CAB007817: AB_598185, HPA053294: AB_2682104							unprognostic (3.19e-3)				unprognostic (2.30e-2)							Hepatocytes
SAA2		ENSG00000134339	Serum amyloid A2	P0DJI9	11	18239223-18248668	Disease related genes, Predicted secreted proteins	Acute phase		Amyloidosis	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	20	liver: 36265.6	Cell type enriched	Detected in many	5	Hepatocytes: 44005.0	Cancer enriched	Detected in many	22	liver cancer: 150.5	Group enriched	Detected in some	9	midbrain: 6.3;pons: 4.8;thalamus: 7.7	Immune cell enhanced	Detected in some		neutrophil: 1.1	Low lineage specificity	Detected in single			Group enriched	Detected in many	5	head and neck cancer: 533.7;Kidney cancer: 165.0	Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast)														Secreted to blood			50000000	9200000000	Cluster 17: Basophils - Unknown function	Cluster 62: Liver - Hemostasis	Cluster 60: Keratinocytes - Epithelial cell function	Cluster 29: Hepatocytes - Metabolism				unprognostic (1.73e-3)	unprognostic (4.42e-2)	unprognostic (2.63e-1)	unprognostic (5.03e-2)	unprognostic (1.40e-3)	unprognostic (7.12e-2)	unprognostic (7.45e-2)	unprognostic (2.15e-2)	unprognostic (1.57e-1)	unprognostic (2.86e-2)	unprognostic (2.78e-2)	unprognostic (6.13e-2)	prognostic unfavorable (1.30e-8)	unprognostic (1.53e-1)	unprognostic (9.72e-2)	unprognostic (7.62e-3)	unprognostic (1.28e-1)	Hepatocytes
CFHR4	CFHL4, FHR-4, FHR4	ENSG00000134365	Complement factor H related 4	Q92496	1	196888014-196918713	Plasma proteins, Predicted secreted proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	432	liver: 123.9	Cell type enriched	Detected in some	4	Hepatocytes: 37.0	Cancer enriched	Detected in single	145	liver cancer: 13.3	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Liver - Hepatocytes					Low region specificity	Detected in all								Secreted to blood				170000000		Cluster 62: Liver - Hemostasis	Cluster 44: Myeloma - Humoral immune response	Cluster 29: Hepatocytes - Metabolism									unprognostic (5.97e-1)	prognostic favorable (1.57e-6)	unprognostic (1.89e-1)	unprognostic (4.79e-2)	unprognostic (1.26e-1)				unprognostic (1.68e-2)			unprognostic (4.71e-1)	Hepatocytes
CFHR5	CFHL5, FHR-5, FHR5	ENSG00000134389	Complement factor H related 5	Q9BXR6	1	196977556-197009678	Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins			Disease variant, Hemolytic uremic syndrome	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	1675	liver: 167.5	Cell type enriched	Detected in some	13	Hepatocytes: 96.2	Cancer enriched	Detected in single	396	liver cancer: 57.1	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Liver - Hepatocytes									HPA038915, HPA040726	Supported				Secreted to blood				1900000000		Cluster 62: Liver - Hemostasis	Cluster 61: Liver - Metabolism	Cluster 29: Hepatocytes - Metabolism			HPA038915: AB_2676269, HPA040726: AB_2677101							unprognostic (9.12e-3)											Hepatocytes
SLCO1B1	LST-1, OATP-C, OATP1B1, SLC21A6	ENSG00000134538	Solute carrier organic anion transporter family member 1B1	Q9Y6L6	12	21131194-21239796	Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters	Ion transport, Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	614	liver: 537.2	Cell type enriched	Detected in some	14	Hepatocytes: 157.8	Cancer enriched	Detected in some	96	liver cancer: 52.6	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in some		testis cancer: 2.2	Liver - Hepatocytes									HPA050892, HPA073093	Supported		Supported	Plasma membrane							Cluster 60: Liver - Hemostasis & Lipid metabolism	Cluster 61: Liver - Metabolism	Cluster 13: Hepatocytes - Oxidoreductase activity	Plasma membrane		HPA050892: AB_2681265, HPA073093: 			unprognostic (5.45e-1)			unprognostic (1.82e-4)	unprognostic (2.43e-3)	unprognostic (1.96e-3)		unprognostic (1.80e-1)	unprognostic (2.41e-1)	unprognostic (8.82e-2)		unprognostic (5.63e-2)	unprognostic (3.86e-2)		unprognostic (3.49e-1)	Hepatocytes
BAAT	BAT	ENSG00000136881	Bile acid-CoA:amino acid N-acyltransferase	Q14032	9	101354182-101385400	Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins	Fatty acid metabolism, Lipid metabolism	Acyltransferase, Hydrolase, Serine esterase, Transferase	Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	41	liver: 721.0	Cell type enriched	Detected in some	11	Hepatocytes: 1052.0	Cancer enriched	Detected in many	42	liver cancer: 181.1	Low region specificity	Detected in single			Not detected in immune cells	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	Bile duct cancer: 3.5;Gastric cancer: 2.5;Kidney cancer: 2.6;liver cancer: 9.4	Liver - Hepatocytes	Not detected	Not detected			Not detected	Not detected			HPA021251, HPA021330	Enhanced		Approved	Vesicles					520000		Cluster 60: Liver - Hemostasis & Lipid metabolism	Cluster 61: Liver - Metabolism	Cluster 13: Hepatocytes - Oxidoreductase activity	Vesicles		HPA021251: AB_1845247, HPA021330: AB_2670674	unprognostic (2.53e-2)	unprognostic (1.81e-1)	unprognostic (9.97e-2)	unprognostic (9.33e-2)	unprognostic (7.75e-3)	unprognostic (4.68e-2)	prognostic favorable (4.97e-4)	unprognostic (2.14e-2)	unprognostic (6.19e-2)	unprognostic (4.43e-4)	unprognostic (3.65e-1)	unprognostic (2.15e-1)	prognostic unfavorable (4.24e-7)	unprognostic (1.74e-1)	unprognostic (2.12e-1)	unprognostic (2.17e-2)	unprognostic (1.75e-1)	Hepatocytes
CYP2C9	CYP2C10, P450IIC9	ENSG00000138109	Cytochrome P450 family 2 subfamily C member 9	P11712	10	94938658-94990091	Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins	Lipid metabolism, Steroid metabolism, Sterol metabolism	Monooxygenase, Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	20	liver: 1719.9	Cell type enriched	Detected in some	32	Hepatocytes: 1625.4	Cancer enriched	Detected in some	41	liver cancer: 118.4	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in some		Gastric cancer: 1.8;liver cancer: 1.7	Kidney - Proximal tubular cells, Liver - Hepatocytes, Pancreas - Ductal cells, Stomach - Gastric mucous cells									HPA015066, CAB016123, HPA074424	Enhanced		Uncertain	Vesicles,Plasma membrane	Intracellular and membrane						Cluster 60: Liver - Hemostasis & Lipid metabolism	Cluster 10: Ovarian & Endometrial cancers - Unknown function	Cluster 13: Hepatocytes - Oxidoreductase activity	Vesicles	Plasma membrane	CAB016123: AB_629363, HPA015066: AB_1847433, HPA074424: 	unprognostic (3.37e-1)	unprognostic (5.68e-2)	unprognostic (9.67e-2)	unprognostic (4.16e-2)		unprognostic (1.83e-2)	prognostic favorable (2.83e-6)	unprognostic (2.37e-1)	unprognostic (2.05e-2)		unprognostic (4.93e-2)		unprognostic (1.26e-4)	unprognostic (7.55e-2)	unprognostic (1.12e-1)	unprognostic (2.45e-2)	unprognostic (1.24e-2)	Hepatocytes
CYP2C8	CPC8	ENSG00000138115	Cytochrome P450 family 2 subfamily C member 8	P10632	10	95036772-95069497	Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins	Lipid metabolism, Steroid metabolism	Monooxygenase, Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	359	liver: 2156.6	Cell type enriched	Detected in some	6	Hepatocytes: 1588.5	Cancer enriched	Detected in some	82	liver cancer: 102.3	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in single		Kidney cancer: 1.0	Liver - Hepatocytes, Testis - Early spermatids, Testis - Late spermatids									HPA013547, HPA013970, HPA015066, HPA074424	Enhanced		Uncertain	Vesicles,Plasma membrane	Intracellular and membrane					Cluster 36: GdT-cells - Adaptive immune response	Cluster 62: Liver - Hemostasis	Cluster 39: Non-specific - Unknown function	Cluster 13: Hepatocytes - Oxidoreductase activity	Vesicles	Plasma membrane	HPA013547: AB_1847435, HPA013970: AB_1847434, HPA015066: AB_1847433, HPA074424: 	unprognostic (3.33e-2)	unprognostic (1.38e-1)	unprognostic (1.53e-1)	unprognostic (1.55e-1)	unprognostic (4.41e-2)	unprognostic (1.09e-2)	unprognostic (1.80e-3)	unprognostic (4.29e-2)	unprognostic (1.03e-1)	unprognostic (3.38e-1)	prognostic favorable (9.82e-4)	unprognostic (2.85e-1)	unprognostic (1.44e-3)	unprognostic (2.63e-1)	unprognostic (7.88e-2)	unprognostic (1.39e-1)	unprognostic (4.05e-4)	Hepatocytes
RBP4		ENSG00000138207	Retinol binding protein 4	P02753	10	93591687-93601744	Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Sensory transduction, Transport, Vision		Cancer-related genes, Disease variant, Microphthalmia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	16	liver: 11920.3	Cell type enriched	Detected in many	13	Hepatocytes: 12630.5	Cancer enriched	Detected in all	27	liver cancer: 3135.4	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in many	4	liver cancer: 210.1	Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Liver - Hepatocytes, Lung - Macrophages, Pancreas - Beta cells, Skin - Adipocytes (Skin), Testis - Spermatogonia	Low region specificity	Detected in all			Low region specificity	Detected in many			HPA001641, CAB004555	Supported				Secreted to blood			46100000000	210000000000		Cluster 62: Liver - Hemostasis	Cluster 35: Liver cancer - Metabolism	Cluster 13: Hepatocytes - Oxidoreductase activity			CAB004555: AB_670938, HPA001641: AB_1079795	unprognostic (9.42e-3)	unprognostic (3.40e-2)	unprognostic (1.90e-1)	prognostic unfavorable (1.50e-4)	unprognostic (2.60e-2)	unprognostic (6.69e-4)	prognostic favorable (1.74e-8)	unprognostic (2.39e-1)	unprognostic (5.76e-2)	unprognostic (3.26e-2)	unprognostic (3.26e-1)	unprognostic (3.44e-1)	unprognostic (7.14e-3)	unprognostic (9.88e-3)	unprognostic (2.31e-1)	unprognostic (1.03e-1)	unprognostic (8.60e-2)	Hepatocytes
AOX1	AO, AOH1	ENSG00000138356	Aldehyde oxidase 1	Q06278	2	200586014-200677064	Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins	Lipid metabolism	Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	6	adrenal gland: 300.5;liver: 891.0	Cell type enriched	Detected in many	4	Hepatocytes: 710.0	Cancer enriched	Detected in many	9	liver cancer: 122.5	Low region specificity	Detected in many			Not detected in immune cells	Not detected			Not detected	Not detected			Low cancer specificity	Detected in many			Colon - Macrophages, Kidney - Proximal tubular cells, Liver - Hepatocytes, Skeletal muscle - Macrophages	Low region specificity	Detected in all			Low region specificity	Detected in many			HPA040199, HPA040215	Enhanced								3300000		Cluster 85: Liver - Metabolism	Cluster 59: Fibroblasts - Metabolism	Cluster 29: Hepatocytes - Metabolism			HPA040199: AB_10795273, HPA040215: AB_10795360	unprognostic (4.39e-2)	unprognostic (1.03e-3)	unprognostic (1.96e-1)	unprognostic (3.15e-2)	unprognostic (1.17e-4)	unprognostic (1.92e-2)	unprognostic (2.34e-2)	unprognostic (3.54e-1)	unprognostic (1.15e-1)	unprognostic (4.93e-2)	unprognostic (5.48e-2)	unprognostic (2.00e-2)	prognostic favorable (6.05e-5)	unprognostic (1.33e-2)	unprognostic (8.16e-3)	unprognostic (3.38e-2)	unprognostic (4.99e-3)	Hepatocytes
SLC38A4	ATA3, NAT3, PAAT	ENSG00000139209	Solute carrier family 38 member 4	Q969I6	12	46764761-46832408	FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters	Amino-acid transport, Ion transport, Sodium transport, Symport, Transport		FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	60	liver: 609.9	Cell type enriched	Detected in some	18	Hepatocytes: 242.2	Cancer enriched	Detected in many	14	liver cancer: 61.0	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in many		Sarcoma: 9.3	Liver - Hepatocytes, Liver - Hepatocytes	Low region specificity	Detected in many			Low region specificity	Detected in all													Cluster 15: NK-cells - Transcription	Cluster 62: Liver - Hemostasis	Cluster 42: Sarcoma - Muscle contraction	Cluster 13: Hepatocytes - Oxidoreductase activity				unprognostic (3.81e-2)	unprognostic (7.46e-3)	unprognostic (5.22e-3)	unprognostic (1.75e-2)	unprognostic (3.12e-1)	unprognostic (1.11e-1)	prognostic favorable (5.37e-4)	unprognostic (3.06e-2)	unprognostic (2.57e-3)	unprognostic (1.75e-2)	unprognostic (1.95e-1)	unprognostic (6.06e-2)	unprognostic (2.84e-2)	unprognostic (1.89e-2)	unprognostic (8.28e-2)	unprognostic (6.31e-3)	unprognostic (2.21e-2)	Hepatocytes
AMDHD1	MGC35366	ENSG00000139344	Amidohydrolase domain containing 1	Q96NU7	12	95943331-95968720	Enzymes, Metabolic proteins, Predicted intracellular proteins	Histidine metabolism	Hydrolase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		liver: 60.7;skeletal muscle: 27.3	Cell type enriched	Detected in some	5	Hepatocytes: 134.6	Cancer enriched	Detected in many	14	liver cancer: 23.4	Low region specificity	Detected in all			Low immune cell specificity	Detected in some			Low lineage specificity	Detected in many			Cancer enhanced	Detected in many		Esophageal cancer: 67.9;head and neck cancer: 73.7	Kidney - Proximal tubular cells, Kidney - Proximal tubular cells, Liver - Hepatocytes	Not detected	Not detected			Low region specificity	Detected in many			HPA039720, HPA040149	Uncertain		Approved	Nucleoplasm,Plasma membrane,Cytosol		No			1400000	Cluster 27: Non-specific - Gene expression	Cluster 39: Non-specific - Mitochondria	Cluster 60: Keratinocytes - Epithelial cell function	Cluster 29: Hepatocytes - Metabolism	Cytosol	Nucleoplasm, Plasma membrane	HPA039720: AB_10672967, HPA040149: 	unprognostic (4.81e-2)	unprognostic (2.91e-1)	unprognostic (1.53e-1)	unprognostic (2.09e-2)	unprognostic (1.80e-2)	unprognostic (2.88e-2)	unprognostic (2.33e-2)	unprognostic (6.62e-3)	unprognostic (1.06e-1)	unprognostic (7.01e-2)	unprognostic (3.35e-3)	unprognostic (1.17e-1)	unprognostic (4.63e-3)	unprognostic (3.98e-2)	unprognostic (1.70e-1)	unprognostic (4.08e-3)	unprognostic (2.61e-1)	Hepatocytes
RDH16	RODH-4, SDR9C8	ENSG00000139547	Retinol dehydrogenase 16	O75452	12	56951431-56959374	Enzymes, Metabolic proteins, Predicted membrane proteins	Lipid metabolism, Steroid metabolism	Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	152	liver: 793.0	Cell type enriched	Detected in some	4	Hepatocytes: 344.0	Cancer enriched	Detected in many	20	liver cancer: 44.0	Low region specificity	Detected in single			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in some		head and neck cancer: 1.6;prostate cancer: 1.6	Liver - Hepatocytes, Testis - Late spermatids	Not detected	Not detected			Low region specificity	Detected in all			HPA038518	Enhanced									Cluster 36: GdT-cells - Adaptive immune response	Cluster 62: Liver - Hemostasis	Cluster 60: Keratinocytes - Epithelial cell function	Cluster 29: Hepatocytes - Metabolism			HPA038518: AB_10672713	unprognostic (5.42e-3)	unprognostic (4.20e-2)	unprognostic (2.99e-2)	unprognostic (1.14e-1)	unprognostic (1.88e-1)	unprognostic (2.92e-2)	prognostic favorable (2.16e-5)	unprognostic (8.83e-3)	unprognostic (1.04e-1)	unprognostic (2.84e-1)	unprognostic (6.85e-2)	unprognostic (6.10e-1)	unprognostic (7.99e-12)	unprognostic (2.24e-1)	unprognostic (1.29e-2)	unprognostic (1.62e-1)	unprognostic (2.01e-2)	Hepatocytes
SERPINA10	PZI, ZPI	ENSG00000140093	Serpin family A member 10	Q9UK55	14	94280460-94293268	Plasma proteins, Predicted membrane proteins, Predicted secreted proteins	Blood coagulation, Hemostasis	Heparin-binding, Protease inhibitor, Serine protease inhibitor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	104	liver: 346.9	Cell type enriched	Detected in some	11	Hepatocytes: 219.9	Cancer enriched	Detected in some	51	liver cancer: 40.6	Low region specificity	Detected in many			Not detected in immune cells	Not detected			Not detected	Not detected			Low cancer specificity	Detected in many			Breast - Breast glandular cells, Liver - Hepatocytes, Pancreas - Alpha cells, Stomach - Gastric enteroendocrine cells	Not detected	Not detected							HPA048739			Approved	Nucleoplasm,Cytosol	Secreted to blood			3960000000	4700000000		Cluster 60: Liver - Hemostasis & Lipid metabolism	Cluster 41: Non-specific - Cilium assembly	Cluster 29: Hepatocytes - Metabolism	Nucleoplasm	Cytosol	HPA048739: AB_2797237	unprognostic (7.14e-2)	unprognostic (2.03e-1)	unprognostic (2.69e-2)	unprognostic (2.01e-1)	unprognostic (1.21e-1)	unprognostic (1.45e-1)	prognostic favorable (9.00e-4)	unprognostic (6.11e-2)		unprognostic (2.81e-4)	unprognostic (2.31e-4)	unprognostic (2.77e-2)	unprognostic (2.91e-3)	unprognostic (1.38e-1)	unprognostic (1.58e-1)	unprognostic (1.11e-1)	unprognostic (7.93e-3)	Hepatocytes
SLC25A47	C14orf68	ENSG00000140107	Solute carrier family 25 member 47	Q6Q0C1	14	100323339-100330421	Predicted membrane proteins, Transporters	Transport			Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Tissue enriched	Detected in some	355	liver: 534.7	Cell type enriched	Detected in some	53	Hepatocytes: 231.6	Cancer enriched	Detected in single	273	liver cancer: 56.9	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected				Low region specificity	Detected in all			Low region specificity	Detected in single														Cluster 62: Liver - Hemostasis	Cluster 41: Non-specific - Cilium assembly	Cluster 13: Hepatocytes - Oxidoreductase activity				unprognostic (2.54e-3)	unprognostic (2.57e-3)	unprognostic (5.12e-2)	unprognostic (2.27e-2)	unprognostic (6.07e-2)	unprognostic (1.30e-2)	unprognostic (4.25e-2)	unprognostic (1.14e-1)	unprognostic (2.89e-2)	unprognostic (2.50e-1)	unprognostic (1.96e-3)	unprognostic (4.46e-1)	unprognostic (1.44e-1)	unprognostic (4.50e-1)	unprognostic (5.64e-2)	unprognostic (1.02e-2)	unprognostic (1.94e-1)	Hepatocytes
CYP1A2	CP12, P3-450	ENSG00000140505	Cytochrome P450 family 1 subfamily A member 2	P05177	15	74748845-74756607	Cancer-related genes, Enzymes, Metabolic proteins, Predicted membrane proteins	Fatty acid metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism	Lyase, Monooxygenase, Oxidoreductase	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	313	liver: 513.4	Cell type enriched	Detected in some	56	Hepatocytes: 541.7	Group enriched	Detected in some	22	liver cancer: 25.3;urothelial cancer: 6.5	Low region specificity	Detected in some			Immune cell enhanced	Detected in some		neutrophil: 2.1	Low lineage specificity	Detected in single			Low cancer specificity	Detected in some			Liver - Hepatocytes	Not detected	Not detected			Not detected	Not detected			CAB016531	Enhanced									Cluster 33: Neutrophils - Chromatin organization	Cluster 60: Liver - Hemostasis & Lipid metabolism	Cluster 60: Keratinocytes - Epithelial cell function	Cluster 13: Hepatocytes - Oxidoreductase activity			CAB016531: AB_629359				unprognostic (1.54e-4)			unprognostic (1.29e-1)	unprognostic (1.98e-1)	unprognostic (1.74e-1)	unprognostic (1.59e-2)		unprognostic (1.76e-1)	unprognostic (1.17e-2)	unprognostic (5.48e-2)	unprognostic (2.33e-2)	unprognostic (7.41e-2)	unprognostic (2.53e-1)	Hepatocytes
ASGR1	CLEC4H1	ENSG00000141505	Asialoglycoprotein receptor 1	P07306	17	7173431-7179564	Predicted intracellular proteins, Predicted secreted proteins	Endocytosis, Host-virus interaction	Receptor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	41	liver: 1092.3	Cell type enriched	Detected in many	4	Hepatocytes: 988.7	Cancer enriched	Detected in many	90	liver cancer: 131.6	Low region specificity	Detected in all			Group enriched	Detected in many	5	classical monocyte: 115.2;intermediate monocyte: 55.5;myeloid DC: 41.2	Group enriched	Detected in many	8	dendritic cells: 41.2;monocytes: 115.2	Cancer enriched	Detected in many	10	liver cancer: 83.3	Testis - Early spermatids, Testis - Late spermatids	Region enriched	Detected in all	9	cerebellum: 44.1	Not detected	Not detected			HPA011954, HPA012852	Enhanced		Supported	Vesicles,Cell Junctions	Secreted to blood				10000	Cluster 25: Monocytes - Inflammatory response	Cluster 62: Liver - Hemostasis	Cluster 35: Liver cancer - Metabolism	Cluster 13: Hepatocytes - Oxidoreductase activity	Vesicles	Cell Junctions	HPA011954: AB_1845079, HPA012852: AB_1845080	unprognostic (3.56e-3)	unprognostic (3.57e-1)	unprognostic (8.76e-2)	unprognostic (4.05e-2)	unprognostic (1.88e-1)	unprognostic (1.22e-1)	unprognostic (1.86e-2)	unprognostic (5.37e-2)	unprognostic (2.15e-1)	unprognostic (2.39e-1)	unprognostic (8.55e-5)	unprognostic (1.55e-1)	unprognostic (8.33e-11)	unprognostic (1.45e-1)	unprognostic (2.00e-1)	unprognostic (1.73e-3)	unprognostic (4.46e-3)	Hepatocytes
F13B	FXIIIB	ENSG00000143278	Coagulation factor XIII B chain	P05160	1	197038741-197067260	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Blood coagulation, Hemostasis		Cancer-related genes, Disease variant, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	211	liver: 200.2	Cell type enriched	Detected in some	16	Hepatocytes: 59.8	Cancer enriched	Detected in single	816	liver cancer: 46.3	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Liver - Hepatocytes	Not detected	Not detected			Low region specificity	Detected in all			HPA003827, HPA052139	Supported				Secreted to blood				4700000000		Cluster 60: Liver - Hemostasis & Lipid metabolism	Cluster 35: Liver cancer - Metabolism	Cluster 13: Hepatocytes - Oxidoreductase activity			HPA003827: AB_1078794, HPA052139: AB_2681744					unprognostic (1.46e-1)		prognostic favorable (6.78e-5)							unprognostic (1.21e-2)				Hepatocytes
AHSG	A2HS, FETUA, HSGA	ENSG00000145192	Alpha 2-HS glycoprotein	P02765	3	186613060-186621318	Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins	Mineral balance		Cancer-related genes, Disease variant, Hypotrichosis, Intellectual disability	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	4302	liver: 5817.6	Cell type enriched	Detected in some	12	Hepatocytes: 1133.3	Cancer enriched	Detected in some	284	liver cancer: 1231.6	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in some	16	liver cancer: 532.8	Liver - Hepatocytes, Testis - Late spermatids	Not detected	Not detected			Not detected	Not detected			HPA001524, HPA001525, CAB026209	Enhanced		Enhanced	Golgi apparatus	Secreted to blood			864000000000	110000000000	Cluster 48: NK-cells - Unknown function	Cluster 62: Liver - Hemostasis	Cluster 35: Liver cancer - Metabolism	Cluster 29: Hepatocytes - Metabolism	Golgi apparatus		CAB026209: , HPA001524: AB_1078851, HPA001525: AB_1078849		unprognostic (6.40e-2)	unprognostic (1.31e-1)	unprognostic (2.03e-2)	unprognostic (3.20e-2)	unprognostic (1.07e-2)	unprognostic (1.16e-2)	unprognostic (7.47e-3)	unprognostic (3.05e-1)	unprognostic (5.27e-2)	unprognostic (8.64e-2)		unprognostic (3.99e-7)	unprognostic (5.21e-2)	unprognostic (5.21e-2)	unprognostic (1.04e-1)		Hepatocytes
IGFBP1	AFBP, hIGFBP-1, IBP1, IGF-BP25, PP12	ENSG00000146678	Insulin like growth factor binding protein 1	P08833	7	45888360-45893660	Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins		Growth factor binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	6	liver: 1198.4	Cell type enriched	Detected in some	8	Hepatocytes: 911.0	Cancer enriched	Detected in many	29	liver cancer: 385.9	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Group enriched	Detected in many	6	Gastric cancer: 32.4;liver cancer: 84.6;ovarian cancer: 103.1;pancreatic cancer: 51.0	Breast - Breast glandular cells (progenitors), Kidney - Intercalated cells	Not detected	Not detected			Not detected	Not detected			CAB004445, HPA046972, HPA050640	Enhanced		Approved	Golgi apparatus	Secreted to blood			28100000	25000000		Cluster 85: Liver - Metabolism	Cluster 37: Ovarian cancer RMG-I - Cellular stress response	Cluster 13: Hepatocytes - Oxidoreductase activity	Golgi apparatus		CAB004445: AB_627782, HPA046972: AB_2679884, HPA050640: AB_2681197	unprognostic (8.66e-3)	unprognostic (1.45e-1)	unprognostic (9.41e-2)	unprognostic (7.80e-2)	unprognostic (7.04e-2)	unprognostic (2.93e-1)	unprognostic (1.01e-1)	prognostic unfavorable (1.03e-4)	unprognostic (1.89e-2)	unprognostic (2.09e-3)	unprognostic (8.95e-2)		prognostic unfavorable (6.90e-11)	prognostic unfavorable (6.64e-4)	unprognostic (7.20e-2)	unprognostic (7.98e-2)	unprognostic (3.43e-1)	Hepatocytes
RIPPLY1		ENSG00000147223	Ripply transcriptional repressor 1	Q0D2K3	X	106900063-106903341	Predicted intracellular proteins	Transcription, Transcription regulation	Developmental protein, Repressor		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	5	kidney: 3.4;liver: 5.8	Cell type enriched	Detected in some	4	Hepatocytes: 5.2	Cancer enhanced	Detected in some		liver cancer: 2.2;renal cancer: 3.6	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in single		Uterine cancer: 1.0		Not detected	Not detected			Not detected	Not detected			HPA052284	Uncertain				Intracellular and membrane						Cluster 81: Kidney & Liver - Metabolism	Cluster 39: Non-specific - Unknown function	Cluster 13: Hepatocytes - Oxidoreductase activity			HPA052284: AB_2681785	unprognostic (1.48e-1)	unprognostic (4.35e-2)	unprognostic (1.67e-1)	unprognostic (9.52e-3)	unprognostic (7.00e-3)	unprognostic (1.13e-2)	unprognostic (1.66e-3)	unprognostic (1.50e-1)	unprognostic (2.42e-1)	unprognostic (5.37e-2)	unprognostic (2.53e-1)	unprognostic (1.36e-1)	unprognostic (2.49e-3)	unprognostic (1.97e-1)	unprognostic (1.97e-1)	unprognostic (1.97e-3)	unprognostic (1.31e-1)	Hepatocytes
SAA4	C-SAA, CSAA	ENSG00000148965	Serum amyloid A4, constitutive	P35542	11	18231355-18236802	Plasma proteins, Predicted secreted proteins	Acute phase			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	124	liver: 1943.5	Cell type enriched	Detected in some	17	Hepatocytes: 1693.4	Cancer enriched	Detected in many	141	liver cancer: 118.6	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in some		head and neck cancer: 8.2;liver cancer: 6.9	Adipose visceral - Adipocytes (Visceral), Liver - Hepatocytes, Testis - Early spermatids, Testis - Late spermatids	Not detected	Not detected							CAB026061, HPA060139	Supported				Secreted to blood			65000000000	33000000000		Cluster 62: Liver - Hemostasis	Cluster 35: Liver cancer - Metabolism	Cluster 13: Hepatocytes - Oxidoreductase activity			CAB026061: , HPA060139: AB_2684210	unprognostic (4.70e-4)	unprognostic (1.17e-1)	unprognostic (1.17e-1)	unprognostic (4.83e-1)	unprognostic (4.15e-2)	unprognostic (6.05e-2)	unprognostic (3.63e-3)	unprognostic (5.94e-2)		unprognostic (2.40e-2)	unprognostic (1.41e-1)	unprognostic (7.35e-2)	unprognostic (2.54e-8)	unprognostic (2.49e-1)			unprognostic (6.46e-2)	Hepatocytes
MAT1A	MAT, MATA1, SAMS, SAMS1	ENSG00000151224	Methionine adenosyltransferase 1A	Q00266	10	80271820-80289658	Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins	One-carbon metabolism	Transferase	Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	23	liver: 1346.5	Cell type enriched	Detected in some	31	Hepatocytes: 5245.2	Cancer enriched	Detected in many	54	liver cancer: 209.8	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in many		liver cancer: 9.4;skin cancer: 5.1	Liver - Hepatocytes, Lung - Respiratory ciliated cells, Testis - Early spermatids, Testis - Late spermatids	Not detected	Not detected			Low region specificity	Detected in many			HPA048627	Supported								1900000		Cluster 62: Liver - Hemostasis	Cluster 35: Liver cancer - Metabolism	Cluster 13: Hepatocytes - Oxidoreductase activity			HPA048627: AB_2680465	unprognostic (6.92e-2)	unprognostic (2.63e-1)	unprognostic (2.88e-2)	unprognostic (9.43e-2)	unprognostic (3.79e-2)	unprognostic (2.49e-2)	unprognostic (2.03e-3)	unprognostic (1.46e-1)	unprognostic (1.09e-1)	unprognostic (2.58e-2)	unprognostic (1.76e-1)	unprognostic (8.66e-2)	unprognostic (1.11e-16)	unprognostic (8.59e-3)	unprognostic (9.90e-2)	unprognostic (3.58e-1)	unprognostic (5.98e-2)	Hepatocytes
THRSP	Lpgp, LPGP1, S14, SPOT14, THRP	ENSG00000151365	Thyroid hormone responsive	Q92748	11	78063861-78068351	Predicted intracellular proteins	Lipid biosynthesis, Lipid metabolism, Transcription, Transcription regulation			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		adipose tissue: 210.0;liver: 408.9	Cell type enriched	Detected in some	6	Hepatocytes: 142.2	Cancer enhanced	Detected in many		liver cancer: 44.1	Region enriched	Detected in single	6	cerebellum: 2.7	Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in some		breast cancer: 10.6;lymphoma: 4.2	Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Liver - Hepatocytes, Skin - Sebaceous gland cells	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA040642	Approved		Approved	Nucleoplasm						Cluster 40: NK-cells - Unknown function	Cluster 85: Liver - Metabolism	Cluster 65: Breast cancer - Unknown function	Cluster 29: Hepatocytes - Metabolism	Nucleoplasm		HPA040642: AB_10794878	unprognostic (1.19e-1)	unprognostic (2.88e-1)	unprognostic (2.84e-1)	unprognostic (2.73e-2)	unprognostic (3.07e-1)	unprognostic (9.91e-3)	unprognostic (1.59e-2)	unprognostic (9.60e-2)	unprognostic (1.07e-2)	unprognostic (8.23e-2)	unprognostic (1.68e-1)	unprognostic (2.58e-1)	prognostic unfavorable (1.16e-4)	unprognostic (9.64e-2)	unprognostic (1.57e-1)	prognostic favorable (3.28e-4)	unprognostic (1.69e-3)	Hepatocytes
ITIH2	H2P	ENSG00000151655	Inter-alpha-trypsin inhibitor heavy chain 2	P19823	10	7703316-7749520	Plasma proteins, Predicted secreted proteins		Protease inhibitor, Serine protease inhibitor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	668	liver: 2156.1	Cell type enriched	Detected in some	4	Hepatocytes: 410.8	Cancer enriched	Detected in many	279	liver cancer: 626.9	Low region specificity	Detected in many			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in some	30	liver cancer: 159.6	Liver - Hepatocytes	Low region specificity	Detected in all			Not detected	Not detected			HPA059150	Supported		Approved	Golgi apparatus	Secreted to blood				32000000000		Cluster 62: Liver - Hemostasis	Cluster 35: Liver cancer - Metabolism	Cluster 29: Hepatocytes - Metabolism	Golgi apparatus		HPA059150: AB_2683930	unprognostic (4.82e-2)	unprognostic (6.10e-2)	unprognostic (2.48e-2)	unprognostic (1.21e-2)	unprognostic (2.01e-2)	unprognostic (2.55e-3)	prognostic favorable (1.48e-4)	unprognostic (1.37e-1)	unprognostic (1.79e-1)	unprognostic (1.47e-2)	unprognostic (2.28e-1)	unprognostic (2.02e-1)	unprognostic (2.10e-8)	unprognostic (9.91e-3)	unprognostic (1.70e-1)	unprognostic (2.35e-1)	unprognostic (4.46e-4)	Hepatocytes
TDO2	TDO, TPH2	ENSG00000151790	Tryptophan 2,3-dioxygenase	P48775	4	155854738-155920406	Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins	Tryptophan catabolism	Dioxygenase, Oxidoreductase	Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	47	liver: 797.8	Cell type enriched	Detected in some	8	Hepatocytes: 1549.6	Cancer enriched	Detected in many	18	liver cancer: 35.7	Low region specificity	Detected in some			Not detected in immune cells	Not detected			Not detected	Not detected			Low cancer specificity	Detected in many				Group enriched	Detected in some	7	cerebellum: 6.3;hippocampal formation: 5.3;white matter: 1.9	Low region specificity	Detected in all			HPA039611	Uncertain		Approved	Plasma membrane,Cytosol							Cluster 60: Liver - Hemostasis & Lipid metabolism	Cluster 61: Liver - Metabolism	Cluster 13: Hepatocytes - Oxidoreductase activity	Plasma membrane, Cytosol		HPA039611: 	unprognostic (1.10e-1)	unprognostic (3.00e-3)	unprognostic (3.84e-2)	unprognostic (1.95e-1)	unprognostic (7.06e-2)	unprognostic (3.50e-1)	unprognostic (1.18e-1)	unprognostic (1.03e-1)	unprognostic (1.00e-1)	unprognostic (2.13e-2)	unprognostic (1.42e-1)	unprognostic (1.01e-1)	unprognostic (4.68e-8)	unprognostic (7.99e-2)	unprognostic (9.29e-3)	unprognostic (1.28e-1)	unprognostic (1.95e-2)	Hepatocytes
UGT2B4	UGT2B11	ENSG00000156096	UDP glucuronosyltransferase family 2 member B4	P06133	4	69480165-69526014	Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins	Lipid metabolism	Glycosyltransferase, Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	107	liver: 1273.7	Cell type enriched	Detected in some	15	Hepatocytes: 816.6	Cancer enriched	Detected in some	96	liver cancer: 351.5	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in some	18	liver cancer: 31.5	Liver - Hepatocytes									CAB033260, HPA045108	Enhanced				Intracellular and membrane						Cluster 62: Liver - Hemostasis	Cluster 61: Liver - Metabolism	Cluster 13: Hepatocytes - Oxidoreductase activity			CAB033260: AB_2241496, HPA045108: AB_2679218	unprognostic (7.46e-2)						unprognostic (1.50e-1)	unprognostic (9.37e-2)			unprognostic (1.51e-1)	unprognostic (2.47e-2)	unprognostic (1.47e-1)	unprognostic (9.43e-3)	unprognostic (3.52e-1)			Hepatocytes
C8A		ENSG00000157131	Complement C8 alpha chain	P07357	1	56854797-56918223	Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters	Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	195	liver: 635.7	Cell type enriched	Detected in some	9	Hepatocytes: 260.8	Cancer enriched	Detected in single	279	liver cancer: 85.3	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in single	6	liver cancer: 1.4	Liver - Hepatocytes	Not detected	Not detected			Not detected	Not detected								Secreted to blood				6400000000		Cluster 60: Liver - Hemostasis & Lipid metabolism	Cluster 35: Liver cancer - Metabolism	Cluster 29: Hepatocytes - Metabolism										unprognostic (3.73e-3)	unprognostic (2.44e-1)			unprognostic (1.28e-1)			unprognostic (6.40e-2)		unprognostic (9.82e-2)		Hepatocytes
APOA2		ENSG00000158874	Apolipoprotein A2	P02652	1	161222292-161223631	Cancer-related genes, Candidate cardiovascular disease genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Host-virus interaction, Lipid transport, Transport		Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	1388	liver: 36012.6	Cell type enriched	Detected in some	62	Hepatocytes: 52487.7	Cancer enriched	Detected in many	329	liver cancer: 11230.1	Low region specificity	Detected in many			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in some	8	liver cancer: 2323.0	Liver - Hepatocytes	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB025885, HPA072575	Supported				Secreted to blood			115000000000	92000000000	Cluster 1: Neutrophils - Mixed function	Cluster 60: Liver - Hemostasis & Lipid metabolism	Cluster 35: Liver cancer - Metabolism	Cluster 13: Hepatocytes - Oxidoreductase activity			CAB025885: , HPA072575: 		unprognostic (2.05e-1)	unprognostic (4.70e-2)	unprognostic (1.12e-1)	unprognostic (2.99e-1)		unprognostic (9.82e-2)	unprognostic (1.92e-1)	unprognostic (3.16e-1)	unprognostic (2.79e-1)	unprognostic (1.57e-2)		unprognostic (4.40e-3)	unprognostic (3.16e-2)	unprognostic (2.22e-1)	unprognostic (1.60e-1)	unprognostic (6.09e-2)	Hepatocytes
PGLYRP2	PGLYRPL, PGRP-L, PGRPL, tagL, tagL-alpha, tagl-beta, TAGL-like	ENSG00000161031	Peptidoglycan recognition protein 2	Q96PD5	19	15468645-15498956	Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins	Immunity	Hydrolase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	45	liver: 258.8	Cell type enriched	Detected in some	11	Hepatocytes: 133.9	Cancer enriched	Detected in some	16	liver cancer: 42.9	Not detected	Not detected			Low immune cell specificity	Detected in many			Group enriched	Detected in many	7	granulocytes: 3.4;monocytes: 5.1;T-cells: 2.3	Group enriched	Detected in some	4	Bone cancer: 6.0;breast cancer: 2.8	Breast - Breast glandular cells, Breast - Breast glandular cells, Liver - Hepatocytes, Testis - Sertoli cells	Not detected	Not detected			Not detected	Not detected			CAB033468, HPA046311, HPA075237	Supported		Approved	Cell Junctions	Secreted to blood				87000000000	Cluster 51: Monocytes - Innate immune response	Cluster 62: Liver - Hemostasis	Cluster 65: Breast cancer - Unknown function	Cluster 13: Hepatocytes - Oxidoreductase activity	Cell Junctions		CAB033468: AB_1127187, HPA046311: AB_2679621, HPA075237: AB_2686739	unprognostic (7.39e-3)	unprognostic (1.52e-2)	unprognostic (5.22e-2)	unprognostic (8.79e-2)	unprognostic (3.97e-1)	unprognostic (4.88e-4)	unprognostic (5.93e-3)	unprognostic (6.48e-2)	unprognostic (1.99e-1)	unprognostic (1.18e-2)	unprognostic (3.15e-2)	unprognostic (2.40e-1)	unprognostic (6.66e-16)	unprognostic (6.35e-3)	unprognostic (2.80e-1)	unprognostic (2.45e-2)	unprognostic (2.81e-4)	Hepatocytes
ASGR2	CLEC4H2	ENSG00000161944	Asialoglycoprotein receptor 2	P07307	17	7101322-7115700	Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins	Endocytosis, Host-virus interaction	Receptor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	48	liver: 840.7	Cell type enriched	Detected in some	5	Hepatocytes: 773.1	Cancer enriched	Detected in many	66	liver cancer: 214.2	Low region specificity	Detected in many			Group enriched	Detected in many	8	classical monocyte: 110.0;myeloid DC: 64.1	Group enriched	Detected in many	51	dendritic cells: 64.1;monocytes: 110.0	Cancer enriched	Detected in some	12	liver cancer: 103.7	Adipose subcutaneous - Macrophages, Breast - Macrophages, Liver - Hepatocytes, Lung - Neutrophil_2	Not detected	Not detected			Not detected	Not detected			HPA014899, HPA015998	Enhanced		Supported	Endoplasmic reticulum,Plasma membrane					14000000	Cluster 25: Monocytes - Inflammatory response	Cluster 60: Liver - Hemostasis & Lipid metabolism	Cluster 35: Liver cancer - Metabolism	Cluster 29: Hepatocytes - Metabolism	Endoplasmic reticulum, Plasma membrane		HPA014899: AB_1845085, HPA015998: AB_1845084	unprognostic (6.76e-2)	unprognostic (7.45e-7)	unprognostic (1.61e-1)	unprognostic (2.55e-2)	unprognostic (1.03e-2)	unprognostic (4.99e-2)	unprognostic (1.16e-3)	unprognostic (1.32e-1)	unprognostic (1.81e-1)	unprognostic (9.74e-2)	unprognostic (1.63e-1)	unprognostic (1.66e-1)	unprognostic (9.35e-4)	unprognostic (1.54e-3)	unprognostic (6.95e-2)	unprognostic (1.86e-1)	unprognostic (7.31e-2)	Hepatocytes
CYP4A22		ENSG00000162365	Cytochrome P450 family 4 subfamily A member 22	Q5TCH4	1	47137435-47149735	Enzymes, Metabolic proteins, Predicted membrane proteins	Lipid metabolism	Monooxygenase, Oxidoreductase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	7	liver: 214.2	Cell type enriched	Detected in some	22	Hepatocytes: 98.8	Cancer enriched	Detected in some	13	liver cancer: 20.0	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Kidney - Proximal tubular cells, Kidney - Proximal tubular cells, Liver - Hepatocytes																				Cluster 85: Liver - Metabolism	Cluster 42: Sarcoma - Muscle contraction	Cluster 13: Hepatocytes - Oxidoreductase activity				unprognostic (5.34e-2)	unprognostic (1.24e-1)		unprognostic (3.19e-2)			unprognostic (2.88e-3)	unprognostic (2.76e-3)		unprognostic (1.50e-3)	unprognostic (2.21e-1)	unprognostic (2.75e-1)	unprognostic (1.93e-2)	unprognostic (5.29e-3)	unprognostic (1.02e-1)	unprognostic (1.71e-1)	unprognostic (8.59e-4)	Hepatocytes
SLC2A2	GLUT2	ENSG00000163581	Solute carrier family 2 member 2	P11168	3	170996347-171026743	Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters	Sugar transport, Transport		Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	13	liver: 836.1	Cell type enriched	Detected in some	4	Hepatocytes: 412.5	Cancer enriched	Detected in some	12	liver cancer: 105.2	Low region specificity	Detected in single			Not detected in immune cells	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	Bladder cancer: 4.5;Kidney cancer: 7.0;liver cancer: 4.4	Kidney - Proximal tubular cells, Liver - Hepatocytes	Not detected	Not detected			Low region specificity	Detected in many			CAB010444, HPA028997, HPA069490	Enhanced		Supported	Plasma membrane							Cluster 85: Liver - Metabolism	Cluster 68: Kidney - Mixed function	Cluster 13: Hepatocytes - Oxidoreductase activity	Plasma membrane		CAB010444: AB_641068, HPA028997: AB_2672860, HPA069490: 			unprognostic (9.56e-2)		unprognostic (1.24e-1)		prognostic favorable (2.63e-5)				unprognostic (3.10e-1)		unprognostic (1.02e-1)	unprognostic (2.95e-2)	unprognostic (6.31e-2)			Hepatocytes
ALB		ENSG00000163631	Albumin	P02768	4	73397114-73421482	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins			Cancer-related genes, Disease variant, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	135	liver: 212494.0	Cell type enriched	Detected in many	4	Hepatocytes: 60343.6	Cancer enriched	Detected in many	384	liver cancer: 14213.7	Low region specificity	Detected in some			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in many	24	liver cancer: 2047.9	Kidney - Proximal tubular cells, Liver - Hepatocytes	Not detected	Not detected			Low region specificity	Detected in all			CAB006262, HPA031024, HPA031025	Enhanced		Enhanced	Endoplasmic reticulum,Golgi apparatus	Secreted to blood			40000000000000			Cluster 62: Liver - Hemostasis	Cluster 35: Liver cancer - Metabolism	Cluster 13: Hepatocytes - Oxidoreductase activity	Golgi apparatus	Endoplasmic reticulum	CAB006262: AB_425297, HPA031024: AB_2673703, HPA031025: AB_2673704	unprognostic (1.38e-1)	unprognostic (8.72e-2)	unprognostic (1.73e-1)	unprognostic (2.60e-1)	unprognostic (4.44e-1)	unprognostic (2.46e-1)	unprognostic (9.53e-3)	unprognostic (2.16e-2)	unprognostic (2.40e-1)	unprognostic (6.43e-2)	unprognostic (3.84e-2)	unprognostic (5.37e-2)	unprognostic (1.25e-1)	prognostic unfavorable (7.87e-4)	unprognostic (7.23e-2)	unprognostic (1.05e-3)	unprognostic (1.02e-2)	Hepatocytes
RTP3	LTM1, TMEM7, Z3CXXC3	ENSG00000163825	Receptor transporter protein 3	Q9BQQ7	3	46497976-46500950	Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	130	liver: 119.5	Cell type enriched	Detected in some	22	Hepatocytes: 121.5	Cancer enriched	Detected in some	5	liver cancer: 22.9	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in some		cervical cancer: 2.7;head and neck cancer: 3.2	Liver - Hepatocytes	Not detected	Not detected			Low region specificity	Detected in all			HPA075932			Uncertain	Mitochondria							Cluster 62: Liver - Hemostasis	Cluster 44: Myeloma - Humoral immune response	Cluster 13: Hepatocytes - Oxidoreductase activity	Mitochondria		HPA075932: 		unprognostic (2.09e-1)				unprognostic (1.64e-1)	prognostic favorable (3.11e-6)								unprognostic (1.08e-1)	unprognostic (1.58e-1)		Hepatocytes
KLKB1	KLK3	ENSG00000164344	Kallikrein B1	P03952	4	186208979-186258471	Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Blood coagulation, Fibrinolysis, Hemostasis, Inflammatory response	Hydrolase, Protease, Serine protease	Disease variant, FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	25	liver: 328.4	Cell type enriched	Detected in many	4	Hepatocytes: 226.3	Cancer enriched	Detected in some	17	liver cancer: 27.6	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Liver - Hepatocytes	Not detected	Not detected			Low region specificity	Detected in single								Secreted to blood			28900000000	5300000000		Cluster 62: Liver - Hemostasis	Cluster 28: Bone cancer CADO-ES1 - Glutamate signalling	Cluster 13: Hepatocytes - Oxidoreductase activity				unprognostic (4.80e-2)	unprognostic (4.53e-3)	unprognostic (4.36e-2)	unprognostic (4.17e-2)	unprognostic (5.93e-2)	unprognostic (1.90e-2)	unprognostic (1.15e-2)	unprognostic (2.83e-1)	unprognostic (8.14e-2)	unprognostic (1.35e-1)	unprognostic (1.38e-2)	unprognostic (1.15e-1)	unprognostic (1.45e-2)	unprognostic (6.01e-2)	unprognostic (7.30e-2)	unprognostic (1.20e-1)	unprognostic (1.59e-2)	Hepatocytes
LEAP2	LEAP-2	ENSG00000164406	Liver enriched antimicrobial peptide 2	Q969E1	5	132873444-132875046	Plasma proteins, Predicted secreted proteins		Antibiotic, Antimicrobial		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	23	liver: 532.0	Cell type enriched	Detected in many	6	Hepatocytes: 1817.3	Cancer enriched	Detected in many	17	liver cancer: 40.0	Low region specificity	Detected in many			Low immune cell specificity	Detected in many			Low lineage specificity	Detected in many			Low cancer specificity	Detected in some				Not detected	Not detected			Low region specificity	Detected in many								Secreted to blood				790000	Cluster 50: Neutrophils - Cellular senescence	Cluster 62: Liver - Hemostasis	Cluster 35: Liver cancer - Metabolism	Cluster 13: Hepatocytes - Oxidoreductase activity				unprognostic (2.14e-2)	unprognostic (8.78e-2)	unprognostic (4.75e-1)	unprognostic (2.16e-1)	unprognostic (2.82e-1)	unprognostic (1.06e-2)	unprognostic (2.78e-3)	unprognostic (6.53e-2)	unprognostic (3.86e-2)	unprognostic (1.62e-1)	unprognostic (7.08e-3)	unprognostic (2.91e-2)	unprognostic (1.02e-1)	unprognostic (2.39e-1)	unprognostic (3.97e-1)	unprognostic (1.11e-1)	prognostic favorable (2.68e-4)	Hepatocytes
MBL2	COLEC1, MBL	ENSG00000165471	Mannose binding lectin 2	P11226	10	52765380-52772784	Human disease related genes, Plasma proteins, Predicted secreted proteins	Complement activation lectin pathway, Complement pathway, Immunity, Innate immunity			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	2810	liver: 280.9	Cell type enriched	Detected in some	96	Hepatocytes: 233.7	Cancer enriched	Detected in single	275	liver cancer: 22.6	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Liver - Hepatocytes	Not detected	Not detected			Region enriched	Detected in single	11	basal ganglia: 1.1	HPA002027, CAB016782	Enhanced				Secreted to blood			1220000000	1900000000		Cluster 60: Liver - Hemostasis & Lipid metabolism	Cluster 35: Liver cancer - Metabolism	Cluster 13: Hepatocytes - Oxidoreductase activity			CAB016782: , HPA002027: AB_1079324							unprognostic (1.72e-2)		unprognostic (3.03e-1)									Hepatocytes
LIPC	HL, HTGL	ENSG00000166035	Lipase C, hepatic type	P11150	15	58410569-58569844	Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted secreted proteins	Lipid degradation, Lipid metabolism	Heparin-binding, Hydrolase	Disease variant	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	28	liver: 171.0	Cell type enriched	Detected in some	7	Hepatocytes: 151.1	Group enriched	Detected in some	14	liver cancer: 20.4;renal cancer: 10.4	Low region specificity	Detected in some			Low immune cell specificity	Detected in some			Group enriched	Detected in many	7	granulocytes: 1.6;NK-cells: 1.5;T-cells: 1.8	Group enriched	Detected in many	4	Gastric cancer: 24.5;Kidney cancer: 6.8;liver cancer: 19.3	Liver - Hepatocytes, Skin - Fibroblast_1	Not detected	Not detected			Low region specificity	Detected in many								Secreted to blood				5500000	Cluster 10: Basophils - Unknown function	Cluster 62: Liver - Hemostasis	Cluster 35: Liver cancer - Metabolism	Cluster 13: Hepatocytes - Oxidoreductase activity				unprognostic (1.76e-2)	unprognostic (9.15e-3)	unprognostic (7.89e-2)	unprognostic (7.15e-4)	unprognostic (1.40e-1)	unprognostic (1.33e-2)	unprognostic (9.93e-3)	unprognostic (6.25e-2)	unprognostic (3.79e-2)	unprognostic (1.10e-2)	unprognostic (3.06e-1)	unprognostic (2.31e-1)	unprognostic (2.82e-2)	unprognostic (1.41e-1)	unprognostic (2.87e-2)	unprognostic (1.80e-2)	unprognostic (2.27e-2)	Hepatocytes
PLIN1	PLIN	ENSG00000166819	Perilipin 1	O60240	15	89664367-89679427	Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins	Lipid metabolism			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	17	adipose tissue: 956.3;breast: 463.0	Cell type enriched	Detected in some	7	Hepatocytes: 55.8	Group enriched	Detected in many	5	breast cancer: 8.4;liver cancer: 2.3;pancreatic cancer: 2.2	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Low cancer specificity	Detected in some			Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Skin - Adipocytes (Skin), Testis - Early spermatids, Testis - Late spermatids	Not detected	Not detected			Not detected	Not detected			HPA024299, CAB033821, CAB037333	Enhanced		Uncertain	Peroxisomes					22000		Cluster 82: Adipose tissue - ECM organization	Cluster 59: Fibroblasts - Metabolism	Cluster 13: Hepatocytes - Oxidoreductase activity	Peroxisomes		CAB033821: AB_2252681, CAB037333: , HPA024299: AB_1855467	unprognostic (4.62e-2)	unprognostic (2.22e-1)	unprognostic (2.13e-1)	unprognostic (1.67e-1)	unprognostic (1.90e-1)	unprognostic (3.51e-3)	unprognostic (9.89e-3)	unprognostic (3.54e-1)	unprognostic (7.01e-2)	unprognostic (2.13e-2)	unprognostic (8.00e-3)	unprognostic (2.28e-3)	unprognostic (2.62e-6)	unprognostic (5.56e-2)	unprognostic (1.22e-1)	unprognostic (1.63e-1)	unprognostic (4.85e-2)	Hepatocytes
CYP7A1	CYP7	ENSG00000167910	Cytochrome P450 family 7 subfamily A member 1	P22680	8	58490178-58500163	Enzymes, Metabolic proteins, Predicted intracellular proteins	Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism	Monooxygenase, Oxidoreductase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	80	liver: 49.5	Cell type enriched	Detected in single	16	Hepatocytes: 6.8	Cancer enriched	Detected in single	96	liver cancer: 28.4	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Liver - Hepatocytes	Not detected	Not detected			Not detected	Not detected														Cluster 60: Liver - Hemostasis & Lipid metabolism		Cluster 13: Hepatocytes - Oxidoreductase activity				unprognostic (5.20e-2)			unprognostic (1.93e-2)	unprognostic (1.77e-2)		prognostic favorable (3.19e-4)	unprognostic (7.60e-2)	unprognostic (5.31e-2)	unprognostic (1.50e-1)	unprognostic (1.18e-1)	unprognostic (2.64e-1)	unprognostic (8.43e-3)	unprognostic (3.01e-1)	unprognostic (1.57e-2)	unprognostic (1.51e-1)		Hepatocytes
ATF5		ENSG00000169136	Activating transcription factor 5	Q9Y2D1	19	49928702-49933935	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, DNA-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in all	21	liver: 2479.9	Cell type enriched	Detected in many	4	Hepatocytes: 1306.8	Cancer enriched	Detected in all	7	liver cancer: 200.0	Low region specificity	Detected in all			Group enriched	Detected in many	4	classical monocyte: 24.0;intermediate monocyte: 22.4;myeloid DC: 14.3;plasmacytoid DC: 38.5	Group enriched	Detected in all	9	dendritic cells: 38.5;monocytes: 24.0	Cancer enhanced	Detected in all		lymphoma: 438.5		Low region specificity	Detected in all			Low region specificity	Detected in all			HPA030187	Uncertain		Supported	Nucleoplasm,Cytosol						Cluster 25: Monocytes - Inflammatory response	Cluster 62: Liver - Hemostasis	Cluster 9: Lymphoid cancers - Immune response	Cluster 29: Hepatocytes - Metabolism	Nucleoplasm	Cytosol	HPA030187: AB_10601666	unprognostic (2.09e-2)	prognostic favorable (1.14e-4)	unprognostic (9.38e-3)	prognostic unfavorable (1.16e-4)	unprognostic (1.18e-1)	unprognostic (1.03e-2)	unprognostic (2.52e-1)	unprognostic (6.70e-2)	unprognostic (3.11e-2)	unprognostic (2.36e-1)	unprognostic (4.83e-2)	unprognostic (2.96e-3)	prognostic unfavorable (3.39e-7)	unprognostic (3.06e-2)	unprognostic (8.06e-2)	unprognostic (1.19e-1)	unprognostic (2.51e-1)	Hepatocytes
LRG1	LRG	ENSG00000171236	Leucine rich alpha-2-glycoprotein 1	P02750	19	4536402-4540036	Plasma proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	21	liver: 944.2	Cell type enriched	Detected in many	5	Hepatocytes: 628.8	Cancer enriched	Detected in many	9	liver cancer: 160.9	Low region specificity	Detected in some			Immune cell enriched	Detected in many	19	neutrophil: 285.2	Lineage enriched	Detected in many	44	granulocytes: 285.2	Low cancer specificity	Detected in many			Adipose visceral - Neutrophils, Heart muscle - Neutrophils	Low region specificity	Detected in single							HPA001888, HPA001889	Enhanced		Approved	Vesicles	Secreted to blood			21000000000	42000000000	Cluster 9: Neutrophils - Innate immune response	Cluster 60: Liver - Hemostasis & Lipid metabolism	Cluster 54: Lymphoma - Cytokine signaling	Cluster 29: Hepatocytes - Metabolism	Vesicles		HPA001888: AB_1079276, HPA001889: AB_1079275	unprognostic (5.54e-3)	unprognostic (1.78e-1)	unprognostic (1.78e-1)	unprognostic (1.42e-1)	unprognostic (2.64e-2)	unprognostic (1.05e-1)	unprognostic (1.88e-1)	unprognostic (1.13e-1)	unprognostic (1.01e-1)	unprognostic (1.16e-2)	unprognostic (1.46e-3)	unprognostic (9.83e-2)	prognostic unfavorable (3.66e-6)	unprognostic (4.06e-2)	unprognostic (1.45e-1)	prognostic favorable (3.49e-4)	unprognostic (2.60e-2)	Hepatocytes
FGG		ENSG00000171557	Fibrinogen gamma chain	P02679	4	154604134-154612967	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Blood coagulation, Hemostasis		Cancer-related genes, Disease variant, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	330	liver: 16556.3	Cell type enriched	Detected in some	7	Hepatocytes: 9963.2	Cancer enriched	Detected in many	19	liver cancer: 1503.5	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in many	6	liver cancer: 254.5	Liver - Hepatocytes	Not detected	Not detected			Not detected	Not detected			HPA027529, CAB033120, HPA074638	Supported		Approved	Endoplasmic reticulum	Secreted to blood			267000000000	73000000000		Cluster 62: Liver - Hemostasis	Cluster 40: Non-specific - Enzymes	Cluster 29: Hepatocytes - Metabolism	Endoplasmic reticulum		CAB033120: AB_2103818, HPA027529: AB_10601322, HPA074638: 	unprognostic (1.26e-2)				unprognostic (4.77e-3)	unprognostic (6.33e-3)	unprognostic (3.69e-3)	unprognostic (2.18e-3)		unprognostic (9.63e-2)	unprognostic (7.57e-3)		prognostic unfavorable (1.00e-6)	unprognostic (1.75e-3)	unprognostic (3.21e-1)		unprognostic (1.14e-1)	Hepatocytes
FGA		ENSG00000171560	Fibrinogen alpha chain	P02671	4	154583128-154590745	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins	Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity		Amyloidosis, Cancer-related genes, Disease variant, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	388	liver: 18396.9	Cell type enriched	Detected in some	24	Hepatocytes: 13790.7	Cancer enriched	Detected in many	43	liver cancer: 2431.6	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in some	5	liver cancer: 216.5	Liver - Hepatocytes, Stomach - Parietal cells, Testis - Early spermatids, Testis - Late spermatids	Not detected	Not detected			Not detected	Not detected			CAB016776, HPA051370, HPA064755	Supported		Enhanced	Endoplasmic reticulum	Secreted to blood			407000000	140000000000		Cluster 62: Liver - Hemostasis	Cluster 40: Non-specific - Enzymes	Cluster 29: Hepatocytes - Metabolism	Endoplasmic reticulum		CAB016776: , HPA051370: AB_2681458, HPA064755: AB_2685345		unprognostic (5.95e-2)	unprognostic (6.25e-2)	unprognostic (2.02e-1)		unprognostic (5.68e-2)	prognostic favorable (7.33e-4)	unprognostic (1.29e-3)			unprognostic (1.84e-1)		prognostic unfavorable (4.23e-6)	unprognostic (4.20e-1)	unprognostic (1.41e-1)			Hepatocytes
FGB		ENSG00000171564	Fibrinogen beta chain	P02675	4	154563011-154572807	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity		Cancer-related genes, Disease variant, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	373	liver: 17944.9	Cell type enriched	Detected in some	5	Hepatocytes: 16176.2	Cancer enriched	Detected in many	42	liver cancer: 2262.6	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in many	6	liver cancer: 197.8	Liver - Hepatocytes	Not detected	Not detected			Low region specificity	Detected in all			HPA001900, HPA001901, CAB008624	Enhanced		Enhanced	Endoplasmic reticulum	Secreted to blood				110000000000		Cluster 62: Liver - Hemostasis	Cluster 40: Non-specific - Enzymes	Cluster 29: Hepatocytes - Metabolism	Endoplasmic reticulum		CAB008624: AB_1615610, HPA001900: AB_1078865, HPA001901: AB_1078864	unprognostic (1.16e-1)	unprognostic (3.89e-2)	unprognostic (4.65e-2)	unprognostic (3.44e-1)			unprognostic (2.20e-3)	unprognostic (1.42e-2)			unprognostic (1.79e-1)		prognostic unfavorable (5.72e-5)	unprognostic (2.48e-2)	unprognostic (7.91e-2)			Hepatocytes
CYP4F11		ENSG00000171903	Cytochrome P450 family 4 subfamily F member 11	Q9HBI6	19	15912367-15934867	Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins	Fatty acid metabolism, Lipid metabolism	Monooxygenase, Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		intestine: 23.9;liver: 72.3	Cell type enriched	Detected in many	4	Hepatocytes: 57.0	Cancer enhanced	Detected in many		liver cancer: 25.7	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in many	5	Gallbladder cancer: 213.3	Liver - Hepatocytes									HPA017265, CAB033648, HPA058960	Enhanced				Intracellular and membrane						Cluster 85: Liver - Metabolism	Cluster 61: Liver - Metabolism	Cluster 29: Hepatocytes - Metabolism			CAB033648: AB_2088410, HPA017265: AB_1847451, HPA058960: AB_2683862	prognostic favorable (4.05e-4)	unprognostic (4.12e-2)	unprognostic (1.79e-1)	unprognostic (5.99e-2)	unprognostic (5.92e-3)	unprognostic (1.06e-2)	unprognostic (1.24e-1)	unprognostic (1.65e-1)	unprognostic (2.33e-1)	unprognostic (1.19e-1)	prognostic unfavorable (9.28e-4)	unprognostic (4.44e-2)	unprognostic (9.50e-3)	unprognostic (2.14e-2)	unprognostic (2.24e-1)	unprognostic (2.78e-2)	unprognostic (4.64e-2)	Hepatocytes
AGXT	AGT, AGT1, AGXT1, PH1, SPAT, SPT	ENSG00000172482	Alanine--glyoxylate and serine--pyruvate aminotransferase	P21549	2	240868824-240880502	Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins		Aminotransferase, Transferase	Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	315	liver: 2199.2	Cell type enriched	Detected in some	5	Hepatocytes: 2181.1	Cancer enriched	Detected in some	425	liver cancer: 253.1	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in some		Gastric cancer: 1.9;liver cancer: 1.1	Adipose visceral - Adipocytes (Visceral), Kidney - Proximal tubular cells, Liver - Hepatocytes	Not detected	Not detected			Not detected	Not detected			HPA035370, HPA035371	Enhanced		Supported	Vesicles					4700000		Cluster 62: Liver - Hemostasis	Cluster 35: Liver cancer - Metabolism	Cluster 13: Hepatocytes - Oxidoreductase activity	Vesicles		HPA035370: AB_10673218, HPA035371: AB_2674593	unprognostic (3.14e-2)	unprognostic (2.58e-1)	unprognostic (3.37e-4)	unprognostic (1.04e-1)	unprognostic (1.23e-2)	unprognostic (9.56e-2)	prognostic favorable (5.92e-5)	unprognostic (8.28e-2)	unprognostic (2.77e-1)	unprognostic (5.39e-2)	unprognostic (1.55e-1)	unprognostic (7.57e-3)	unprognostic (2.54e-1)	unprognostic (9.22e-2)	unprognostic (1.37e-1)		unprognostic (3.26e-2)	Hepatocytes
ACOT12	Cach, STARD15, THEAL	ENSG00000172497	Acyl-CoA thioesterase 12	Q8WYK0	5	81329996-81394179	Enzymes, Metabolic proteins, Predicted intracellular proteins, Transporters	Fatty acid metabolism, Lipid metabolism	Hydrolase, Serine esterase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	36	liver: 100.7	Cell type enriched	Detected in some	10	Hepatocytes: 42.3	Cancer enriched	Detected in single	76	liver cancer: 13.9	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in some		liver cancer: 1.1;lymphoma: 1.9	Kidney - Proximal tubular cells, Liver - Hepatocytes, Testis - Early spermatids, Testis - Late spermatids	Not detected	Not detected			Low region specificity	Detected in some			HPA037723			Approved	Nucleoplasm,Cytokinetic bridge,Cytosol		Yes					Cluster 62: Liver - Hemostasis	Cluster 54: Lymphoma - Cytokine signaling	Cluster 13: Hepatocytes - Oxidoreductase activity	Cytosol	Nucleoplasm, Cytokinetic bridge	HPA037723: AB_10672606	unprognostic (6.06e-2)				unprognostic (1.39e-1)		prognostic favorable (5.30e-4)		unprognostic (7.68e-2)	unprognostic (8.22e-2)	unprognostic (5.68e-3)	unprognostic (2.46e-1)	unprognostic (6.86e-2)	unprognostic (1.46e-2)	unprognostic (3.07e-1)	unprognostic (1.06e-1)		Hepatocytes
ADH6	ADH-5	ENSG00000172955	Alcohol dehydrogenase 6 (class V)	P28332	4	99202638-99219537	Enzymes, Metabolic proteins, Predicted intracellular proteins		Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	13	liver: 703.8	Cell type enriched	Detected in some	4	Hepatocytes: 325.3	Cancer enriched	Detected in many	18	liver cancer: 46.9	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in some		liver cancer: 6.6	Kidney - Proximal tubular cells, Liver - Hepatocytes, Lung - Respiratory ciliated cells	Not detected	Not detected							HPA067946, HPA069081	Enhanced								3400000		Cluster 85: Liver - Metabolism	Cluster 35: Liver cancer - Metabolism	Cluster 13: Hepatocytes - Oxidoreductase activity			HPA067946: AB_2732776, HPA069081: AB_2732127	unprognostic (1.38e-2)	unprognostic (1.83e-2)	unprognostic (5.82e-2)	unprognostic (1.49e-3)	unprognostic (8.49e-2)	unprognostic (1.08e-1)	unprognostic (5.11e-3)	unprognostic (2.40e-1)	unprognostic (3.60e-2)	unprognostic (1.35e-1)	unprognostic (9.72e-3)	unprognostic (1.67e-1)	unprognostic (3.66e-3)	unprognostic (1.35e-1)	unprognostic (2.43e-1)	unprognostic (8.74e-3)	unprognostic (3.86e-3)	Hepatocytes
SAA1	PIG4, SAA, TP53I4	ENSG00000173432	Serum amyloid A1	P0DJI8	11	18266260-18269977	Disease related genes, Predicted secreted proteins	Acute phase	Heparin-binding	Amyloidosis	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	20	liver: 48144.3	Cell type enriched	Detected in many	8	Hepatocytes: 89372.2	Cancer enriched	Detected in many	16	liver cancer: 1249.6	Group enriched	Detected in some	5	midbrain: 3.8;pons: 2.6;thalamus: 6.0	Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in many		head and neck cancer: 590.2;Kidney cancer: 254.2	Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast)														Secreted to blood			300000000	11000000000	Cluster 7: Monocytes - Unknown function	Cluster 62: Liver - Hemostasis	Cluster 60: Keratinocytes - Epithelial cell function	Cluster 29: Hepatocytes - Metabolism				unprognostic (2.86e-3)	unprognostic (1.41e-1)	unprognostic (2.82e-1)	unprognostic (1.50e-1)	unprognostic (4.54e-3)	unprognostic (1.79e-2)	unprognostic (1.63e-2)	unprognostic (7.04e-2)	unprognostic (1.54e-1)	unprognostic (1.08e-2)	unprognostic (8.95e-2)	unprognostic (1.90e-2)	prognostic unfavorable (4.57e-12)	unprognostic (5.15e-2)	unprognostic (9.78e-2)	unprognostic (9.23e-3)	unprognostic (1.64e-1)	Hepatocytes
CA5A	CA5, CAV, CAVA	ENSG00000174990	Carbonic anhydrase 5A	P35218	16	87881546-87936580	Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins		Lyase	Disease variant, FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	30	liver: 24.2	Cell type enriched	Detected in some	9	Hepatocytes: 37.5	Cancer enriched	Detected in single	26	liver cancer: 2.0	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in some		Gallbladder cancer: 1.1;Gastric cancer: 1.8;liver cancer: 2.0		Not detected	Not detected			Low region specificity	Detected in all														Cluster 60: Liver - Hemostasis & Lipid metabolism	Cluster 41: Non-specific - Cilium assembly	Cluster 13: Hepatocytes - Oxidoreductase activity				unprognostic (1.91e-1)	unprognostic (8.64e-3)	unprognostic (3.36e-2)	unprognostic (6.11e-2)	unprognostic (2.49e-2)	unprognostic (2.96e-1)	unprognostic (8.39e-3)	unprognostic (3.50e-3)	unprognostic (1.42e-2)	unprognostic (1.12e-1)	unprognostic (6.55e-2)	unprognostic (4.23e-2)	unprognostic (7.99e-3)	unprognostic (1.77e-1)	unprognostic (5.03e-3)	unprognostic (3.37e-2)	unprognostic (2.76e-2)	Hepatocytes
SLC22A1	OCT1	ENSG00000175003	Solute carrier family 22 member 1	O15245	6	160121815-160158718	Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters	Ion transport, Transport			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	381	liver: 609.6	Cell type enriched	Detected in some	22	Hepatocytes: 813.0	Cancer enriched	Detected in some	81	liver cancer: 83.0	Not detected	Not detected			Immune cell enriched	Detected in single	12	neutrophil: 3.5	Lineage enriched	Detected in single	12	granulocytes: 3.5	Not detected	Not detected			Liver - Hepatocytes	Not detected	Not detected			Not detected	Not detected			HPA029846	Approved									Cluster 1: Neutrophils - Mixed function	Cluster 62: Liver - Hemostasis	Cluster 44: Myeloma - Humoral immune response	Cluster 13: Hepatocytes - Oxidoreductase activity			HPA029846: AB_10603026	unprognostic (8.28e-2)	unprognostic (2.10e-1)	unprognostic (7.80e-2)	unprognostic (2.68e-1)	unprognostic (1.93e-1)	unprognostic (2.10e-2)	prognostic favorable (1.35e-5)	unprognostic (2.28e-1)	unprognostic (8.61e-2)	unprognostic (3.35e-1)	unprognostic (9.11e-2)	unprognostic (9.94e-2)	unprognostic (1.46e-7)	unprognostic (1.58e-1)	unprognostic (1.24e-1)	unprognostic (4.72e-2)	unprognostic (8.07e-4)	Hepatocytes
INHBC		ENSG00000175189	Inhibin subunit beta C	P55103	12	57434784-57452062	Plasma proteins, Predicted secreted proteins		Growth factor, Hormone		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Tissue enriched	Detected in single	172	liver: 165.0	Cell type enriched	Detected in some	5	Hepatocytes: 44.9	Cancer enriched	Detected in single	85	liver cancer: 22.1	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	lymphoma: 2.0;Myeloma: 4.9	Liver - Hepatocytes, Testis - Early spermatids	Not detected	Not detected			Low region specificity	Detected in all			HPA050755			Approved	Cytosol	Secreted to blood				21000000		Cluster 62: Liver - Hemostasis	Cluster 44: Myeloma - Humoral immune response	Cluster 29: Hepatocytes - Metabolism	Cytosol		HPA050755: 	unprognostic (5.26e-2)	unprognostic (4.58e-1)	unprognostic (3.43e-3)	unprognostic (4.08e-3)	unprognostic (3.76e-1)	unprognostic (1.98e-2)	unprognostic (1.03e-2)	unprognostic (1.10e-1)	unprognostic (1.34e-1)	unprognostic (1.23e-1)	unprognostic (6.10e-2)	unprognostic (2.48e-2)	unprognostic (1.68e-4)	unprognostic (2.90e-2)	unprognostic (1.52e-1)	unprognostic (3.55e-3)	unprognostic (5.05e-2)	Hepatocytes
C8G		ENSG00000176919	Complement C8 gamma chain	P07360	9	136945185-136946975	Human disease related genes, Plasma proteins, Predicted secreted proteins	Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	18	liver: 564.4	Cell type enriched	Detected in some	9	Hepatocytes: 1048.9	Cancer enriched	Detected in all	58	liver cancer: 260.0	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	Gastric cancer: 7.2;liver cancer: 2.2		Low region specificity	Detected in all			Low region specificity	Detected in many			HPA046269	Approved				Secreted to blood				2800000000	Cluster 36: GdT-cells - Adaptive immune response	Cluster 62: Liver - Hemostasis	Cluster 19: Stomach & Colon cancer - Absorption	Cluster 29: Hepatocytes - Metabolism			HPA046269: AB_2679606	unprognostic (5.00e-2)	unprognostic (4.05e-3)	prognostic unfavorable (2.99e-4)	unprognostic (3.94e-1)	unprognostic (4.53e-1)	unprognostic (2.75e-2)	unprognostic (1.71e-3)	unprognostic (2.79e-1)	unprognostic (1.88e-1)	unprognostic (3.67e-1)	unprognostic (2.96e-2)	unprognostic (3.00e-1)	unprognostic (5.02e-3)	unprognostic (2.16e-1)	unprognostic (7.67e-2)	unprognostic (1.65e-1)	unprognostic (1.05e-2)	Hepatocytes
CPN2	ACBP	ENSG00000178772	Carboxypeptidase N subunit 2	P22792	3	194339768-194351328	Plasma proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	15	liver: 218.6	Cell type enriched	Detected in some	10	Hepatocytes: 145.5	Cancer enriched	Detected in some	32	liver cancer: 72.7	Low region specificity	Detected in some			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in single	12	liver cancer: 7.8	Adipose visceral - Adipocytes (Visceral), Kidney - Proximal tubular cells, Liver - Hepatocytes	Not detected	Not detected			Low region specificity	Detected in single			HPA004732	Uncertain				Secreted to blood				25000000000		Cluster 62: Liver - Hemostasis	Cluster 35: Liver cancer - Metabolism	Cluster 13: Hepatocytes - Oxidoreductase activity			HPA004732: AB_1078561	unprognostic (4.27e-2)	unprognostic (3.04e-1)	unprognostic (1.42e-1)			unprognostic (4.12e-2)	prognostic favorable (2.05e-4)	unprognostic (1.27e-1)	unprognostic (8.65e-2)	unprognostic (8.56e-2)	unprognostic (1.64e-1)		prognostic unfavorable (4.59e-4)	unprognostic (2.91e-2)	unprognostic (2.40e-1)	unprognostic (6.90e-5)	unprognostic (8.42e-2)	Hepatocytes
F2		ENSG00000180210	Coagulation factor II, thrombin	P00734	11	46719196-46739506	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Acute phase, Blood coagulation, Hemostasis	Hydrolase, Protease, Serine protease	Cancer-related genes, Disease variant, FDA approved drug targets, Thrombophilia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	1518	liver: 1217.3	Cell type enriched	Detected in some	6	Hepatocytes: 851.0	Cancer enriched	Detected in some	110	liver cancer: 508.2	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in some	9	liver cancer: 63.5	Liver - Hepatocytes	Not detected	Not detected			Low region specificity	Detected in all			CAB016780, HPA051476, HPA054698	Enhanced				Secreted to blood			108000000000	41000000000		Cluster 62: Liver - Hemostasis	Cluster 35: Liver cancer - Metabolism	Cluster 29: Hepatocytes - Metabolism			CAB016780: , HPA051476: AB_2681498, HPA054698: AB_2682578	unprognostic (1.98e-1)	unprognostic (2.52e-1)	unprognostic (2.64e-2)	unprognostic (1.85e-1)	unprognostic (2.29e-1)	unprognostic (2.81e-1)	unprognostic (2.23e-2)	unprognostic (3.94e-2)		unprognostic (5.79e-2)	unprognostic (8.29e-2)	unprognostic (4.46e-2)	prognostic unfavorable (6.75e-12)	unprognostic (5.65e-3)	unprognostic (5.80e-2)		unprognostic (1.54e-3)	Hepatocytes
CYP8B1	CYP12	ENSG00000180432	Cytochrome P450 family 8 subfamily B member 1	Q9UNU6	3	42856005-42875898	Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins	Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis	Monooxygenase, Oxidoreductase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	28	liver: 404.5	Cell type enriched	Detected in some	61	Hepatocytes: 791.7	Cancer enriched	Detected in some	46	liver cancer: 69.6	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Kidney - Proximal tubular cells, Liver - Hepatocytes	Not detected	Not detected			Low region specificity	Detected in many														Cluster 62: Liver - Hemostasis	Cluster 60: Keratinocytes - Epithelial cell function	Cluster 13: Hepatocytes - Oxidoreductase activity				unprognostic (1.58e-2)	unprognostic (5.41e-2)	unprognostic (6.38e-2)	unprognostic (1.15e-2)	unprognostic (8.95e-2)	unprognostic (1.42e-3)	unprognostic (4.47e-3)	unprognostic (1.49e-1)	unprognostic (9.85e-2)	unprognostic (4.04e-3)	unprognostic (5.86e-3)	unprognostic (2.74e-1)	unprognostic (3.37e-1)	unprognostic (1.03e-1)	unprognostic (3.63e-1)	unprognostic (3.19e-1)	unprognostic (1.24e-1)	Hepatocytes
TSKU	E2IG4, LRRC54, TSK	ENSG00000182704	Tsukushi, small leucine rich proteoglycan	Q8WUA8	11	76782251-76798153	Predicted secreted proteins	Neurogenesis	Developmental protein		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		liver: 237.3	Cell type enriched	Detected in many	5	Hepatocytes: 439.0	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Low cancer specificity	Detected in all			Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Skeletal muscle - Macrophages	Low region specificity	Detected in all			Low region specificity	Detected in many			HPA008164	Approved		Approved	Nucleoplasm,Nuclear bodies	Secreted to blood				6200000	Cluster 6: Non-specific - Transcription	Cluster 85: Liver - Metabolism	Cluster 61: Liver - Metabolism	Cluster 13: Hepatocytes - Oxidoreductase activity	Nucleoplasm	Nuclear bodies	HPA008164: AB_1853327	unprognostic (1.07e-2)	unprognostic (2.29e-3)	unprognostic (6.15e-2)	prognostic favorable (3.66e-4)	unprognostic (7.05e-2)	unprognostic (2.39e-1)	unprognostic (3.08e-1)	unprognostic (2.17e-3)	unprognostic (4.81e-2)	unprognostic (4.62e-2)	prognostic unfavorable (2.87e-4)	prognostic favorable (1.66e-4)	prognostic unfavorable (2.80e-8)	unprognostic (1.47e-1)	unprognostic (4.93e-2)	unprognostic (6.71e-2)	unprognostic (3.88e-2)	Hepatocytes
PLGLB1	PLGL, PRP-B	ENSG00000183281	Plasminogen like B1	Q02325	2	87002559-87021852	Predicted secreted proteins				Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence	No human protein/transcript evidence	Tissue enriched	Detected in all	6	liver: 234.9	Cell type enriched	Detected in many	4	Hepatocytes: 62.8	Cancer enriched	Detected in single	7	liver cancer: 0.7	Low region specificity	Detected in all			Low immune cell specificity	Detected in some			Low lineage specificity	Detected in many			Low cancer specificity	Detected in all												HPA053770			Approved	Vesicles	Secreted to blood					Cluster 46: Basophils - DNA binding	Cluster 15: Liver - Metabolism	Cluster 12: Lymphoid cancers - Adaptive immune response	Cluster 29: Hepatocytes - Metabolism	Vesicles		HPA053770: AB_2682256	unprognostic (7.25e-2)	unprognostic (7.25e-2)	unprognostic (2.35e-1)	unprognostic (1.15e-1)	unprognostic (1.75e-2)	unprognostic (1.39e-5)	unprognostic (7.04e-3)	unprognostic (1.15e-1)	unprognostic (8.53e-4)	unprognostic (1.60e-1)	unprognostic (4.56e-4)	unprognostic (9.90e-3)	unprognostic (2.96e-5)	unprognostic (1.02e-1)	unprognostic (1.16e-1)	unprognostic (4.32e-2)	unprognostic (3.98e-5)	Hepatocytes
ACSM5	FLJ20581	ENSG00000183549	Acyl-CoA synthetase medium chain family member 5	Q6NUN0	16	20409534-20441336	Enzymes, Metabolic proteins, Predicted intracellular proteins	Fatty acid metabolism, Lipid metabolism	Ligase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	11	liver: 276.6	Cell type enriched	Detected in some	6	Hepatocytes: 224.0	Group enriched	Detected in some	7	liver cancer: 20.5;renal cancer: 9.6	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in some		Kidney cancer: 2.3	Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Kidney - Proximal tubular cells, Liver - Hepatocytes	Low region specificity	Detected in some			Low region specificity	Detected in all			HPA041435	Uncertain		Uncertain	Vesicles						Cluster 25: Monocytes - Inflammatory response	Cluster 85: Liver - Metabolism	Cluster 59: Fibroblasts - Metabolism	Cluster 13: Hepatocytes - Oxidoreductase activity	Vesicles		HPA041435: AB_10961121	unprognostic (1.01e-1)	unprognostic (1.61e-3)	unprognostic (3.73e-2)	unprognostic (1.98e-2)	unprognostic (1.03e-1)	unprognostic (1.59e-2)	unprognostic (1.84e-2)	unprognostic (4.64e-3)	unprognostic (1.64e-1)	unprognostic (2.01e-2)	unprognostic (2.15e-2)	unprognostic (2.33e-1)	unprognostic (5.11e-3)	unprognostic (2.09e-2)	unprognostic (3.85e-2)	unprognostic (2.78e-2)	unprognostic (1.57e-1)	Hepatocytes
CYP4F3	CYP4F, LTB4H	ENSG00000186529	Cytochrome P450 family 4 subfamily F member 3	Q08477	19	15640897-15662825	Enzymes, Metabolic proteins, Predicted intracellular proteins	Fatty acid metabolism, Lipid metabolism	Monooxygenase, Oxidoreductase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	6	bone marrow: 80.2;liver: 235.8	Cell type enriched	Detected in many	5	Hepatocytes: 448.3	Cancer enhanced	Detected in many		liver cancer: 30.6	Low region specificity	Detected in many			Immune cell enriched	Detected in some	63	neutrophil: 84.1	Lineage enriched	Detected in single	177	granulocytes: 84.1	Cancer enriched	Detected in many	7	Gallbladder cancer: 99.5	Adipose visceral - Neutrophils, Heart muscle - Neutrophils, Kidney - Proximal tubular cells, Kidney - Proximal tubular cells, Liver - Hepatocytes, Prostate - Urothelial cells, Stomach - Gastric mucous cells, Thyroid - Neutrophils	Not detected	Not detected			Low region specificity	Detected in many			HPA058960	Approved									Cluster 9: Neutrophils - Innate immune response	Cluster 60: Liver - Hemostasis & Lipid metabolism	Cluster 61: Liver - Metabolism	Cluster 13: Hepatocytes - Oxidoreductase activity			HPA058960: AB_2683862	unprognostic (1.73e-2)	unprognostic (9.70e-3)	unprognostic (1.21e-1)	unprognostic (1.16e-3)	unprognostic (5.40e-1)	unprognostic (1.57e-1)	unprognostic (7.15e-3)	unprognostic (5.19e-2)	unprognostic (2.12e-1)	unprognostic (3.61e-2)	unprognostic (1.26e-2)	unprognostic (2.32e-1)	unprognostic (1.59e-3)	unprognostic (2.36e-1)	unprognostic (1.12e-1)	unprognostic (1.07e-2)	unprognostic (2.07e-1)	Hepatocytes
SERPINA11		ENSG00000186910	Serpin family A member 11	Q86U17	14	94442464-94452800	Plasma proteins, Predicted secreted proteins		Protease inhibitor, Serine protease inhibitor		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Tissue enriched	Detected in some	92	liver: 490.6	Cell type enriched	Detected in some	5	Hepatocytes: 262.5	Cancer enriched	Detected in some	9	liver cancer: 94.3	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in single	11	liver cancer: 4.8	Breast - Breast glandular cells, Liver - Hepatocytes	Not detected	Not detected			Not detected	Not detected								Secreted to blood				230000000		Cluster 62: Liver - Hemostasis	Cluster 35: Liver cancer - Metabolism	Cluster 29: Hepatocytes - Metabolism				unprognostic (2.50e-2)	unprognostic (3.26e-1)	unprognostic (9.00e-2)	prognostic favorable (6.30e-4)		unprognostic (7.44e-2)	unprognostic (2.02e-2)	unprognostic (1.70e-1)	unprognostic (3.44e-1)		unprognostic (5.14e-2)	unprognostic (1.53e-1)		unprognostic (1.64e-1)				Hepatocytes
CYP4A11	CYP4A2, CYP4AII	ENSG00000187048	Cytochrome P450 family 4 subfamily A member 11	Q02928	1	46929177-46941484	Enzymes, Metabolic proteins, Predicted membrane proteins	Fatty acid metabolism, Lipid metabolism	Monooxygenase, Oxidoreductase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	333	kidney: 218.8;liver: 857.1	Cell type enriched	Detected in some	5	Hepatocytes: 454.5	Cancer enriched	Detected in some	5	liver cancer: 73.4	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Kidney - Proximal tubular cells, Liver - Hepatocytes																				Cluster 85: Liver - Metabolism	Cluster 19: Stomach & Colon cancer - Absorption	Cluster 13: Hepatocytes - Oxidoreductase activity				unprognostic (9.05e-2)	unprognostic (4.98e-2)		unprognostic (4.43e-2)	unprognostic (4.11e-1)	unprognostic (7.81e-5)	unprognostic (5.10e-3)	unprognostic (1.16e-2)	unprognostic (1.83e-2)	unprognostic (1.92e-2)	unprognostic (1.90e-1)	unprognostic (1.12e-1)	unprognostic (4.59e-2)	unprognostic (5.86e-2)	unprognostic (1.96e-1)	unprognostic (3.00e-3)	unprognostic (1.68e-2)	Hepatocytes
ADH1A	ADH1	ENSG00000187758	Alcohol dehydrogenase 1A (class I), alpha polypeptide	P07327	4	99276369-99291003	Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins		Oxidoreductase	FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	306	liver: 2739.1	Cell type enriched	Detected in some	11	Hepatocytes: 210.6	Cancer enriched	Detected in some	251	liver cancer: 165.9	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Adipose subcutaneous - Adipocytes (Subcutaneous), Breast - Adipocytes (Breast), Liver - Hepatocytes									CAB009562, HPA047814, HPA060902	Enhanced		Approved	Plasma membrane,Cytosol					38000000		Cluster 60: Liver - Hemostasis & Lipid metabolism	Cluster 41: Non-specific - Cilium assembly	Cluster 13: Hepatocytes - Oxidoreductase activity	Plasma membrane, Cytosol		CAB009562: AB_2257984, HPA047814: AB_2680163, HPA060902: AB_2684384	unprognostic (5.89e-2)	unprognostic (6.16e-2)		unprognostic (1.20e-1)	unprognostic (2.07e-1)	unprognostic (4.40e-1)	prognostic favorable (2.38e-4)	unprognostic (2.78e-3)		unprognostic (4.25e-1)	unprognostic (4.79e-3)	unprognostic (6.21e-2)	unprognostic (9.36e-2)	unprognostic (3.25e-2)	unprognostic (1.40e-1)		unprognostic (2.86e-2)	Hepatocytes
ACADSB	ACAD7, SBCAD	ENSG00000196177	Acyl-CoA dehydrogenase short/branched chain	P45954	10	123008979-123058290	Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins	Fatty acid metabolism, Lipid metabolism	Oxidoreductase	Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		liver: 360.1	Cell type enriched	Detected in all	4	Hepatocytes: 474.4	Cancer enhanced	Detected in all		liver cancer: 32.5	Low region specificity	Detected in all			Low immune cell specificity	Detected in all			Low lineage specificity	Detected in all			Low cancer specificity	Detected in all			Heart muscle - Cardiomyocytes, Kidney - Proximal tubular cells, Liver - Hepatocytes, Skeletal muscle - Skeletal myocytes	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA041458, HPA063555	Enhanced		Supported	Mitochondria					37000	Cluster 2: Granulocytes - Unknown function	Cluster 85: Liver - Metabolism	Cluster 56: Neurons - Neuronal signaling	Cluster 13: Hepatocytes - Oxidoreductase activity	Mitochondria		HPA041458: AB_2677491, HPA063555: 	unprognostic (1.53e-2)	unprognostic (1.31e-1)	unprognostic (3.91e-3)	unprognostic (2.02e-1)	unprognostic (1.25e-1)	unprognostic (4.87e-2)	unprognostic (4.15e-2)	unprognostic (1.32e-3)	unprognostic (1.30e-1)	unprognostic (3.67e-1)	prognostic favorable (3.40e-4)	unprognostic (9.37e-3)	prognostic favorable (6.37e-12)	unprognostic (2.69e-1)	unprognostic (7.20e-2)	unprognostic (1.60e-3)	unprognostic (7.14e-2)	Hepatocytes
SERPINA1	A1A, A1AT, AAT, alpha-1-antitrypsin, alpha1AT, PI, PI1	ENSG00000197249	Serpin family A member 1	P01009	14	94376747-94390693	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Acute phase, Blood coagulation, Hemostasis	Protease inhibitor, Serine protease inhibitor	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in all	45	liver: 34022.4	Cell type enriched	Detected in many	7	Hepatocytes: 38798.6	Cancer enriched	Detected in all	10	liver cancer: 3850.6	Low region specificity	Detected in all			Group enriched	Detected in all	5	classical monocyte: 2482.1;intermediate monocyte: 3411.9;neutrophil: 2823.2;non-classical monocyte: 4518.8	Group enriched	Detected in all	5	granulocytes: 2823.2;monocytes: 4518.8	Group enriched	Detected in many	4	Gastric cancer: 342.8;liver cancer: 848.0;lymphoma: 256.6	Adipose visceral - Neutrophils, Liver - Hepatocytes, Skeletal muscle - Neutrophils	Not detected	Not detected			Region enriched	Detected in many	6	cerebellum: 130.6	HPA000927, HPA001292, CAB013211, CAB016648, CAB073396	Enhanced		Enhanced	Vesicles	Secreted to blood			2070000000000	140000000000	Cluster 51: Monocytes - Innate immune response	Cluster 60: Liver - Hemostasis & Lipid metabolism	Cluster 35: Liver cancer - Metabolism	Cluster 29: Hepatocytes - Metabolism	Vesicles		CAB013211: , CAB016648: AB_1611888, CAB073396: , HPA000927: AB_1844761, HPA001292: AB_1844762	prognostic favorable (1.61e-5)	unprognostic (3.37e-1)	prognostic favorable (5.86e-4)	unprognostic (1.38e-2)	unprognostic (1.98e-2)	unprognostic (5.50e-3)	unprognostic (3.81e-2)	unprognostic (6.78e-2)	unprognostic (2.54e-2)	unprognostic (7.96e-2)	unprognostic (1.08e-1)	unprognostic (4.54e-1)	unprognostic (1.23e-2)	unprognostic (1.89e-1)	unprognostic (1.30e-2)	unprognostic (1.17e-2)	unprognostic (1.96e-1)	Hepatocytes
CYP2B6	CPB6, CYP2B, CYPIIB6	ENSG00000197408	Cytochrome P450 family 2 subfamily B member 6	P20813	19	40991282-41018398	Metabolic proteins, Plasma proteins, Predicted intracellular proteins	Lipid metabolism	Monooxygenase, Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	35	liver: 533.7	Cell type enriched	Detected in some	9	Hepatocytes: 265.7	Cancer enhanced	Detected in many		liver cancer: 28.8	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in some		colorectal cancer: 9.6;liver cancer: 17.5	Colon - Colon enterocytes, Kidney - Proximal tubular cells, Liver - Hepatocytes					Region enhanced	Detected in single		spinal cord: 2.3	CAB033866, HPA048124, HPA062973	Enhanced		Approved	Nucleoplasm,Nuclear membrane,Cytosol	Intracellular and membrane					Cluster 17: Basophils - Unknown function	Cluster 62: Liver - Hemostasis	Cluster 19: Stomach & Colon cancer - Absorption	Cluster 13: Hepatocytes - Oxidoreductase activity	Nuclear membrane	Nucleoplasm, Cytosol	CAB033866: AB_2292644, HPA048124: AB_2680274, HPA062973: AB_2684914	unprognostic (1.86e-1)	unprognostic (1.23e-2)	unprognostic (1.13e-2)	unprognostic (6.13e-2)		unprognostic (4.59e-2)	unprognostic (4.63e-2)	unprognostic (4.41e-2)	unprognostic (1.73e-1)		unprognostic (5.78e-2)		unprognostic (1.04e-3)	unprognostic (2.19e-1)	unprognostic (9.43e-2)		unprognostic (5.44e-1)	Hepatocytes
CYP2A7	CYP2A	ENSG00000198077	Cytochrome P450 family 2 subfamily A member 7	P20853	19	40875439-40882752	Enzymes, Metabolic proteins, Predicted intracellular proteins		Monooxygenase, Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Tissue enriched	Detected in some	71	liver: 152.5	Cell type enriched	Detected in some	17	Hepatocytes: 89.7	Group enriched	Detected in some	238	breast cancer: 9.2;liver cancer: 25.6	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Liver - Hepatocytes									CAB033510, HPA046713, HPA047262	Enhanced				Intracellular and membrane						Cluster 62: Liver - Hemostasis	Cluster 65: Breast cancer - Unknown function	Cluster 29: Hepatocytes - Metabolism			CAB033510: AB_782366, HPA046713: AB_2679767, HPA047262: AB_2680005	unprognostic (2.18e-1)				unprognostic (3.60e-2)		unprognostic (2.65e-3)	unprognostic (8.89e-2)		unprognostic (1.39e-2)	unprognostic (3.95e-1)	unprognostic (9.21e-2)	unprognostic (8.71e-2)	unprognostic (3.99e-2)		unprognostic (1.06e-2)		Hepatocytes
ADH4	ADH-2	ENSG00000198099	Alcohol dehydrogenase 4 (class II), pi polypeptide	P08319	4	99123657-99157792	Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins	Lipid metabolism	Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	31	liver: 5151.4	Cell type enriched	Detected in some	35	Hepatocytes: 1118.2	Cancer enriched	Detected in some	60	liver cancer: 230.7	Low region specificity	Detected in some			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in some		liver cancer: 3.3	Liver - Hepatocytes, Testis - Early spermatids, Testis - Late spermatids	Not detected	Not detected			Low region specificity	Detected in many			HPA020525	Enhanced		Uncertain	Nucleoplasm,Cytosol					20000000	Cluster 34: Basophils - Unknown function	Cluster 60: Liver - Hemostasis & Lipid metabolism	Cluster 35: Liver cancer - Metabolism	Cluster 13: Hepatocytes - Oxidoreductase activity	Nucleoplasm, Cytosol		HPA020525: AB_1844609	unprognostic (2.75e-1)	unprognostic (1.69e-2)	unprognostic (1.85e-2)	unprognostic (5.54e-3)	unprognostic (2.14e-2)	unprognostic (1.33e-2)	prognostic favorable (7.08e-6)	unprognostic (1.49e-1)		unprognostic (1.39e-2)	unprognostic (6.91e-2)	unprognostic (1.88e-1)	unprognostic (2.34e-2)	unprognostic (7.16e-3)	unprognostic (2.20e-1)		unprognostic (5.89e-3)	Hepatocytes
AKR1C4	3-alpha-HSD, C11, CDR, CHDR, DD4, HAKRA, MGC22581	ENSG00000198610	Aldo-keto reductase family 1 member C4	P17516	10	5195462-5218949	Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins	Lipid metabolism	Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	17	liver: 717.5	Cell type enriched	Detected in some	21	Hepatocytes: 834.6	Cancer enriched	Detected in some	86	liver cancer: 108.4	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in some		Bile duct cancer: 4.0;colorectal cancer: 4.5;liver cancer: 7.6	Kidney - Proximal tubular cells, Liver - Hepatocytes									HPA044720, HPA068265	Uncertain		Approved	Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol					3800000		Cluster 60: Liver - Hemostasis & Lipid metabolism	Cluster 26: NCI-H716 - Unknown function	Cluster 13: Hepatocytes - Oxidoreductase activity	Nucleoplasm, Cytosol	Nucleoli fibrillar center, Endoplasmic reticulum	HPA044720: AB_2679058, HPA068265: AB_2685966	unprognostic (2.21e-1)	unprognostic (3.04e-1)	unprognostic (5.15e-2)	unprognostic (1.25e-1)		unprognostic (5.99e-2)	unprognostic (9.40e-2)	unprognostic (2.32e-1)		unprognostic (1.26e-1)	unprognostic (1.52e-2)		unprognostic (1.29e-1)	unprognostic (3.31e-1)	unprognostic (7.34e-2)		unprognostic (1.45e-2)	Hepatocytes
TAT		ENSG00000198650	Tyrosine aminotransferase	P17735	16	71565660-71577092	Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins	Phenylalanine catabolism, Tyrosine catabolism	Aminotransferase, Transferase	Disease variant, Intellectual disability, Palmoplantar keratoderma	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	22	liver: 1272.2	Cell type enriched	Detected in some	24	Hepatocytes: 3600.9	Cancer enriched	Detected in some	10	liver cancer: 152.8	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in single	4	breast cancer: 2.0	Breast - Breast glandular cells, Lung - Respiratory ciliated cells, Testis - Early spermatids	Not detected	Not detected			Not detected	Not detected													Cluster 17: Basophils - Unknown function	Cluster 60: Liver - Hemostasis & Lipid metabolism	Cluster 65: Breast cancer - Unknown function	Cluster 13: Hepatocytes - Oxidoreductase activity				unprognostic (3.66e-3)	unprognostic (1.29e-1)	unprognostic (8.17e-2)	unprognostic (2.21e-1)	unprognostic (1.67e-1)	unprognostic (1.01e-2)	prognostic favorable (6.51e-4)	unprognostic (1.69e-1)	unprognostic (9.32e-2)	unprognostic (2.27e-1)	unprognostic (3.73e-3)	unprognostic (1.88e-1)	unprognostic (1.27e-4)	unprognostic (1.19e-1)	unprognostic (1.28e-1)	unprognostic (1.09e-1)	unprognostic (1.05e-2)	Hepatocytes
LPA	LP, Lp(a)	ENSG00000198670	Lipoprotein(a)	P08519	6	160531482-160664275	Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Lipid transport, Transport	Hydrolase, Protease, Serine protease	Atherosclerosis	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	12	liver: 76.7	Cell type enriched	Detected in some	4	Hepatocytes: 34.9	Cancer enriched	Detected in single	38	liver cancer: 3.6	Low region specificity	Detected in many			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Kidney - Proximal tubular cells, Liver - Hepatocytes									CAB016072, HPA060604	Supported				Secreted to blood			78800000000	1800000000		Cluster 60: Liver - Hemostasis & Lipid metabolism	Cluster 12: Lymphoid cancers - Adaptive immune response	Cluster 29: Hepatocytes - Metabolism			CAB016072: AB_2135240, HPA060604: AB_2684330		unprognostic (2.16e-1)	unprognostic (5.10e-1)	unprognostic (7.75e-3)	unprognostic (6.70e-2)	unprognostic (1.60e-1)	unprognostic (4.17e-3)	unprognostic (1.59e-1)		unprognostic (6.38e-3)	unprognostic (3.63e-2)	unprognostic (3.18e-1)	unprognostic (7.45e-3)	unprognostic (2.56e-1)	unprognostic (1.80e-1)	unprognostic (1.34e-1)	unprognostic (3.72e-2)	Hepatocytes
LRCOL1		ENSG00000204583	Leucine rich colipase like 1	A6NCL2	12	132603150-132610582	Predicted secreted proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Tissue enriched	Detected in some	21	epididymis: 50.1	Cell type enriched	Detected in some	6	Hepatocytes: 27.8	Group enriched	Detected in some	4	endometrial cancer: 0.8;liver cancer: 3.0	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Kidney - Fibroblasts	Not detected	Not detected												Secreted in male reproductive system						Cluster 30: Epididymis - Antimicrobial activity	Cluster 2: DU4475 - Unknown function	Cluster 29: Hepatocytes - Metabolism				unprognostic (5.09e-3)	unprognostic (7.83e-3)	unprognostic (3.26e-1)	unprognostic (6.94e-2)	unprognostic (3.15e-2)	unprognostic (2.38e-2)	prognostic favorable (7.04e-4)	unprognostic (4.54e-2)	unprognostic (6.08e-2)	unprognostic (5.29e-2)	unprognostic (4.66e-3)	unprognostic (1.52e-1)	unprognostic (6.50e-6)	unprognostic (1.46e-3)	unprognostic (9.63e-2)	unprognostic (3.31e-1)	unprognostic (4.00e-3)	Hepatocytes
LCAT		ENSG00000213398	Lecithin-cholesterol acyltransferase	P04180	16	67939750-67944131	Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins	Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism	Acyltransferase, Hydrolase, Transferase	Corneal dystrophy, Disease variant	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in all	5	liver: 283.0	Cell type enriched	Detected in many	7	Hepatocytes: 207.4	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Immune cell enhanced	Detected in some		eosinophil: 1.9	Low lineage specificity	Detected in single			Low cancer specificity	Detected in all			Colon - Enteric glia cells, Heart muscle - Fibroblasts, Liver - Hepatocytes	Low region specificity	Detected in all			Region enhanced	Detected in many		cerebellum: 29.2	HPA044767			Approved	Nucleoplasm	Secreted to blood			6470000000	6400000000	Cluster 52: Eosinophils - Transcription	Cluster 15: Liver - Metabolism	Cluster 6: BEWO - Unknown function	Cluster 13: Hepatocytes - Oxidoreductase activity	Nucleoplasm		HPA044767: AB_2756312	unprognostic (3.34e-2)	unprognostic (3.56e-2)	prognostic unfavorable (8.50e-4)	unprognostic (5.43e-3)	unprognostic (1.25e-2)	unprognostic (2.16e-1)	prognostic favorable (4.21e-8)	unprognostic (6.42e-2)	unprognostic (4.26e-1)	unprognostic (4.12e-1)	unprognostic (1.50e-2)	unprognostic (7.21e-2)	prognostic unfavorable (1.71e-4)	unprognostic (9.93e-2)	unprognostic (1.83e-1)	unprognostic (2.85e-1)	unprognostic (1.90e-3)	Hepatocytes
GBP7	FLJ38822, GBP4L	ENSG00000213512	Guanylate binding protein 7	Q8N8V2	1	89131742-89176009	Predicted intracellular proteins	Antiviral defense, Immunity	Antimicrobial, Hydrolase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	156	liver: 100.2	Cell type enriched	Detected in some	4	Hepatocytes: 13.9	Cancer enriched	Detected in single	58	liver cancer: 10.6	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Liver - Hepatocytes									HPA051245	Uncertain										Cluster 62: Liver - Hemostasis	Cluster 41: Non-specific - Cilium assembly	Cluster 29: Hepatocytes - Metabolism			HPA051245: AB_2681404	unprognostic (4.22e-5)	unprognostic (7.32e-2)	unprognostic (6.30e-2)	unprognostic (1.29e-1)	unprognostic (1.63e-1)	unprognostic (3.66e-3)	unprognostic (4.93e-3)	unprognostic (2.15e-2)	unprognostic (2.80e-1)	unprognostic (8.79e-2)	unprognostic (1.57e-2)	unprognostic (1.39e-1)	unprognostic (1.34e-1)	unprognostic (1.02e-1)	unprognostic (8.15e-2)	unprognostic (1.57e-1)	unprognostic (6.35e-2)	Hepatocytes
ANG	RAA1, RNASE5	ENSG00000214274	Angiogenin	P03950	14	20684177-20698971	Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins	Angiogenesis, Differentiation, Stress response	Developmental protein, DNA-binding, Endonuclease, Hydrolase, Nuclease, Protein synthesis inhibitor	Amyotrophic lateral sclerosis, Cancer-related genes, Disease variant, Neurodegeneration	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in all	52	liver: 3018.1	Cell type enriched	Detected in many	25	Hepatocytes: 5233.5	Cancer enriched	Detected in all	17	liver cancer: 279.2	Low region specificity	Detected in all			Immune cell enhanced	Detected in many		classical monocyte: 24.5;myeloid DC: 14.5	Low lineage specificity	Detected in many			Low cancer specificity	Detected in all			Heart muscle - Fibroblasts, Liver - Hepatocytes, Liver - Hepatocytes, Stomach - Gastric mucous cells, Testis - Sertoli cells	Low region specificity	Detected in all							HPA055896			Approved	Nucleoli,Nucleoli rim,Mitotic chromosome,Actin filaments	Secreted to blood	Yes	No	308000000	410000000	Cluster 25: Monocytes - Inflammatory response	Cluster 62: Liver - Hemostasis	Cluster 19: Stomach & Colon cancer - Absorption	Cluster 13: Hepatocytes - Oxidoreductase activity	Nucleoli, Nucleoli rim, Mitotic chromosome	Actin filaments	HPA055896: 	unprognostic (2.50e-2)	unprognostic (1.82e-1)	unprognostic (9.77e-2)	prognostic favorable (6.85e-4)	unprognostic (5.71e-3)	unprognostic (6.99e-2)	prognostic favorable (7.83e-5)	unprognostic (1.16e-1)	unprognostic (3.20e-3)	unprognostic (9.19e-3)	unprognostic (1.31e-1)	unprognostic (3.69e-1)	unprognostic (6.65e-2)	unprognostic (1.03e-1)	unprognostic (3.39e-1)	unprognostic (2.00e-1)	unprognostic (3.09e-1)	Hepatocytes
GCGR	GGR	ENSG00000215644	Glucagon receptor	P47871	17	81804132-81814008	FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters		G-protein coupled receptor, Receptor, Transducer	Diabetes mellitus, Disease variant, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	17	kidney: 50.0;liver: 169.6	Cell type enriched	Detected in some	6	Hepatocytes: 56.9	Cancer enriched	Detected in many	4	liver cancer: 10.3	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Pancreas - Beta cells	Not detected	Not detected			Low region specificity	Detected in many			HPA071228			Uncertain	Golgi apparatus							Cluster 85: Liver - Metabolism	Cluster 41: Non-specific - Cilium assembly	Cluster 29: Hepatocytes - Metabolism	Golgi apparatus		HPA071228: AB_2686368	unprognostic (3.28e-4)	unprognostic (9.30e-2)	unprognostic (2.20e-1)	unprognostic (1.53e-4)	unprognostic (1.11e-1)	unprognostic (2.30e-3)	unprognostic (4.38e-2)	unprognostic (1.79e-3)	unprognostic (2.18e-1)	unprognostic (2.77e-1)	unprognostic (3.09e-1)	unprognostic (2.61e-1)	unprognostic (6.42e-2)	unprognostic (5.99e-3)	unprognostic (1.71e-1)	unprognostic (1.17e-3)	unprognostic (8.36e-3)	Hepatocytes
APOC4-APOC2		ENSG00000224916	APOC4-APOC2 readthrough (NMD candidate)		19	44942238-44949565	Predicted membrane proteins				Evidence at protein level	Evidence at protein level			Tissue enriched	Detected in some	1258	liver: 2221.0	Cell type enriched	Detected in some	18	Hepatocytes: 99.1	Cancer enriched	Detected in some	17	liver cancer: 9.6	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected												HPA055877	Supported										Cluster 62: Liver - Hemostasis	Cluster 66: Myeloid cells - Innate immune response	Cluster 13: Hepatocytes - Oxidoreductase activity			HPA055877: AB_2682953	unprognostic (1.45e-1)	unprognostic (4.00e-2)	unprognostic (1.86e-1)	unprognostic (1.33e-1)	unprognostic (1.27e-1)	unprognostic (1.42e-1)	unprognostic (1.49e-2)	unprognostic (2.07e-2)	unprognostic (1.52e-1)	unprognostic (4.73e-2)	unprognostic (1.25e-1)	unprognostic (1.85e-1)	unprognostic (2.01e-4)	unprognostic (2.28e-1)	unprognostic (2.88e-1)	unprognostic (5.95e-2)	unprognostic (1.68e-2)	Hepatocytes
ORM2	AGP-B, AGP-B', AGP2	ENSG00000228278	Orosomucoid 2	P19652	9	114329869-114333251	Plasma proteins, Predicted secreted proteins	Acute phase, Transport			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	327	liver: 8873.2	Cell type enriched	Detected in some	44	Hepatocytes: 9796.1	Cancer enriched	Detected in many	34	liver cancer: 873.1	Not detected	Not detected			Immune cell enriched	Detected in single	40	neutrophil: 12.0	Lineage enriched	Detected in single	40	granulocytes: 12.0	Cancer enriched	Detected in some	26	liver cancer: 93.5	Liver - Hepatocytes, Testis - Late spermatids									HPA046438, HPA047725, HPA057726	Approved		Approved	Golgi apparatus,Vesicles	Secreted to blood			422000000	41000000000	Cluster 9: Neutrophils - Innate immune response	Cluster 60: Liver - Hemostasis & Lipid metabolism	Cluster 35: Liver cancer - Metabolism	Cluster 13: Hepatocytes - Oxidoreductase activity	Vesicles	Golgi apparatus	HPA046438: AB_2679666, HPA047725: AB_2680133, HPA057726: AB_2683512	unprognostic (6.77e-2)	unprognostic (8.00e-2)	unprognostic (1.19e-1)	unprognostic (4.44e-3)	unprognostic (1.18e-1)	unprognostic (5.61e-2)	unprognostic (5.66e-2)	unprognostic (9.70e-2)	unprognostic (3.05e-1)	unprognostic (1.48e-1)	unprognostic (1.99e-2)	unprognostic (5.76e-2)	prognostic unfavorable (1.23e-9)	unprognostic (3.23e-1)	unprognostic (6.80e-2)	unprognostic (7.62e-2)	unprognostic (9.15e-4)	Hepatocytes
ORM1		ENSG00000229314	Orosomucoid 1	P02763	9	114323056-114326475	Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins	Acute phase, Transport		Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	193	liver: 42973.6	Cell type enriched	Detected in some	53	Hepatocytes: 55465.9	Cancer enriched	Detected in many	16	liver cancer: 2506.9	Not detected	Not detected			Immune cell enriched	Detected in some	47	neutrophil: 193.9	Lineage enriched	Detected in many	47	granulocytes: 193.9	Cancer enriched	Detected in many	6	liver cancer: 231.9	Liver - Hepatocytes, Lung - Neutrophil_2									CAB006265, HPA046438, HPA047725, HPA057726	Approved		Approved	Golgi apparatus,Vesicles	Secreted to blood			945000000000	61000000000	Cluster 9: Neutrophils - Innate immune response	Cluster 60: Liver - Hemostasis & Lipid metabolism	Cluster 35: Liver cancer - Metabolism	Cluster 13: Hepatocytes - Oxidoreductase activity	Vesicles	Golgi apparatus	CAB006265: AB_425575, HPA046438: AB_2679666, HPA047725: AB_2680133, HPA057726: AB_2683512	unprognostic (3.85e-1)	unprognostic (2.12e-1)	unprognostic (1.09e-2)	unprognostic (2.16e-2)	unprognostic (3.22e-2)	unprognostic (1.47e-1)	unprognostic (2.29e-1)	unprognostic (2.26e-1)		unprognostic (1.16e-1)	unprognostic (4.85e-2)	unprognostic (1.74e-1)	prognostic unfavorable (2.35e-4)	unprognostic (2.10e-1)	unprognostic (4.38e-2)	unprognostic (9.32e-3)	unprognostic (4.51e-2)	Hepatocytes
APOC2		ENSG00000234906	Apolipoprotein C2	P02655	19	44946035-44949565	Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins	Lipid degradation, Lipid metabolism, Lipid transport, Transport		Disease variant, Hyperlipidemia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	83	liver: 9641.4	Cell type enriched	Detected in some	23	Hepatocytes: 830.1	Cancer enriched	Detected in some	17	liver cancer: 49.7	Low region specificity	Detected in all			Immune cell enriched	Detected in single	30	NK-cell: 3.2	Lineage enriched	Detected in single	30	NK-cells: 3.2	Cancer enhanced	Detected in many		Brain cancer: 65.9;Leukemia: 75.8;liver cancer: 82.8	Kidney - Proximal tubular cells, Kidney - Proximal tubular cells, Pancreas - Macrophages									HPA055877	Supported				Secreted to blood			43000000000	49000000000	Cluster 48: NK-cells - Unknown function	Cluster 60: Liver - Hemostasis & Lipid metabolism	Cluster 2: DU4475 - Unknown function	Cluster 29: Hepatocytes - Metabolism			HPA055877: AB_2682953	unprognostic (4.28e-2)	unprognostic (7.73e-3)	unprognostic (1.33e-1)	unprognostic (3.66e-2)	unprognostic (8.91e-2)	unprognostic (1.90e-1)	unprognostic (2.07e-1)	unprognostic (5.41e-2)	unprognostic (2.56e-1)	unprognostic (1.96e-2)	unprognostic (2.86e-1)	unprognostic (1.15e-2)	unprognostic (5.14e-8)	unprognostic (1.32e-1)	unprognostic (1.45e-1)	unprognostic (1.77e-2)	unprognostic (9.80e-3)	Hepatocytes
UGT1A1	GNT1, UGT1, UGT1A	ENSG00000241635	UDP glucuronosyltransferase family 1 member A1	P22309	2	233760270-233773300	Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins	Lipid metabolism	Glycosyltransferase, Transferase	Cancer-related genes, Disease variant	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	26	intestine: 201.2;liver: 322.4	Cell type enriched	Detected in some	6	Hepatocytes: 94.7	Cancer enriched	Detected in some	19	liver cancer: 16.4	Low region specificity	Detected in single			Immune cell enhanced	Detected in single		neutrophil: 1.4	Lineage enriched	Detected in single	4	granulocytes: 1.4	Cancer enhanced	Detected in many		liver cancer: 48.8	Colon - Colon enterocytes, Kidney - Proximal tubular cells, Liver - Hepatocytes, Lung - Respiratory ciliated cells, Skin - Keratinocyte (other), Stomach - Gastric mucous cells	Not detected	Not detected																	Cluster 33: Neutrophils - Chromatin organization	Cluster 41: Intestine & Liver - Lipid metabolism	Cluster 61: Liver - Metabolism	Cluster 13: Hepatocytes - Oxidoreductase activity						unprognostic (7.28e-2)			unprognostic (2.49e-2)	unprognostic (3.60e-1)	unprognostic (5.69e-2)			unprognostic (4.17e-3)	unprognostic (6.31e-3)	unprognostic (1.94e-5)	unprognostic (2.78e-3)			unprognostic (2.99e-4)	Hepatocytes
UGT1A4	HUG-BR2, UGT1D	ENSG00000244474	UDP glucuronosyltransferase family 1 member A4	P22310	2	233718736-233773300	Cancer-related genes, Enzymes, Metabolic proteins, Predicted membrane proteins	Lipid metabolism	Glycosyltransferase, Transferase	Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	68	liver: 391.7	Cell type enriched	Detected in some	14	Hepatocytes: 17.6	Cancer enriched	Detected in single	487	liver cancer: 24.3	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Liver - Hepatocytes																				Cluster 60: Liver - Hemostasis & Lipid metabolism	Cluster 2: DU4475 - Unknown function	Cluster 13: Hepatocytes - Oxidoreductase activity										unprognostic (9.89e-3)						unprognostic (6.77e-5)	unprognostic (2.59e-1)			unprognostic (3.50e-3)	Hepatocytes
CYP2A6	CPA6, CYP2A, CYP2A3	ENSG00000255974	Cytochrome P450 family 2 subfamily A member 6	P11509	19	40843541-40850447	Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins	Lipid metabolism	Monooxygenase, Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	171	liver: 1612.0	Cell type enriched	Detected in some	30	Hepatocytes: 162.7	Cancer enriched	Detected in some	12	liver cancer: 281.2	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Liver - Hepatocytes, Lung - Respiratory ciliated cells									HPA046713, HPA047262	Supported				Intracellular and membrane						Cluster 60: Liver - Hemostasis & Lipid metabolism	Cluster 65: Breast cancer - Unknown function	Cluster 13: Hepatocytes - Oxidoreductase activity			HPA046713: AB_2679767, HPA047262: AB_2680005	unprognostic (5.40e-2)	unprognostic (2.36e-2)	unprognostic (1.21e-1)	unprognostic (4.10e-1)	unprognostic (5.05e-2)	unprognostic (2.64e-2)	prognostic favorable (5.38e-5)	unprognostic (4.98e-3)	unprognostic (4.86e-2)	unprognostic (6.23e-2)	unprognostic (5.20e-2)	unprognostic (1.95e-1)	unprognostic (2.25e-2)	unprognostic (8.83e-3)	unprognostic (2.46e-1)	unprognostic (3.07e-2)	unprognostic (2.55e-1)	Hepatocytes
AKR1C8P	AKR1CL1	ENSG00000264006	Aldo-keto reductase family 1 member C8, pseudogene	Q5T2L2	10	5154140-5185187	Predicted intracellular proteins		Oxidoreductase		Evidence at transcript level	Evidence at transcript level			Group enriched	Detected in some	10	choroid plexus: 3.3;epididymis: 3.4;liver: 8.1	Cell type enriched	Detected in single	6	Hepatocytes: 6.1	Cancer enriched	Detected in single	9	liver cancer: 0.8	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Liver - Hepatocytes																					Cluster 11: Lymphoma - Adaptive immune response	Cluster 13: Hepatocytes - Oxidoreductase activity				unprognostic (3.47e-1)	unprognostic (2.14e-1)	unprognostic (4.76e-1)			unprognostic (4.20e-2)	unprognostic (3.69e-1)	unprognostic (3.07e-1)		unprognostic (1.10e-1)	unprognostic (1.92e-2)		unprognostic (2.66e-2)	unprognostic (6.28e-3)				Hepatocytes
APOC4		ENSG00000267467	Apolipoprotein C4	P55056	19	44942237-44945496	Plasma proteins, Predicted secreted proteins	Lipid transport, Transport			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	208	liver: 629.1	Cell type enriched	Detected in single	40	Hepatocytes: 15.4	Cancer enriched	Detected in single	15	liver cancer: 0.7	Region enhanced	Detected in single		white matter: 3.0	Immune cell enhanced	Detected in single		neutrophil: 1.0	Low lineage specificity	Detected in single			Not detected	Not detected			Liver - Hepatocytes	Not detected	Not detected							HPA062671	Approved				Secreted to blood			1000000000	980000000	Cluster 6: Non-specific - Transcription	Cluster 60: Liver - Hemostasis & Lipid metabolism	Cluster 16: Skin cancer - Melanocyte processes	Cluster 13: Hepatocytes - Oxidoreductase activity			HPA062671: AB_2684828							unprognostic (1.82e-3)											Hepatocytes
CCL16	CKb12, HCC-4, LCC-1, LEC, LMC, Mtn-1, NCC-4, SCYA16, SCYL4	ENSG00000275152	C-C motif chemokine ligand 16	O15467	17	35976493-35981497	Cancer-related genes, Plasma proteins, Predicted secreted proteins	Chemotaxis, Inflammatory response	Cytokine	Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	46	liver: 120.3	Cell type enriched	Detected in some	71	Hepatocytes: 275.7	Cancer enriched	Detected in single	154	liver cancer: 49.0	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Liver - Hepatocytes					Low region specificity	Detected in some								Secreted to blood			2780000	23000000		Cluster 62: Liver - Hemostasis	Cluster 35: Liver cancer - Metabolism	Cluster 13: Hepatocytes - Oxidoreductase activity				unprognostic (3.85e-1)	unprognostic (4.71e-1)	unprognostic (1.49e-1)	unprognostic (3.75e-2)		unprognostic (2.72e-1)	unprognostic (4.58e-2)	unprognostic (2.80e-1)	unprognostic (1.09e-1)	unprognostic (1.54e-1)	unprognostic (1.91e-2)	unprognostic (3.57e-1)	unprognostic (1.40e-3)	unprognostic (1.66e-2)	unprognostic (2.32e-1)	unprognostic (1.09e-1)	unprognostic (4.08e-2)	Hepatocytes
